# FEMSTATE™ FORMULATION Source: https://femstate.me/docs/femstate-formulation.md · Updated: 2026-09-10 --- **FEMSTATE™ FORMULATION** | The nutrients you need when you needed | RESET | LIFT | SHINE | SOOTHE | | --- | --- | --- | --- | --- | | Vitamin A (as Beta-Carotene) | 900mcg RAE /100% | 900mcg RAE /100% | 900mcg /100% | 900mcg /100% | | Vitamin C (Ascorbic Acid) | 250mg / 278% | | 500mg / 556% | | | Vitamin D (as Cholecalciferol) | 25 mcg / 125% | 25 mcg / 125% | 25 mcg / 125% | 25 mcg / 125% | | Vitamin E (as D-Alpha Tocopheryl Succinate) | 15mg / 100% | 15mg / 100% | 35mg / 233% | 15mg / 100% | | Thiamin (as Thiamin HCI) | 5mg / 417% | 5mg / 417% | | | | Riboflavin | 5mg / 385% | 5mg / 385% | | | | Niacin | 5mg NE / 31% | 5mg NE / 31% | | | | Niacin (as Niacinamide) | | | | 100mg / 625% | | Folate (as L-5-Methylterahydrofolate Calcium) | 340mcg DFE / 85% | 340mcg DFE / 85% | | | | Vitamin B12 (as Methylcobalamin) | 150mcg / 6250% | 150mcg / 6250% | | | | Vitamin B6 (as Pyridoxal-5-Phosphate) | 25mg / 1471% | | | 25mg / 1471% | | Pantothenic Acic (as Calcium-D-Pantothenate) | 5mg / 100% | 5mg / 100% | | | | Sour Cherry Fruit Extract | 300mg | | | | | Ginger Root Extract | 250mg | | | | | Ceramides (as CeraLOK™ Rice Bran Extract) | 0.6mg | | | | | Magnesium (as Magnesium Glycinate) | 250mg / 60% | | | 200mg / 48% | | Iron (as Ferrous Bisglycinate Chelate) (Ferrochel®) | 18mg / 100% | | | | | Magnesium (as Magnesium Bysglycinate) | | 200mg / 48% | | | | Zinc (as Zinc Picolinate) | 10mg / 91% | 10mg / 91% | | | | Selenium (as L-Selenomethionine) | 55mcg / 100% | 55mcg / 100% | 55mcg / 100% | 55mcg / 100% | | Chromium (as Chromiu Picolinate) | 35mcg / 100% | 35mcg / 100% | 35mcg / 100% | 35mcg / 100% | | Potasium (as Potassium Citrate) | | | | 200mg / 4% | | Sodium | | 15mg / 1% | 10mg ◁ 1% | | | Quercetin (as Quercetin Dihydrate) | | | 250mg | | | Resveratrol (from Japanese Knotweed Root Extract) | | | 100mg | | | Prebiotic and Probiotic Blend | | | 10mg (3Bill CFU) | | | Astaxamin | | | 6mg | | | Inulin | | | | 3g | | L-Theanine | | | | 200mg | | L-Tryptophan | | | | 150mg | | Coenzime Q10 | | | 100mg | | | Gamma-Aminobutyric (GABA) | | | | 150mg | | Chamomile Flower Extract | | | | 150mg | | Saffron Bulb Extract | | | | 30mg | | Myo-Inositol | | 1g | | | | Hyaluronic Acid (from Sodium Hyaluronate) | | 120mg | | | | Broccoli Sprout Extract | 10mg | 10mg | | | | Vitamin K (as Menaquinone-7) | 90mcg | 90mcg | 90mcg | 90mcg | ### Core Vitamins - Vitamin C - Vitamin D3 - Vitamin K2 - Vitamin E - Vitamin A - B6 - B12 - Folate - Pantothenic Acid - Thiamin - Riboflavin - Niacin ### Minerals - Magnesium Glycinate - Magnesium Bisglycinate - Iron (Ferrochel®) - Zinc - Selenium - Chromium - Potassium - Sodium ### Amino Acids & Neuroactives - L-Theanine - L-Tryptophan - GABA - Myo-Inositol ### Botanicals - Ginger - Tart Cherry - Broccoli Sprout Extract (Sulforaphane source) - Chamomile - Saffron - Resveratrol - Quercetin ### Structural & Metabolic Ingredients - CoQ10 - Hyaluronic Acid - Astaxanthin - Ceramides - Inulin - Probiotic Blend # Ingredient Scientific Monograph # Vitamin C (Ascorbic Acid) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Vitamin C **Chemical Name:** L-Ascorbic Acid **Ingredient Form:** Ascorbic Acid **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 250 mg | | LIFT™ | - | | SHINE™ | 500 mg | | SOOTHE™ | - | Vitamin C is incorporated into RESET™ and SHINE™ because both physiological phases involve active connective tissue remodeling, extracellular matrix turnover, angiogenesis, antioxidant regulation, and increased cellular metabolism. Rather than serving as a general immune-support ingredient, vitamin C was selected because of its established physiological roles in collagen biosynthesis, iron metabolism, tissue repair, and maintenance of endogenous antioxidant systems. # 2. Physiological Role Vitamin C is a water-soluble vitamin that functions as an **essential enzymatic cofactor, antioxidant, and regulator of connective tissue biology. **Humans cannot synthesize vitamin C because of the absence of **L-gulonolactone oxidase**; therefore, adequate intake depends entirely upon dietary or supplemental sources.(1-3) Vitamin C participates in numerous physiological processes including: - Collagen synthesis - Extracellular matrix remodeling - Angiogenesis - Wound healing - Iron absorption - Antioxidant defense - Immune regulation - Catecholamine synthesis - Mitochondrial redox homeostasis These biological functions become particularly relevant during menstrual tissue repair (RESET™) and ovulatory tissue remodeling (SHINE™). # 3. Mechanism of Action Vitamin C exerts multiple complementary biological actions. ### Collagen Synthesis Vitamin C serves as an obligate cofactor for: - Prolyl hydroxylase - Lysyl hydroxylase These enzymes stabilize collagen molecules through hydroxylation of proline and lysine residues. Adequate vitamin C is therefore essential for: - connective tissue integrity - extracellular matrix formation - angiogenesis - wound repair ### Iron Absorption Vitamin C enhances intestinal absorption of **non-heme iron** by reducing ferric iron (Fe³⁺) to the more absorbable ferrous form (Fe²⁺). This mechanism is particularly relevant during the menstrual phase when physiological iron loss occurs. ### Antioxidant Physiology Vitamin C functions as a potent water-soluble antioxidant. It contributes to: - scavenging reactive oxygen species - regeneration of oxidized vitamin E - maintenance of endogenous antioxidant systems - preservation of physiological redox balance Importantly, vitamin C supports **normal oxidative balance** without suppressing physiological oxidative signaling required for tissue remodeling. ### Immune Physiology Vitamin C contributes to normal immune function by supporting: - neutrophil migration - macrophage function - lymphocyte physiology - cytokine regulation Its role is best described as maintenance of **normal immune physiology**, not immune stimulation. # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase emphasizes: - tissue regeneration - connective tissue remodeling - angiogenesis - restoration of iron homeostasis - controlled inflammatory repair Vitamin C supports these physiological processes through collagen synthesis, antioxidant regulation, and enhancement of dietary iron absorption. ## SHINE™ Ovulation represents one of the most metabolically active transitions of the menstrual cycle. Physiological priorities include: - extracellular matrix remodeling - angiogenesis - ovarian tissue repair - endogenous antioxidant regulation - mitochondrial metabolism The higher vitamin C dose in SHINE™ supports these coordinated biological processes during physiological ovulatory remodeling. # 5. Dose Justification ## RESET™ ### Selected Dose: 250 mg ### Scientific Rationale The selected dose was chosen because it: - supports collagen synthesis - enhances non-heme iron absorption - contributes to endogenous antioxidant physiology - supports connective tissue remodeling - remains well within established safety limits Randomized controlled trials have consistently demonstrated physiological activity within the **200-500 mg/day** range for collagen synthesis and antioxidant support. ## SHINE™ ### Selected Dose: 500 mg ### Scientific Rationale The ovulatory phase is associated with increased physiological oxidative metabolism and extracellular matrix remodeling. The higher dose was selected to: - support endogenous antioxidant defenses - participate in collagen remodeling - support vascular physiology - maintain physiological redox balance during ovulation The selected dose remains substantially below the established Tolerable Upper Intake Level while providing robust physiological exposure. # 6. Human Clinical Evidence Vitamin C is among the best-studied micronutrients in nutritional science. Human evidence supports its physiological roles in: - collagen synthesis - connective tissue repair - iron absorption - antioxidant physiology - immune cell function ### Evidence Summary | Outcome | Human Evidence | | --- | --- | | Collagen synthesis | Strong | | Iron absorption | Strong | | Antioxidant physiology | Strong | | Immune regulation | Strong | | Female reproductive physiology | Moderate | # 7. Safety Considerations Vitamin C possesses one of the strongest safety profiles among nutritional ingredients. ### Recommended Dietary Allowance (Women): 75 mg/day ### FEMSTATE Dose RESET™: 250 mg SHINE™: 500 mg ### Tolerable Upper Intake Level 2,000 mg/day The FEMSTATE doses remain substantially below the adult UL. Potential adverse effects associated with excessive intake include: - gastrointestinal discomfort - osmotic diarrhea - increased urinary oxalate in susceptible individuals Neither FEMSTATE dose approaches levels commonly associated with toxicity. # 8. HR+ Safety Review Vitamin C was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for evidence of: - estrogen receptor agonism - progesterone receptor activity - aromatase stimulation - phytoestrogen content - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable oncology safety profile Vitamin C is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions ### Iron (Ferrochel®) Vitamin C significantly improves absorption of non-heme iron -> Strong positive synergy **Vitamin E** Vitamin C regenerates oxidized vitamin E -> Positive antioxidant synergy **Collagen-dependent physiology** Vitamin C is essential for collagen maturation -> Strong connective tissue synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Magnesium - Zinc - Selenium - Chromium - Potassium at the doses used in FEMSTATE™. ### Known Considerations Individuals with hereditary hemochromatosis or other iron overload disorders should consult a healthcare professional before using high-dose vitamin C because of its ability to enhance iron absorption. # 10. Regulatory Status Vitamin C is: - Included in the U.S. Dietary Reference Intakes. - Recognized as an essential nutrient by the National Institutes of Health Office of Dietary Supplements. - Widely accepted for use in dietary supplements. - Included in international nutritional recommendations and clinical guidelines. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin C for: - collagen synthesis - iron absorption - antioxidant physiology - connective tissue biology Areas requiring further investigation include: - Phase-specific vitamin C metabolism across the menstrual cycle. - Whether vitamin C requirements differ according to endocrine phase. - Clinical evaluation of vitamin C within a complete phase-aligned nutritional system such as FEMSTATE™. No randomized controlled trials have specifically evaluated vitamin C as part of a phase-aligned formulation. # 12. Conclusion Vitamin C is a foundational ingredient within the FEMSTATE™ platform because of its established roles in connective tissue biology, collagen synthesis, antioxidant homeostasis, immune physiology, and iron metabolism. Its inclusion in **RESET™ (250 mg)** and **SHINE™ (500 mg)** reflects the changing physiological priorities of these two endocrine environments. The selected doses were derived through a structured framework integrating physiological relevance, human clinical evidence, safety, formulation compatibility, and HR+ considerations. Rather than targeting endocrine regulation directly, vitamin C supports the normal biological processes of tissue regeneration during menstruation and connective tissue remodeling during ovulation, making it a key component of the phase-aligned formulation strategy. ## References - National Institutes of Health Office of Dietary Supplements. Vitamin C Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on vitamin C physiology and human requirements. - Nutrients. Systematic reviews on vitamin C, collagen synthesis, and antioxidant physiology. - Free Radical Biology and Medicine. Reviews on vitamin C and redox biology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on connective tissue remodeling and reproductive physiology. # Ingredient Scientific Monograph # Vitamin D3 (Cholecalciferol) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Vitamin D3 **Chemical Name:** Cholecalciferol **Ingredient Form:** Vitamin D3 (Cholecalciferol) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 25 mcg (1,000 IU) | | LIFT™ | 25 mcg (1,000 IU) | | SHINE™ | 25 mcg (1,000 IU) | | SOOTHE™ | 25 mcg (1,000 IU) | Vitamin D3 is included in all four formulations because its physiological functions support multiple biological systems throughout the menstrual cycle rather than one specific endocrine phase. # 2. Physiological Role Vitamin D is a fat-soluble secosteroid hormone precursor that regulates calcium and phosphate homeostasis while also influencing immune physiology, skeletal remodeling, muscle function, cellular differentiation, mitochondrial function, and gene transcription. After cutaneous synthesis or dietary intake, vitamin D3 is converted in the liver to **25-hydroxyvitamin D [25(OH)D],** then in the kidney and selected peripheral tissues to its biologically active form, **1,25-dihydroxyvitamin D (calcitriol).**(1-4) Vitamin D receptors (VDRs) are expressed in: - Bone - Skeletal muscle - Immune cells - Brain - Cardiovascular tissue - Skin - Gastrointestinal tract - Ovaries - Endometrium This widespread receptor distribution explains why vitamin D contributes to systemic physiology throughout the menstrual cycle rather than exhibiting phase-specific actions. # 3. Mechanism of Action Vitamin D acts primarily through the **vitamin D receptor (VDR)**, a nuclear transcription factor regulating the expression of hundreds of genes involved in cellular function. Its principal mechanisms include: ### Bone and Calcium Homeostasis Vitamin D promotes: - intestinal calcium absorption - phosphate absorption - bone mineralization - normal skeletal remodeling ### Immune Regulation Vitamin D contributes to: - regulation of innate immunity - adaptive immune function - cytokine balance - maintenance of immune homeostasis Importantly, vitamin D supports **immune regulation**, not generalized immune stimulation. ### Muscle Function Vitamin D supports: - skeletal muscle physiology - neuromuscular function - muscle protein metabolism ### Cellular Physiology Vitamin D influences: - cell differentiation - gene regulation - mitochondrial function - oxidative balance - cellular homeostasis # 4. Why Included in FEMSTATE™ Unlike many ingredients that are phase-specific, vitamin D supports physiological processes active throughout the menstrual cycle. ### RESET™ Supports: - immune homeostasis - tissue repair - maintenance of calcium physiology ### LIFT™ Supports: - skeletal physiology - connective tissue biology - mitochondrial function - cellular proliferation ### SHINE™ Supports: - immune regulation - cellular homeostasis - maintenance of musculoskeletal physiology ### SOOTHE™ Supports: - bone remodeling - neuromuscular physiology - immune balance - metabolic stability For this reason, vitamin D is maintained at the same dose across all four formulations, providing a stable nutritional foundation while phase-specific ingredients address changing physiological priorities. # 5. Dose Justification ## Selected Dose: 25 mcg (1,000 IU) The selected dose was based on five scientific criteria: ### Physiological Relevance A daily dose of **25 mcg (1,000 IU)** supports maintenance of vitamin D status in many healthy adults and provides physiological support for skeletal, muscular, immune, and metabolic functions. ### 6. Human Clinical Evidence Clinical trials evaluating vitamin D have commonly used doses between **10 and 50 mcg/day (400–2,000 IU/day)**, with approximately **20–25 mcg/day (800-1,000 IU)** representing one of the most frequently studied maintenance ranges. Vitamin D is among the most extensively studied nutrients in medicine. Human evidence supports physiological roles in: - bone health - calcium homeostasis - skeletal muscle function - immune regulation - maintenance of normal vitamin D status The strongest evidence exists for skeletal physiology and correction of vitamin D deficiency. Evidence supporting broader systemic outcomes is more variable and depends on baseline vitamin D status, dose, and population studied. Recent clinical guidelines emphasize meeting recommended intakes rather than routine high-dose supplementation for healthy adults. ### 7. Safety Considerations The selected dose is well below the adult **Tolerable Upper Intake Level (UL)** of **100 mcg/day (4,000 IU)** established by the National Institutes of Health Office of Dietary Supplements. Vitamin D has an excellent safety profile at the dose used in FEMSTATE™. Recommended Dietary Allowance (Adults): 15 mcg (600 IU) ### FEMSTATE Dose: 25 mcg (1,000 IU) The FEMSTATE dose is **25% of the adult UL**. Potential adverse effects of excessive long-term intake include: - hypercalcemia - nephrolithiasis in susceptible individuals - soft tissue calcification - vitamin D toxicity (rare and typically associated with intakes far exceeding FEMSTATE levels) ### Formulation Compatibility Using the same dose across RESET™, LIFT™, SHINE™, and SOOTHE™: - simplifies daily intake - maintains nutritional consistency - supports long-term compliance - complements phase-specific ingredients without unnecessarily increasing total capsule burden ### 8. HR+ Safety Review Vitamin D was selected because of its favorable endocrine safety profile and its physiological importance across multiple organ systems without direct estrogenic or progesterone receptor activity. Vitamin D3 was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor agonism - progesterone receptor agonism - aromatase stimulation - phytoestrogen activity - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor agonist activity ✔ No phytoestrogen properties ✔ No aromatase stimulation ✔ Favorable safety profile within nutritional dosing ranges Vitamin D is considered compatible with the HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions ### Vitamin K2 Supports coordinated calcium utilization and skeletal physiology -> Strong positive synergy **Magnesium** Required for activation and metabolism of vitamin D -> Strong physiological synergy **Calcium (dietary)** Vitamin D enhances intestinal calcium absorption -> Strong physiological synergy ### Neutral Interactions - Vitamin C - Zinc - Selenium - Chromium - CoQ10 No clinically meaningful antagonistic interactions at FEMSTATE doses. ### Known Considerations Individuals using medications affecting vitamin D metabolism or those with disorders causing hypercalcemia should consult their healthcare provider before supplementation. # 10. Regulatory Status Vitamin D3 is: - Widely recognized for use in dietary supplements. - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Addressed in recent Endocrine Society Clinical Practice Guidelines on vitamin D supplementation. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin D for maintenance of skeletal health and correction of deficiency. Areas requiring additional investigation include: - Phase-specific vitamin D physiology across the menstrual cycle. - Whether maintaining vitamin D sufficiency differentially influences distinct endocrine environments. - The role of vitamin D within a comprehensive phase-aligned nutritional system such as FEMSTATE™. No randomized controlled trials have specifically evaluated vitamin D as part of a phase-aligned formulation. # 12. Conclusion Vitamin D3 is a **foundational nutrient **within the FEMSTATE™ platform rather than a phase-specific ingredient. Its inclusion at **25 mcg (1,000 IU)** across **RESET™, LIFT™, SHINE™, and SOOTHE™** reflects its established roles in bone remodeling, calcium homeostasis, immune regulation, muscle physiology, and cellular health. The selected dose was chosen using a structured framework integrating physiological relevance, human clinical evidence, safety, formulation compatibility, and HR+ considerations. Maintaining a consistent vitamin D intake across all four formulations provides a stable nutritional foundation while allowing the phase-specific ingredients to address the changing biological priorities generated by the menstrual cycle. ## References - Williams Textbook of Endocrinology. - National Institutes of Health Office of Dietary Supplements. Vitamin D Fact Sheet for Health Professionals. - Endocrine Society. Clinical Practice Guideline: Vitamin D for the Prevention of Disease. - Guyton and Hall Textbook of Medical Physiology. - Yen and Jaffe's Reproductive Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on vitamin D physiology and women's health. # Ingredient Scientific Monograph # Vitamin K2 (Menaquinone-7, MK-7) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Vitamin K2 **Chemical Name:** Menaquinone-7 (MK-7) **Ingredient Form:** Vitamin K2 (Menaquinone-7) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 90 mcg | | LIFT™ | 90 mcg | | SHINE™ | 90 mcg | | SOOTHE™ | 90 mcg | Vitamin K2 is included in all four FEMSTATE™ formulations because of its fundamental role in **calcium homeostasis, skeletal physiology, connective tissue biology, and vascular health**. Unlike phase-specific ingredients, vitamin K2 provides a stable physiological foundation that supports long-term tissue maintenance throughout the menstrual cycle. # 2. Physiological Role Vitamin K2 is a fat-soluble vitamin that functions as an essential cofactor for the enzyme **γ-glutamyl carboxylase**, which activates vitamin K-dependent proteins involved in calcium regulation, bone remodeling, vascular physiology, and connective tissue biology. Unlike vitamin K1, which is primarily involved in hepatic blood coagulation, vitamin K2 (MK-7) has a longer half-life and preferentially supports extrahepatic tissues such as bone, blood vessels, and connective tissue.(1-4) Vitamin K-dependent proteins include: - Osteocalcin - Matrix Gla Protein (MGP) - Growth Arrest-Specific Protein 6 (Gas6) Through activation of these proteins, vitamin K2 contributes to: - Bone mineralization - Calcium homeostasis - Vascular integrity - Connective tissue maintenance - Normal cellular physiology These biological functions remain important throughout every phase of the menstrual cycle. # 3. Mechanism of Action Vitamin K2 exerts its physiological effects by activating vitamin K-dependent proteins through y-carboxylation. ### Bone Remodeling Vitamin K2 activates **osteocalcin**, enabling: - calcium incorporation into bone matrix - bone mineralization - maintenance of skeletal integrity ### Vascular Physiology Vitamin K2 activates **Matrix Gla Protein (MGP),** which contributes to: - regulation of vascular calcium deposition - maintenance of vascular tissue integrity - physiological cardiovascular function ### Calcium Homeostasis Vitamin K2 helps regulate the physiological distribution of calcium by supporting its incorporation into mineralized tissues rather than soft tissues. ### Connective Tissue Emerging evidence suggests vitamin K-dependent proteins also participate in: - extracellular matrix biology - cartilage physiology - connective tissue maintenance Although these mechanisms continue to be investigated, they support the inclusion of vitamin K2 within a systems physiology framework. # 4. Why Included in FEMSTATE™ Vitamin K2 is maintained at a constant dose across all four formulations because its physiological functions support long-term tissue maintenance rather than phase-specific endocrine transitions. ### RESET™ Supports: - connective tissue regeneration - bone remodeling - maintenance of calcium physiology during tissue repair ### LIFT™ Supports: - connective tissue synthesis - extracellular matrix maintenance - skeletal physiology during anabolic growth ### SHINE™ Supports: - connective tissue integrity - vascular physiology - extracellular matrix maintenance during ovulatory remodeling ### SOOTHE™ Supports: - bone remodeling - connective tissue maintenance - long-term calcium homeostasis during physiological stabilization # 5. Dose Justification ## Selected Dose: 90 mcg The selected dose was based upon five scientific criteria. ### Physiological Relevance A daily intake of **90 mcg MK-7** has been shown to effectively support activation of vitamin K-dependent proteins involved in bone and vascular physiology. # 6. Human Clinical Evidence Human intervention studies consistently demonstrate improved activation of vitamin K-dependent proteins with MK-7 supplementation. Multiple human studies evaluating MK-7 have used doses ranging from **45–180 mcg/day**, with **90 mcg/day** representing one of the most frequently studied maintenance doses for extrahepatic vitamin K function.(2-5) Vitamin K2 has been investigated extensively in relation to: - bone health - calcium metabolism - vascular physiology - activation of osteocalcin and Matrix Gla Protein ### Safety Vitamin K2 demonstrates an excellent safety profile with no established tolerable upper intake level in healthy adults. ### Formulation Compatibility Using the same dose throughout all four formulations: - simplifies daily use - maintains consistent nutritional support - complements vitamin D3 and magnesium - supports long-term skeletal physiology # 7. Safety Considerations Vitamin K2 possesses an excellent safety profile. Adequate Intake (Women): 90 mcg/day ### FEMSTATE Dose: 90 mcg/day ### Tolerable Upper Intake Level. No UL has been established for vitamin K because adverse effects have not been identified in healthy individuals at nutritional doses.² Potential consideration: Vitamin K may interact with **vitamin K antagonist anticoagulants** (e.g., Warfarin), and individuals taking these medications should consult their healthcare provider before supplementation. # 8. HR+ Safety Review Vitamin K2 demonstrates no known estrogenic or progesterone receptor activity and aligns well with the HR+-conscious formulation philosophy. Vitamin K2 was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - phytoestrogen properties - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonism ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Vitamin K2 is considered fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin D3** Vitamin D promotes synthesis of osteocalcin. Vitamin K2 activates osteocalcin -> Strong physiological synergy **Magnesium** Magnesium supports vitamin D metabolism, indirectly complementing vitamin K2-dependent calcium regulation -> Positive synergy **Calcium (dietary)** Vitamin K2 supports physiological utilization of absorbed calcium -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Zinc - Selenium - Chromium - CoQ10 at FEMSTATE doses. ### Known Considerations Individuals taking vitamin K antagonist anticoagulants require medical supervision before initiating vitamin K supplementation. # 10. Regulatory Status Vitamin K2 (MK-7) is: - Widely used in dietary supplements. - Recognized as a dietary ingredient in multiple international markets. - Included in dietary reference recommendations for vitamin K. - Supported by numerous clinical investigations evaluating bone and vascular physiology. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin K2 for: - activation of osteocalcin - calcium homeostasis - bone physiology - vascular biology Areas requiring further investigation include: - Phase-specific vitamin K physiology across the menstrual cycle. - Connective tissue remodeling during reproductive physiology. - Evaluation of vitamin K2 within a comprehensive phase-aligned nutritional system. No randomized controlled trials have specifically evaluated vitamin K2 within a phase-aligned formulation such as FEMSTATE™. # 12. Conclusion Vitamin K2 (MK-7) is a foundational nutrient within the FEMSTATE™ platform because of its established roles in calcium homeostasis, skeletal remodeling, connective tissue biology, and vascular physiology. The selected dose of **90 mcg/day** is supported by human clinical evidence, aligns with established nutritional recommendations, and complements vitamin D3 and magnesium within the formulation architecture. Its inclusion across all four FEMSTATE™ formulations reflects its continuous physiological importance rather than phase-specific endocrine changes. The dose was selected using a structured framework integrating biological plausibility, human clinical evidence, safety, formulation compatibility, and HR+ considerations, providing a stable nutritional foundation that supports long-term tissue integrity throughout the menstrual cycle. ## References - Williams Textbook of Endocrinology. - National Institutes of Health Office of Dietary Supplements. Vitamin K Fact Sheet for Health Professionals. - Osteoporosis International. Reviews on vitamin K2 and bone health. - Nutrients. Systematic reviews on menaquinone-7, osteocalcin activation, and calcium physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on vitamin K-dependent proteins and skeletal physiology. - Endocrine Reviews. Reviews on calcium homeostasis and endocrine regulation. # Ingredient Scientific Monograph # Vitamin E (D-Alpha Tocopheryl Succinate) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Vitamin E **Chemical Name:** D-Alpha Tocopheryl Succinate **Ingredient Form:** Natural Vitamin E (D-Alpha Tocopheryl Succinate) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 15 mg | | LIFT™ | 15 mg | | SHINE™ | 35 mg | | SOOTHE™ | 15 mg | Vitamin E is incorporated into all four formulations because of its role as a **lipid-soluble antioxidant** that protects cellular membranes from oxidative damage. The higher dose in **SHINE™** reflects the increased physiological oxidative metabolism and membrane remodeling associated with ovulation. # 2. Physiological Role Vitamin E is the principal fat-soluble antioxidant in human physiology. It protects polyunsaturated fatty acids within cell membranes from lipid peroxidation and contributes to maintenance of membrane integrity throughout the body. Vitamin E also participates in immune regulation, vascular biology, mitochondrial function, skeletal muscle physiology, and cellular signaling.(1-4) Vitamin E is distributed throughout numerous tissues including: - Brain - Skeletal muscle - Liver - Skin - Cardiovascular system - Immune cells - Reproductive tissues Its primary physiological role is preservation of **cell membrane integrity** under conditions of normal oxidative metabolism. # 3. Mechanism of Action Vitamin E exerts its physiological actions primarily through antioxidant protection of lipid membranes. ### Membrane Protection Vitamin E resides within phospholipid membranes where it: - scavenges lipid peroxyl radicals - interrupts lipid peroxidation chain reactions - preserves membrane fluidity - maintains cellular integrity ### Antioxidant Network Vitamin E functions together with: - Vitamin C - Glutathione - Superoxide dismutase - Catalase Vitamin C regenerates oxidized vitamin E, allowing continued antioxidant activity. ### Immune Physiology Vitamin E contributes to: - maintenance of immune cell membrane integrity - normal lymphocyte physiology - regulation of oxidative signaling ### Vascular Physiology Vitamin E supports: - endothelial membrane stability - protection of lipoproteins from oxidation - maintenance of normal vascular physiology # 4. Why Included in FEMSTATE™ Vitamin E supports cellular physiology throughout the menstrual cycle, with greatest physiological relevance during periods of increased oxidative metabolism. ### RESET™ Supports: - antioxidant homeostasis - tissue regeneration - membrane protection during endometrial repair ### LIFT™ Supports: - mitochondrial physiology - connective tissue growth - protection of proliferating cells ### SHINE™ Supports: - physiological oxidative balance during ovulation - membrane integrity - extracellular matrix remodeling - vascular physiology For this reason, SHINE™ contains a higher dose. ### SOOTHE™ Supports: - maintenance of cellular membranes - neurophysiology - immune homeostasis - long-term tissue stability # 5. Dose Justification ## Selected Dose: 15 mg RESET™, LIFT™ & SOOTHE™ ### Scientific Rationale The selected dose: - corresponds to the adult Recommended Dietary Allowance - supports normal antioxidant physiology - maintains membrane integrity - complements vitamin C and selenium - provides foundational antioxidant support ## Selected Dose: 35 mg SHINE™ ### Scientific Rationale Ovulation is associated with: - localized oxidative metabolism - extracellular matrix remodeling - angiogenesis - increased mitochondrial respiration The increased dose was selected to: - support endogenous antioxidant systems - protect membrane lipids - maintain physiological redox balance - complement vitamin C, astaxanthin, CoQ10, quercetin, and resveratrol The dose remains substantially below the established Tolerable Upper Intake Level while providing enhanced physiological support during this metabolically active phase. # 6. Human Clinical Evidence Vitamin E has been extensively investigated in human nutrition. The strongest evidence supports its physiological roles in: - membrane protection - antioxidant physiology - immune function - maintenance of vitamin E status Evidence for broader clinical outcomes varies depending on study population and baseline nutritional status. # 7. Safety Considerations Vitamin E has an excellent safety profile at FEMSTATE™ doses. ### Recommended Dietary Allowance (Women): 15 mg/day ### FEMSTATE Doses = RESET™: 15 mg / LIFT™”:15 mg / SHINE™: 35 mg / SOOTHE™: 15 mg ### Tolerable Upper Intake Level: 1,000 mg/day (1,500 IU natural vitamin E).(2) All FEMSTATE doses remain far below the UL. Potential considerations at excessive doses include: - increased bleeding risk - interaction with anticoagulants - gastrointestinal discomfort (rare) These concerns are associated with doses substantially higher than those used in FEMSTATE™. # 8. HR+ Safety Review Vitamin E was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - phytoestrogen properties - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable oncology safety profile at nutritional doses Vitamin E is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin C** Vitamin C regenerates oxidized vitamin E -> Strong antioxidant synergy **Selenium** Supports glutathione peroxidase activity, complementing vitamin E within endogenous antioxidant systems. -> Positive synergy **Astaxanthin** Works together to support lipid membrane protection during SHINE™ -> Positive synergy **CoQ10** Supports mitochondrial antioxidant physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Magnesium - Zinc - Vitamin D - Vitamin K2 at FEMSTATE doses. ### Known Considerations Individuals using anticoagulant therapy or with bleeding disorders should consult their healthcare provider before taking high-dose vitamin E supplements. The doses included in FEMSTATE™ remain within nutritional ranges. # 10. Regulatory Status Vitamin E is: - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Widely accepted for use in dietary supplements. - Included in international nutritional recommendations. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin E for: - antioxidant physiology - membrane protection - maintenance of vitamin E status Areas requiring further investigation include: - Phase-specific vitamin E requirements across the menstrual cycle. - Lipid antioxidant physiology during ovulation. - Evaluation of vitamin E within comprehensive phase-aligned nutritional systems. No randomized controlled trials have specifically evaluated vitamin E within a phase-aligned formulation such as FEMSTATE™. # 12. Conclusion Vitamin E is a foundational antioxidant within the FEMSTATE™ platform because of its established roles in membrane protection, antioxidant physiology, immune regulation, and cellular homeostasis. The inclusion of **15 mg** in **RESET™, LIFT™,** and **SOOTHE™** provides consistent physiological support throughout the menstrual cycle, while the increased dose of **35 mg** in **SHINE™** reflects the greater oxidative metabolism and membrane remodeling associated with ovulation. The selected doses were determined through a structured framework integrating biological plausibility, human clinical evidence, safety, formulation compatibility, and HR+ considerations. Rather than functioning as a general antioxidant supplement, vitamin E was incorporated to support the changing physiological environments generated by the HPO axis, particularly the increased lipid membrane protection required during the ovulatory transition. ## References - National Institutes of Health Office of Dietary Supplements. Vitamin E Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on vitamin E physiology and antioxidant biology. - Free Radical Biology and Medicine. Reviews on lipid peroxidation, membrane biology, and vitamin E. - Nutrients. Systematic reviews on vitamin E supplementation and human physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on oxidative physiology and women's health. # Ingredient Scientific Monograph # Vitamin A (as Beta-Carotene) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Vitamin A **Chemical Name:** Provitamin A (Beta-Carotene) **Ingredient Form:** Natural Beta-Carotene **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 900 mcg RAE | | LIFT™ | 900 mcg RAE | | SHINE™ | 900 mcg RAE | | SOOTHE™ | 900 mcg RAE | Vitamin A is included in all four FEMSTATE™ formulations as **beta-carotene**, the principal provitamin A carotenoid. Beta-carotene was intentionally selected instead of preformed retinol because it provides physiological vitamin A activity while maintaining a wider margin of safety for long-term daily supplementation. Vitamin A supports epithelial integrity, immune physiology, vision, cellular differentiation, and reproductive tissue maintenance throughout the menstrual cycle. # 2. Physiological Role Vitamin A is an essential fat-soluble nutrient involved in the regulation of cellular growth, differentiation, epithelial maintenance, immune homeostasis, vision, and reproductive physiology. Following intestinal absorption, beta-carotene is converted enzymatically into retinal and retinoic acid according to physiological need, allowing endogenous regulation of vitamin A production.(1-4) Vitamin A receptors (retinoic acid receptors [RAR] and retinoid X receptors [RXR]) regulate the expression of hundreds of genes involved in: - epithelial regeneration - immune regulation - cellular differentiation - embryonic development - skin physiology - reproductive tissue maintenance - vision - mucosal integrity These biological functions remain important throughout all phases of the menstrual cycle. # 3. Mechanism of Action Vitamin A functions primarily through regulation of gene transcription. ### Cellular Differentiation Retinoic acid binds to nuclear receptors (RAR/RXR), regulating genes responsible for: - epithelial maturation - tissue differentiation - cellular development - extracellular matrix organization ### Epithelial Integrity Vitamin A supports maintenance of: - skin - gastrointestinal epithelium - reproductive tract epithelium - respiratory mucosa Healthy epithelial barriers are essential for normal tissue homeostasis. ### Immune Physiology Vitamin A contributes to: - innate immune regulation - adaptive immune function - maintenance of mucosal immunity - lymphocyte differentiation Importantly, vitamin A regulates normal immune physiology rather than stimulating immune activity indiscriminately. ### Antioxidant Activity Beta-carotene also functions as a carotenoid antioxidant, helping protect cellular membranes against oxidative damage under normal physiological conditions. # 4. Why Included in FEMSTATE™ Vitamin A supports fundamental biological processes active throughout the menstrual cycle. ### RESET™ Supports: - epithelial regeneration - endometrial repair - immune homeostasis - tissue restoration ### LIFT™ Supports: - cellular differentiation - connective tissue growth - epithelial maintenance - anabolic physiology ### SHINE™ Supports: - epithelial integrity - antioxidant physiology - reproductive tissue maintenance ### SOOTHE™ Supports: - tissue maintenance - immune regulation - skin physiology - mucosal integrity Because these physiological functions remain active throughout the menstrual cycle, vitamin A is maintained at a consistent dose across all four formulations. # 5. Dose Justification ## Selected Dose: 900 mcg RAE The selected dose was based on five scientific criteria. ### Physiological Relevance The dose provides the Recommended Dietary Allowance for adult women while supporting normal epithelial physiology, immune regulation, and cellular differentiation. ### Human Clinical Evidence Vitamin A has been extensively studied in relation to: - epithelial biology - immune physiology - reproductive health - vision - skin The selected dose aligns with established nutritional recommendations and supports long-term maintenance of vitamin A status. ### Safety Beta-carotene provides a favorable safety profile because conversion to active vitamin A is physiologically regulated according to need. Unlike preformed retinol, beta-carotene does not readily accumulate to toxic levels under normal conditions. ### Formulation Compatibility The selected dose: - complements vitamin D3 and vitamin K2 - supports immune physiology - supports skin and epithelial biology - fits within long-term daily supplementation ### HR+ Philosophy The provitamin A form (beta-carotene) was selected because of its favorable physiological regulation and safety profile. # 6. Human Clinical Evidence Vitamin A is one of the most extensively studied micronutrients in human physiology. Human evidence strongly supports its role in: - epithelial maintenance - immune regulation - vision - cellular differentiation Evidence specifically evaluating menstrual cycle physiology is more limited. **7. Safety Considerations** Beta-carotene possesses an excellent safety profile when used at nutritional doses. Recommended Dietary Allowance: 900 mcg RAE/day ### FEMSTATE Dose: 900 mcg RAE/day ### Tolerable Upper Intake Level No UL has been established for beta-carotene itself because conversion to vitamin A is physiologically regulated. The UL of **3,000 mcg RAE/day** applies to **preformed vitamin A (retinol)** rather than beta-carotene.² Potential considerations: - High supplemental beta-carotene has been associated with increased lung cancer risk in smokers when administered at pharmacological doses substantially exceeding nutritional intake. The FEMSTATE dose remains within recommended nutritional ranges. # 8. HR+ Safety Review Beta-carotene was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Beta-carotene is considered fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin E** Both nutrients contribute to maintenance of membrane integrity and antioxidant physiology -> Positive antioxidant synergy **Vitamin C** Vitamin C helps maintain antioxidant network function alongside carotenoids -> Positive synergy **Dietary Fat** Absorption of beta-carotene is enhanced in the presence of dietary fat -> Positive physiological interaction ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Vitamin K2 - Magnesium - Zinc - Selenium at FEMSTATE doses. ### Known Considerations Individuals who smoke or have significant occupational asbestos exposure should avoid high-dose beta-carotene supplementation beyond nutritional recommendations because of evidence from pharmacological-dose intervention studies. The dose used in FEMSTATE remains within normal dietary ranges. # 10. Regulatory Status Vitamin A (beta-carotene) is: - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Widely accepted for use in dietary supplements. - Recommended in international nutritional guidelines. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin A for: - epithelial integrity - immune physiology - cellular differentiation - vision Areas requiring additional investigation include: - Phase-specific vitamin A metabolism across the menstrual cycle. - Reproductive tissue remodeling during different endocrine environments. - Evaluation of beta-carotene within comprehensive phase-aligned nutritional systems. No randomized controlled trials have specifically evaluated vitamin A within a phase-aligned formulation such as FEMSTATE™. # 12. Conclusion Vitamin A, provided as **beta-carotene**, serves as a foundational nutrient within the FEMSTATE™ platform because of its established roles in epithelial integrity, immune regulation, cellular differentiation, connective tissue biology, and reproductive tissue maintenance. The selected dose of **900 mcg RAE** provides the Recommended Dietary Allowance for adult women while maintaining an excellent safety profile through physiologically regulated conversion to active vitamin A. Beta-carotene was intentionally selected over preformed retinol to maximize long-term safety and compatibility with the HR+-conscious formulation philosophy. Its inclusion across all four FEMSTATE™ formulations reflects its continuous importance in maintaining normal cellular function throughout the menstrual cycle rather than supporting a single endocrine phase. ## References - National Institutes of Health Office of Dietary Supplements. Vitamin A and Carotenoids Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on vitamin A physiology and carotenoid metabolism. - Nutrients. Systematic reviews on vitamin A, epithelial biology, and immune function. - Endocrine Reviews. Reviews on retinoid signaling and gene regulation. - The Journal of Clinical Endocrinology & Metabolism. Reviews on vitamin A and reproductive physiology. # Ingredient Scientific Monograph # Vitamin B6 (Pyridoxal-5'-Phosphate, P5P) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Vitamin B6 **Chemical Name:** Pyridoxal-5'-Phosphate (P5P) **Ingredient Form:** Pyridoxal-5'-Phosphate (Active Vitamin B6) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 25 mg | | LIFT™ | — | | SHINE™ | — | | SOOTHE™ | 25 mg | Vitamin B6 is incorporated into **RESET™** and **SOOTHE™** because these phases emphasize **neuroendocrine regulation, cellular energy metabolism, amino acid metabolism, neurotransmitter synthesis, and hemoglobin production**. The active form, **Pyridoxal-5'-Phosphate (P5P),** was intentionally selected because it is the biologically active coenzyme form and does not require hepatic activation. # 2. Physiological Role Vitamin B6 functions as a coenzyme in more than **140 enzymatic reactions**, primarily involving amino acid metabolism, neurotransmitter synthesis, hemoglobin production, glycogen metabolism, immune physiology, and one-carbon metabolism.(1-4) P5P participates in the synthesis of: - Serotonin - Dopamine - Gamma-aminobutyric acid (GABA) - Norepinephrine - Histamine It also contributes to: - Hemoglobin synthesis - Energy metabolism - Homocysteine metabolism - Immune regulation - Protein metabolism Because these biological processes remain particularly relevant during the menstrual and luteal phases, P5P serves as an important neuro-metabolic support nutrient within FEMSTATE™. # 3. Mechanism of Action P5P functions as the active coenzyme form of vitamin B6. ### Neurotransmitter Synthesis P5P is required for enzymes involved in synthesis of: - Serotonin from tryptophan - Dopamine from L-DOPA - GABA from glutamate - Norepinephrine from dopamine This makes vitamin B6 one of the most important nutritional cofactors for normal neurotransmitter physiology. ### Amino Acid Metabolism Vitamin B6 regulates: - transamination - decarboxylation - amino acid utilization - nitrogen metabolism These pathways support tissue repair and protein synthesis. ### Hemoglobin Synthesis P5P participates in: - heme synthesis - red blood cell production - oxygen transport This physiological role is particularly relevant during the menstrual phase. ### Energy Metabolism Vitamin B6 contributes to: - glycogen metabolism - mitochondrial ATP production - glucose utilization # 4. Why Included in FEMSTATE™ ## RESET™ During the menstrual phase, physiological priorities include: - restoration of iron homeostasis - hemoglobin synthesis - tissue repair - mitochondrial recovery P5P supports these processes through its role in amino acid metabolism, heme synthesis, and cellular energy production. ## SOOTHE™ The luteal phase emphasizes: - neuroendocrine regulation - GABA physiology - serotonin synthesis - metabolic stability - cellular maintenance P5P supports these biological processes by serving as an essential cofactor for neurotransmitter synthesis and normal nervous system physiology. # 5. Dose Justification ## Selected Dose: 25 mg The selected dose was based on five scientific criteria. ### Physiological Relevance The dose supports neurotransmitter synthesis, amino acid metabolism, hemoglobin production, and energy metabolism during phases where these biological processes are particularly active. ### Human Clinical Evidence Randomized controlled trials evaluating P5P and vitamin B6 have commonly investigated doses between **10-100 mg/day**, depending on the physiological outcome studied. A dose of **25 mg/day** falls within clinically studied ranges while remaining substantially below doses associated with chronic toxicity. ### Safety The selected dose remains well below the current adult **Tolerable Upper Intake Level (UL)** established by the U.S. National Academies (12 mg/day under the 2023 update) but above the RDA. Notably, other authorities, including the European Food Safety Authority and older U.S. guidance, have used different ULs. Peripheral neuropathy has primarily been associated with **chronic high-dose supplementation**, generally well above typical nutritional intakes. The FEMSTATE dose was selected to balance physiological activity with long-term safety and should be evaluated in the context of total vitamin B6 intake from all supplements.² ### Formulation Compatibility Using the same dose in RESET™ and SOOTHE™: - supports neurophysiology - supports hemoglobin synthesis - complements magnesium and tryptophan - maintains consistent physiological exposure ### HR+ Philosophy P5P demonstrates no direct estrogenic activity and aligns well with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Vitamin B6 has been extensively studied in human physiology. Strong evidence supports its roles in: - neurotransmitter synthesis - amino acid metabolism - hemoglobin production - immune physiology - homocysteine metabolism Evidence supporting reproductive physiology is primarily mechanistic, with some clinical studies evaluating luteal-phase symptom outcomes. Those studies are heterogeneous, and they should not be interpreted as establishing efficacy for phase-aligned supplementation. **7. Safety Considerations** Vitamin B6 is generally safe at nutritional doses. ### Recommended Dietary Allowance (Women): 1.3-1.5 mg/day (depending on age) ### FEMSTATE Dose: 25 mg/day ### Tolerable Upper Intake Level Current U.S. National Academies UL (2023): **12 mg/day** for adults, based on peripheral neuropathy risk with chronic supplemental intake. Other authorities have established different limits, reflecting differences in interpretation of the available evidence.(2) Potential adverse effects associated with prolonged excessive intake include: - sensory neuropathy - paresthesia - gait disturbance (primarily reported with substantially higher chronic doses) The FEMSTATE dose should be considered in the context of total daily B6 intake from all supplements. # 8. HR+ Safety Review Vitamin B6 was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor agonist activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Vitamin B6 is considered compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Magnesium** Supports multiple shared enzymatic pathways involved in energy metabolism and nervous system physiology -> Strong physiological synergy **L-Tryptophan** P5P is required for conversion of tryptophan into serotonin -> Strong neurophysiological synergy **GABA** Supports endogenous neurotransmitter physiology through complementary pathways -> Positive synergy **Iron** Supports normal hemoglobin synthesis through complementary biochemical pathways -> Positive physiological interaction ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Vitamin K2 - Vitamin C - Zinc at FEMSTATE doses. ### Known Considerations Individuals taking levodopa without a peripheral decarboxylase inhibitor or certain anticonvulsants should consult a healthcare professional regarding vitamin B6 supplementation because of potential medication interactions. # 10. Regulatory Status Vitamin B6 (P5P) is: - Included in the U.S. Dietary Reference Intakes. - Recognized as an essential nutrient by the National Institutes of Health Office of Dietary Supplements. - Widely accepted for use in dietary supplements. - Supported by international nutrition guidelines. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin B6 for: - neurotransmitter synthesis - amino acid metabolism - hemoglobin production - energy metabolism Areas requiring further investigation include: - Phase-specific vitamin B6 utilization across the menstrual cycle. - Long-term outcomes of active P5P supplementation within phase-aligned nutritional systems. - Clinical evaluation of P5P as part of the complete FEMSTATE™ formulation. No randomized controlled trials have specifically evaluated P5P within a phase-aligned nutritional system. # 12. Conclusion Vitamin B6, provided as **Pyridoxal-5'-Phosphate (P5P)**, was selected for **RESET™** and **SOOTHE™** because of its established roles in neurotransmitter synthesis, amino acid metabolism, hemoglobin production, and cellular energy metabolism. The active coenzyme form was intentionally chosen to maximize bioavailability and avoid reliance on metabolic activation. The **25 mg** dose was selected based on physiological relevance, clinical evidence, formulation compatibility, and HR+ considerations. Given evolving guidance on upper intake limits, this dose reflects a balance between biological rationale and the need for careful long-term safety consideration within total supplemental intake. Within the FEMSTATE™ platform, P5P supports the neuroendocrine and metabolic priorities of the menstrual and luteal phases without directly modifying reproductive hormone physiology. ## References - National Institutes of Health Office of Dietary Supplements. Vitamin B6 Fact Sheet for Health Professionals. - Dietary Reference Intakes for Energy. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on vitamin B6 physiology and metabolism. - Nutrients. Systematic reviews on vitamin B6, neurotransmitter synthesis, and human health. - The Journal of Clinical Endocrinology & Metabolism. Reviews on reproductive physiology and micronutrient metabolism. # Ingredient Scientific Monograph # Vitamin B12 (Methylcobalamin) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Vitamin B12 **Chemical Name:** Cobalamin **Ingredient Form:** Methylcobalamin **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 150 mcg | | LIFT™ | 150 mcg | | SHINE™ | - | | SOOTHE™ | - | Vitamin B12 is included in **RESET™** and **LIFT™** because these phases emphasize **cellular regeneration, DNA synthesis, red blood cell production, mitochondrial energy metabolism, and anabolic physiology**. The methylcobalamin form was selected because it is one of the biologically active coenzyme forms of vitamin B12 and participates directly in methylation reactions without requiring conversion from cyanocobalamin. # 2. Physiological Role Vitamin B12 is an essential water-soluble vitamin involved in **DNA synthesis, methylation, neurological function, erythropoiesis, mitochondrial metabolism, and one-carbon metabolism**. Humans cannot synthesize vitamin B12, making dietary intake essential.(1-4) Vitamin B12 functions primarily as a cofactor for two critical enzymes: - **Methionine synthase** - **Methylmalonyl-CoA mutase** Through these enzymes, vitamin B12 contributes to: - DNA synthesis - Red blood cell production - Myelin maintenance - Homocysteine metabolism - Cellular energy production - Methylation reactions These physiological functions are particularly relevant during the regenerative (RESET™) and anabolic (LIFT™) phases of the menstrual cycle. # 3. Mechanism of Action Vitamin B12 exerts its physiological effects through two major biochemical pathways. ### DNA Synthesis Vitamin B12 functions together with folate in one-carbon metabolism. It is essential for: - DNA replication - cell division - tissue regeneration - rapidly proliferating cells This mechanism supports endometrial regeneration during RESET™ and cellular proliferation during LIFT™. ### Methylation Vitamin B12 converts homocysteine to methionine. This reaction supports: - methylation reactions - neurotransmitter synthesis - phospholipid synthesis - gene regulation ### Energy Metabolism Vitamin B12 functions as a cofactor for methylmalonyl-CoA mutase, contributing to: - mitochondrial metabolism - fatty acid oxidation - ATP production ### Neurological Function Vitamin B12 supports: - myelin synthesis - neuronal integrity - nervous system maintenance These mechanisms make vitamin B12 important for normal neurophysiology throughout the menstrual cycle. # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase emphasizes: - tissue regeneration - DNA synthesis - red blood cell production - restoration of cellular homeostasis Vitamin B12 supports these physiological processes through its roles in erythropoiesis, DNA synthesis, and methylation. ## LIFT™ The follicular phase emphasizes: - cellular proliferation - anabolic metabolism - mitochondrial activation - protein synthesis Vitamin B12 supports these biological priorities through methylation, DNA synthesis, and cellular energy metabolism. # 5. Dose Justification ## Selected Dose: 150 mcg The selected dose was based upon five scientific criteria. ### Physiological Relevance Vitamin B12 absorption through intrinsic factor becomes saturated at relatively low doses. Larger oral doses rely partly on passive diffusion, allowing meaningful absorption even when intrinsic factor-mediated uptake is limited. The selected dose ensures consistent physiological exposure while supporting long-term maintenance of vitamin B12 status. ### Human Clinical Evidence Human supplementation studies have evaluated doses ranging from **25 mcg to 1,000 mcg/day**, depending on baseline status and clinical objectives. A dose of **150 mcg/day** provides substantially greater exposure than the Recommended Dietary Allowance while remaining well within established safety parameters. ### Safety Vitamin B12 demonstrates one of the strongest safety profiles among vitamins. No Tolerable Upper Intake Level has been established because toxicity has not been demonstrated at nutritional or supplemental doses. ### Formulation Compatibility The selected dose: - complements folate - supports methylation - supports mitochondrial metabolism - maintains formulation consistency across RESET™ and LIFT™ ### HR+ Philosophy Vitamin B12 demonstrates no known endocrine activity and aligns fully with the HR+-conscious formulation philosophy **6.Human Clinical Evidence** Vitamin B12 has been extensively studied in relation to: - vitamin B12 deficiency - red blood cell production - neurological physiology - homocysteine metabolism - DNA synthesis The strongest human evidence supports correction and prevention of vitamin B12 deficiency and maintenance of normal neurological and hematological function. # 7. Safety Considerations Vitamin B12 has an excellent safety profile. ### Recommended Dietary Allowance (Women): 2.4 mcg/day ### FEMSTATE Dose: 150 mcg/day ### Tolerable Upper Intake Level No UL has been established because no adverse effects have been consistently associated with high oral vitamin B12 intake.(2) Occasional reports include: - mild acneiform eruptions (rare) - hypersensitivity reactions (extremely rare) # 8. HR+ Safety Review Vitamin B12 was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable oncology safety profile Vitamin B12 is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Folate (L-5-MTHF)** Vitamin B12 and folate function together in one-carbon metabolism and DNA synthesis -> Strong physiological synergy **Vitamin B6** Supports complementary methylation and amino acid metabolism pathways -> Positive synergy **Iron** Vitamin B12 contributes to normal erythropoiesis alongside iron -> Positive physiological interaction ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Vitamin C - Magnesium - Zinc at FEMSTATE doses. ### Known Considerations Long-term use of **metformin**, proton pump inhibitors, or certain gastrointestinal disorders may reduce vitamin B12 absorption and increase the likelihood of deficiency, making adequate intake particularly important in these populations. # 10. Regulatory Status Vitamin B12 is: - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Widely accepted for use in dietary supplements. - Included in international nutritional recommendations. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin B12 for: - erythropoiesis - neurological physiology - methylation - DNA synthesis Areas requiring further investigation include: - Phase-specific vitamin B12 metabolism throughout the menstrual cycle. - Vitamin B12 requirements during regenerative versus anabolic physiology. - Clinical evaluation of methylcobalamin within comprehensive phase-aligned nutritional systems. No randomized controlled trials have specifically evaluated methylcobalamin within a phase-aligned formulation such as FEMSTATE™. # 12. Conclusion Vitamin B12, provided as **methylcobalamin**, is a foundational nutrient within the FEMSTATE™ platform because of its established roles in DNA synthesis, methylation, erythropoiesis, mitochondrial metabolism, and neurological physiology. The selected dose of **150 mcg/day** provides robust physiological exposure while maintaining an excellent safety profile. Its inclusion in **RESET™** and **LIFT™** reflects the biological priorities of tissue regeneration, cellular proliferation, and anabolic metabolism that characterize these phases. The dose was selected using a structured framework integrating physiological relevance, human clinical evidence, safety, formulation compatibility, and HR+ considerations, making vitamin B12 a key contributor to the regenerative and growth-oriented physiology of the FEMSTATE™ platform. ## References - National Institutes of Health Office of Dietary Supplements. Vitamin B12 Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on vitamin B12 physiology and human metabolism. - Nutrients. Systematic reviews on vitamin B12, methylation, and neurological function. - The Journal of Clinical Endocrinology & Metabolism. Reviews on micronutrients, endocrine physiology, and women's health. - Endocrine Society. Clinical guidance on vitamin B12 deficiency and endocrine health. # Ingredient Scientific Monograph # Folate (L-5-Methyltetrahydrofolate Calcium) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Folate **Chemical Name:** L-5-Methyltetrahydrofolate Calcium (L-5-MTHF) **Ingredient Form:** L-5-Methyltetrahydrofolate Calcium (Active Folate) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 340 mcg DFE | | LIFT™ | 340 mcg DFE | | SHINE™ | - | | SOOTHE™ | - | Folate is included in **RESET™** and** LIFT™** because these phases are characterized by **cellular regeneration, DNA synthesis, tissue growth, endometrial repair, and cellular proliferation**. The active form**, L-5-MTHF**, was intentionally selected instead of folic acid because it is the biologically active circulating form of folate and bypasses the methylenetetrahydrofolate reductase (MTHFR) enzymatic conversion step. # 2. Physiological Role Folate is an essential water-soluble B vitamin that participates in **one-carbon metabolism**, a network of biochemical reactions responsible for DNA synthesis, RNA synthesis, methylation, amino acid metabolism, and cellular replication. Folate is particularly important in rapidly dividing tissues, including the endometrium, bone marrow, gastrointestinal epithelium, and developing ovarian follicles.(1-4) The active form, **L-5-MTHF**, contributes to: - DNA synthesis - Cell division - Methylation reactions - Red blood cell production - Homocysteine metabolism - Neural tissue physiology - Endometrial regeneration These physiological functions are especially relevant during the regenerative (RESET™) and anabolic (LIFT™) phases of the menstrual cycle. # 3. Mechanism of Action L-5-MTHF functions as the biologically active methyl donor within one-carbon metabolism. ### DNA Synthesis Folate provides one-carbon units required for: - purine synthesis - thymidine synthesis - DNA replication - cellular proliferation These mechanisms support: - endometrial regeneration - tissue repair - follicular development ### Methylation L-5-MTHF donates methyl groups for conversion of homocysteine to methionine. This pathway supports: - gene regulation - neurotransmitter synthesis - phospholipid production - epigenetic regulation This reaction requires adequate **vitamin B12**, making these nutrients physiologically interdependent. ### Erythropoiesis Folate supports: - red blood cell production - bone marrow function - normal cell maturation This function is particularly relevant following menstrual blood loss. # 4. Why Included in FEMSTATE™ ## RESET™ During menstruation, the body emphasizes: - tissue regeneration - endometrial repair - cellular replacement - restoration of homeostasis Folate supports these processes through DNA synthesis, cell division, and red blood cell production. ## LIFT™ The follicular phase emphasizes: - follicular growth - cellular proliferation - anabolic physiology - endometrial regeneration L-5-MTHF supports these physiological priorities through its central role in one-carbon metabolism and DNA synthesis. # 5. Dose Justification ## Selected Dose: 340 mcg Dietary Folate Equivalents (DFE) The selected dose was based on five scientific criteria. ### Physiological Relevance A dose of **340 mcg DFE** provides approximately **85% of the Daily Value**, supplying meaningful physiological support while complementing dietary folate intake. This dose supports: - DNA synthesis - cellular regeneration - methylation - erythropoiesis without approaching excessive intake. ### Human Clinical Evidence Human intervention studies consistently demonstrate that folate supports normal: - methylation - homocysteine metabolism - red blood cell production - cellular replication The selected dose aligns with nutritional recommendations while contributing to long-term maintenance of folate status. ### Safety The active L-5-MTHF form has an excellent safety profile at nutritional doses. Unlike folic acid, L-5-MTHF does not produce unmetabolized folic acid in circulation and may offer theoretical metabolic advantages in individuals with reduced MTHFR activity, although clinical superiority has not been definitively established for all outcomes. ### Formulation Compatibility The selected dose: - complements methylcobalamin - supports one-carbon metabolism - supports tissue regeneration - supports cellular proliferation ### HR+ Philosophy L-5-MTHF demonstrates no known estrogenic activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Folate has been extensively studied in human nutrition. Strong evidence supports its role in: - DNA synthesis - prevention of folate deficiency - homocysteine metabolism - erythropoiesis - fetal neural tube development (outside the scope of FEMSTATE) The evidence supporting folate's biochemical functions is among the strongest in nutritional science. # 7. Safety Considerations Folate demonstrates an excellent safety profile at nutritional doses. ### Recommended Dietary Allowance (Women): 400 mcg DFE/day ### FEMSTATE Dose: 340 mcg DFE/day ### Tolerable Upper Intake Level The adult UL of **1,000 mcg/day** applies to **synthetic folic acid**, not naturally occurring food folate or active L-5-MTHF. Current evidence suggests L-5-MTHF has a favorable safety profile, but total folate intake should still be considered.(2) Potential consideration: High folic acid intake may mask vitamin B12 deficiency. This concern is minimized through concurrent inclusion of **methylcobalamin** within FEMSTATE. # 8. HR+ Safety Review L-5-MTHF was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile L-5-MTHF is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin B12 (Methylcobalamin)** Essential partner in one-carbon metabolism -> Strong physiological synergy **Vitamin B6** Supports complementary methylation pathways -> Positive synergy **Iron** Supports coordinated erythropoiesis -> Positive physiological interaction Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Vitamin C - Magnesium - Zinc at FEMSTATE doses. ### Known Considerations Adequate vitamin B12 status should accompany folate supplementation to prevent masking of vitamin B12 deficiency, a consideration addressed by the inclusion of methylcobalamin in FEMSTATE™. # 10. Regulatory Status L-5-MTHF is: - Recognized for use in dietary supplements. - Considered a bioactive form of folate. - Included in dietary reference recommendations through Dietary Folate Equivalents (DFE). - Supported by international nutrition guidelines. # 11. Evidence Gaps & Future Research Current evidence strongly supports folate for: - DNA synthesis - methylation - erythropoiesis - one-carbon metabolism Areas requiring further investigation include: - Phase-specific folate metabolism throughout the menstrual cycle. - Comparative evaluation of L-5-MTHF versus folic acid within phase-aligned nutritional systems. - Clinical evaluation of L-5-MTHF within the complete FEMSTATE™ formulation. No randomized controlled trials have specifically evaluated active folate within a phase-aligned nutritional platform. # 13. Conclusion Folate, provided as** L-5-Methyltetrahydrofolate (L-5-MTHF),** is a core regenerative nutrient within the FEMSTATE™ platform because of its established roles in DNA synthesis, cellular proliferation, methylation, erythropoiesis, and tissue regeneration. The selected dose of **340 mcg DFE** provides meaningful physiological support while complementing dietary intake and remaining within established nutritional recommendations. The active L-5-MTHF form was intentionally selected to provide the biologically active form of folate and avoid reliance on metabolic activation. Within FEMSTATE™, folate supports the regenerative priorities of **RESET™** and the anabolic physiology of **LIFT™**, contributing to normal cellular renewal without directly modifying reproductive hormone physiology. ## References - National Institutes of Health Office of Dietary Supplements. Folate Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on folate physiology and one-carbon metabolism. - Nutrients. Systematic reviews on folate, methylation, and human health. - The Journal of Clinical Endocrinology & Metabolism. Reviews on micronutrients, reproductive physiology, and cellular metabolism. # Ingredient Scientific Monograph # Pantothenic Acid (Vitamin B5) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Pantothenic Acid **Chemical Name:** Pantothenic Acid **Ingredient Form:** Calcium D-Pantothenate **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 5 mg | | LIFT™ | 5 mg | | SHINE™ | - | | SOOTHE™ | - | Pantothenic acid is included in **RESET™** and **LIFT™** because of its central role in **cellular energy production, coenzyme A (CoA) synthesis, fatty acid metabolism, steroid hormone synthesis, and tissue regeneration**. As a precursor to coenzyme A, vitamin B5 is essential for virtually every cell in the body and supports the regenerative and anabolic physiology characteristic of the menstrual and follicular phases. # 2. Physiological Role Pantothenic acid is an essential water-soluble B vitamin required for the synthesis of **coenzyme A (CoA)** and **acyl carrier protein (ACP),** two molecules fundamental to cellular metabolism. Coenzyme A participates in hundreds of biochemical reactions involving carbohydrate metabolism, lipid metabolism, amino acid metabolism, mitochondrial ATP production, and steroidogenesis.(1-4) Pantothenic acid contributes to: - Coenzyme A synthesis - Cellular energy production - Fatty acid metabolism - Cholesterol metabolism - Steroid hormone synthesis - Acetylcholine synthesis - Cellular repair - Mitochondrial metabolism Because these metabolic pathways are continuously active but particularly important during tissue regeneration and anabolic growth, pantothenic acid provides foundational metabolic support within FEMSTATE™. # 3. Mechanism of Action Pantothenic acid functions primarily through formation of **coenzyme A**. ### Coenzyme A Synthesis Pantothenic acid is an obligatory precursor of CoA. CoA is required for: - Acetyl-CoA formation - Citric acid (Krebs) cycle - Fatty acid oxidation - Fatty acid synthesis - ATP production Without adequate pantothenic acid, efficient cellular energy metabolism cannot occur. ### Steroid Hormone Synthesis Coenzyme A participates in: Cholesterol -> Pregnenolone -> Steroid hormone synthesis Although pantothenic acid supports the biochemical pathways involved in steroidogenesis, **it does not increase reproductive hormone production** under normal physiological conditions. ### Cellular Energy Metabolism Pantothenic acid contributes to: - glucose metabolism - lipid metabolism - mitochondrial ATP production - cellular repair These pathways become particularly relevant during regenerative and anabolic physiology. ### Acetylcholine Synthesis Acetyl-CoA generated through pantothenic acid metabolism also contributes to: - acetylcholine production - neuronal physiology - neuromuscular signaling # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase emphasizes: - tissue repair - cellular regeneration - mitochondrial recovery - restoration of homeostasis Pantothenic acid supports these physiological processes through its central role in CoA synthesis and cellular energy metabolism. ## LIFT™ The follicular phase emphasizes: - anabolic metabolism - protein synthesis - follicular growth - mitochondrial activation Pantothenic acid supports these biological priorities by facilitating ATP production and biosynthetic metabolism. # 5. Dose Justification ## Selected Dose: 5 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A daily dose of **5 mg** corresponds to the **Adequate Intake (AI)** established for healthy adults and supports normal coenzyme A synthesis and cellular metabolism. ### Human Clinical Evidence Pantothenic acid deficiency is rare, and most research has focused on prevention of deficiency rather than supraphysiological supplementation. Current evidence indicates that meeting recommended intake supports normal energy metabolism and cellular physiology. ### Safety Pantothenic acid demonstrates an excellent safety profile. No tolerable upper intake level has been established because toxicity has not been demonstrated at nutritional doses. ### Formulation Compatibility The selected dose: - complements the B-complex - supports mitochondrial metabolism - supports energy production - maintains physiological nutrient balance ### HR+ Philosophy Pantothenic acid demonstrates no known endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Pantothenic acid has been extensively characterized biochemically, although fewer clinical supplementation studies exist compared with other B vitamins. Strong evidence supports its role in: - coenzyme A synthesis - energy metabolism - fatty acid metabolism - cellular physiology Clinical evidence supporting benefits beyond correction of deficiency remains limited. # 7. Safety Considerations Pantothenic acid possesses an excellent safety profile. ### Adequate Intake (Women): 5 mg/day ### FEMSTATE Dose: 5 mg/day ### Tolerable Upper Intake Level No UL has been established because adverse effects have not been demonstrated at nutritional intakes.(2) Very high supplemental doses may occasionally produce: - mild gastrointestinal discomfort - diarrhea (rare) These effects occur at doses substantially exceeding those used in FEMSTATE™. # 8. HR+ Safety Review Pantothenic acid was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Pantothenic acid is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Thiamin (Vitamin B1)** Supports complementary carbohydrate metabolism -> Positive synergy **Riboflavin (Vitamin B2)** Supports oxidative energy metabolism -> Positive synergy **Niacin (Vitamin B3)** Works together in mitochondrial energy production -> Positive synergy **Magnesium** Supports numerous ATP-dependent enzymatic reactions involving CoA -> Strong physiological synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Vitamin D3 - Zinc - Selenium at FEMSTATE doses. ### Known Considerations No clinically significant nutrient interactions have been reported at nutritional doses. # 10. Regulatory Status Pantothenic acid is: - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Widely accepted for use in dietary supplements. - Included in international nutritional recommendations. # 11. Evidence Gaps & Future Research Current evidence strongly supports pantothenic acid for: - coenzyme A synthesis - cellular energy metabolism - fatty acid metabolism Areas requiring further investigation include: - Phase-specific coenzyme A metabolism during the menstrual cycle. - Cellular energy requirements during regenerative versus anabolic physiology. - Clinical evaluation of pantothenic acid within phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated pantothenic acid within a phase-aligned nutritional formulation. # 12. Conclusion Pantothenic acid, provided as **calcium D-pantothenate**, is a foundational metabolic nutrient within the FEMSTATE™ platform because of its essential role in coenzyme A synthesis, mitochondrial energy production, fatty acid metabolism, and cellular physiology. The selected dose of **5 mg/day** aligns with the adult Adequate Intake and provides physiological support for the regenerative biology of **RESET™** and the anabolic physiology of **LIFT™**. Rather than directly influencing reproductive hormones, pantothenic acid supports the metabolic infrastructure required for tissue repair, cellular growth, and energy production, making it an important component of the phase-aligned nutritional strategy. ## References - National Institutes of Health Office of Dietary Supplements. Pantothenic Acid Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on pantothenic acid and coenzyme A metabolism. - Nutrients. Reviews on B vitamins and cellular metabolism. - The Journal of Clinical Endocrinology & Metabolism. Reviews on mitochondrial metabolism and endocrine physiology. # Ingredient Scientific Monograph # Thiamin (Vitamin B1) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Thiamin **Chemical Name:** Vitamin B1 **Ingredient Form:** Thiamin Hydrochloride (Thiamin HCl) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 5 mg | | LIFT™ | 5 mg | | SHINE™ | - | | SOOTHE™ | - | Thiamin is included in **RESET™** and **LIFT™** because of its essential role in **cellular energy metabolism, mitochondrial ATP production, carbohydrate utilization, and nervous system physiology**. During the regenerative and anabolic phases of the menstrual cycle, efficient energy production is fundamental to tissue repair, cellular proliferation, and restoration of physiological homeostasis. # 2. Physiological Role Thiamin is an essential water-soluble B vitamin that functions as **thiamin pyrophosphate (TPP)**, a coenzyme required for multiple enzymatic reactions involved in carbohydrate metabolism and mitochondrial energy production. Because humans cannot synthesize thiamin, adequate intake is required to support normal cellular metabolism.(1-4) Thiamin contributes to: - ATP production - Carbohydrate metabolism - Krebs (citric acid) cycle activity - Pentose phosphate pathway - Nervous system function - Cardiac physiology - Cellular energy homeostasis These physiological functions are particularly relevant during the menstrual phase, when tissue regeneration requires substantial cellular energy, and during the follicular phase, when anabolic metabolism accelerates. # 3. Mechanism of Action Thiamin functions primarily through its active coenzyme form, **thiamin pyrophosphate (TPP).** ### Mitochondrial Energy Production TPP serves as a cofactor for: - Pyruvate dehydrogenase - α-Ketoglutarate dehydrogenase - Branched-chain α-ketoacid dehydrogenase These enzymes regulate: Glucose -> Pyruvate -> Acetyl-CoA -> Citric Acid Cycle -> ATP Production Consequently, thiamin is essential for efficient cellular energy production. ### Carbohydrate Metabolism Thiamin supports: - glucose utilization - oxidative metabolism - ATP generation This role is particularly important in tissues with high metabolic demand. ### Nervous System Function Thiamin contributes to: - neuronal energy metabolism - neurotransmission - maintenance of normal nerve function Because the nervous system depends heavily on glucose metabolism, adequate thiamin is critical for normal neurological physiology. ### Pentose Phosphate Pathway TPP is also required for **transketolase**, an enzyme involved in: - nucleotide synthesis - NADPH production - antioxidant defense This pathway supports tissue regeneration and cellular proliferation. # 4. Why Included in FEMSTATE™ ## RESET™ During the menstrual phase, biological priorities include: - tissue repair - endometrial regeneration - cellular recovery - restoration of homeostasis These regenerative processes require efficient ATP production. Thiamin supports this physiology by facilitating carbohydrate metabolism and mitochondrial energy production. ## LIFT™ During the follicular phase, anabolic physiology increases demand for: - ATP - cellular biosynthesis - protein synthesis - mitochondrial metabolism Thiamin supports these processes by ensuring efficient conversion of glucose into cellular energy. # 5. Dose Justification ## Selected Dose: 5 mg The selected dose was based on five scientific criteria. ### Physiological Relevance The dose provides approximately **400% of the Daily Value**, ensuring sufficient availability of thiamin for mitochondrial energy metabolism during periods of increased physiological demand while remaining well within recognized safety margins. ### Human Clinical Evidence Clinical research consistently demonstrates that adequate thiamin is essential for: - carbohydrate metabolism - mitochondrial function - neurological physiology Although deficiency is uncommon in healthy populations, maintaining adequate thiamin status is essential for normal energy metabolism. ### Safety Thiamin has an excellent safety profile. Because excess thiamin is readily excreted in urine, toxicity from oral supplementation has not been demonstrated at nutritional doses. ### Formulation Compatibility The selected dose: - complements riboflavin - complements niacin - complements pantothenic acid - supports mitochondrial physiology - supports carbohydrate metabolism ### HR+ Philosophy Thiamin demonstrates no known endocrine activity and aligns fully with the FEMSTATE™ HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Thiamin has been extensively studied in relation to: - energy metabolism - neurological physiology - cardiovascular function - prevention of thiamin deficiency Its biochemical role in ATP production is firmly established. # 7. Safety Considerations Thiamin possesses one of the strongest safety profiles among vitamins. ### Recommended Dietary Allowance (Women): 1.1 mg/day ### FEMSTATE Dose: 5 mg/day ### Tolerable Upper Intake Level No UL has been established because no adverse effects have been consistently associated with oral thiamin supplementation.(2) Excess thiamin is rapidly eliminated through urinary excretion. # 8. HR+ Safety Review Thiamin was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Thiamin is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Riboflavin (Vitamin B2)** Supports complementary mitochondrial energy production -> Strong synergy **Niacin (Vitamin B3)** Supports oxidative metabolism through NAD/NADP pathways -> Positive synergy **Pantothenic Acid (Vitamin B5)** Supports Coenzyme A synthesis and ATP production -> Strong metabolic synergy **Magnesium** Magnesium is required for activation of thiamin into thiamin pyrophosphate -> Strong physiological synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Vitamin D3 - Zinc - Selenium at FEMSTATE doses. ### Known Considerations No clinically significant nutrient interactions have been reported at nutritional doses. # 10. Regulatory Status Thiamin is: - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Widely accepted for use in dietary supplements. - Included in international nutritional recommendations. # 11. Evidence Gaps & Future Research Current evidence strongly supports thiamin for: - mitochondrial energy production - carbohydrate metabolism - neurological physiology Areas requiring further investigation include: - Phase-specific thiamin utilization throughout the menstrual cycle. - Mitochondrial metabolism during regenerative and anabolic physiology. - Clinical evaluation of thiamin within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated thiamin within a phase-aligned nutritional formulation. # 12. Conclusion Thiamin (Vitamin B1), provided as **thiamin hydrochloride**, is a foundational metabolic nutrient within the FEMSTATE™ platform because of its indispensable role in mitochondrial ATP production, carbohydrate metabolism, and nervous system physiology. The selected dose of **5 mg/day** provides robust physiological support while remaining well within established safety margins. Its inclusion in **RESET™** and **LIFT™** reflects the increased metabolic demands associated with tissue regeneration and anabolic growth. Rather than directly influencing endocrine function, thiamin supports the cellular energy systems that enable the regenerative and biosynthetic processes characteristic of these phases, making it a critical component of the phase-aligned nutritional strategy. ## References - National Institutes of Health Office of Dietary Supplements. Thiamin Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - Guyton and Hall Textbook of Medical Physiology. - The American Journal of Clinical Nutrition. Reviews on thiamin metabolism and human physiology. - Nutrients. Reviews on B vitamins, mitochondrial metabolism, and energy production. - The Journal of Clinical Endocrinology & Metabolism. Reviews on metabolism and women's physiology. # Ingredient Scientific Monograph # Riboflavin (Vitamin B2) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Riboflavin **Chemical Name:** Vitamin B2 **Ingredient Form:** Riboflavin **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 5 mg | | LIFT™ | 5 mg | | SHINE™ | - | | SOOTHE™ | - | Riboflavin is included in **RESET™** and **LIFT™** because of its essential role in **mitochondrial energy production, oxidative metabolism, antioxidant defense, and cellular regeneration**. As a precursor to flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), riboflavin is indispensable for ATP production and numerous oxidation-reduction reactions that support tissue repair and anabolic metabolism. # 2. Physiological Role Riboflavin is an essential water-soluble B vitamin that functions as the precursor of the coenzymes **flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN).** These flavin coenzymes participate in hundreds of enzymatic reactions involved in mitochondrial respiration, cellular energy production, fatty acid oxidation, antioxidant defense, and metabolism of other vitamins.(1-4) Riboflavin contributes to: - Mitochondrial ATP production - Electron transport chain function - Fatty acid oxidation - Antioxidant enzyme activity - Cellular growth - Tissue repair - Iron metabolism - Conversion of vitamin B6 to its active form (P5P) These physiological functions are particularly relevant during the regenerative biology of **RESET™** and the anabolic physiology of **LIFT™.** # 3. Mechanism of Action Riboflavin functions through its active coenzymes **FAD** and **FMN**. ### Mitochondrial Energy Production FAD and FMN participate directly in: - Electron Transport Chain Complex I - Electron Transport Chain Complex II - Oxidative phosphorylation - ATP synthesis These pathways generate the majority of cellular ATP. ### Cellular Oxidation–Reduction Riboflavin supports: - electron transfer - oxidative metabolism - mitochondrial respiration - fatty acid metabolism ### Antioxidant Physiology FAD is required for: - glutathione reductase activity - regeneration of reduced glutathione (GSH) - maintenance of endogenous antioxidant systems This mechanism supports normal redox homeostasis during tissue regeneration and anabolic growth. ### Vitamin Metabolism Riboflavin contributes to activation of several other vitamins including: - Vitamin B6 (P5P) - Folate metabolism - Niacin synthesis from tryptophan Thus, riboflavin supports the integrated function of the B-complex. # 4. Why Included in FEMSTATE™ ## RESET™ During the menstrual phase, tissue repair requires: - ATP production - antioxidant regulation - iron metabolism - cellular regeneration Riboflavin supports these physiological priorities through mitochondrial energy production and maintenance of endogenous antioxidant systems. ## LIFT™ The follicular phase emphasizes: - anabolic metabolism - cellular proliferation - mitochondrial activation - connective tissue growth Riboflavin supports these biological priorities through its central role in oxidative phosphorylation and biosynthetic metabolism. # 5. Dose Justification ## Selected Dose: 5 mg The selected dose was based on five scientific criteria. ### Physiological Relevance A dose of **5 mg** provides approximately **385% of the Daily Value**, ensuring adequate flavin coenzyme availability during periods of increased metabolic activity while remaining within a conservative nutritional range. ### Human Clinical Evidence Human studies consistently demonstrate that riboflavin is essential for: - mitochondrial energy metabolism - prevention of riboflavin deficiency - maintenance of glutathione metabolism - support of normal cellular physiology Although most research focuses on deficiency prevention, adequate riboflavin intake is fundamental for optimal mitochondrial function. ### Safety Riboflavin demonstrates an excellent safety profile. Because absorption is regulated and excess riboflavin is readily excreted in urine, toxicity has not been demonstrated from oral supplementation. ### Formulation Compatibility The selected dose: - complements thiamin - complements niacin - complements pantothenic acid - supports vitamin B6 activation - supports mitochondrial physiology ### HR+ Philosophy Riboflavin demonstrates no known endocrine activity and aligns fully with the FEMSTATE™ HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Riboflavin has been extensively studied in relation to: - mitochondrial metabolism - energy production - antioxidant physiology - neurological health - prevention of riboflavin deficiency Strong evidence supports its biochemical role in flavoprotein-dependent metabolism. # 7. Safety Considerations Riboflavin possesses an excellent safety profile. ### Recommended Dietary Allowance (Women): 1.1 mg/day ### FEMSTATE Dose: 5 mg/day ### Tolerable Upper Intake Level No UL has been established because no adverse effects have been consistently associated with oral riboflavin supplementation.(2) The most common observation following supplementation is: - bright yellow urine due to excretion of excess riboflavin This effect is harmless and reflects normal physiological elimination. # 8. HR+ Safety Review Riboflavin was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Riboflavin is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Thiamin (Vitamin B1)** Supports complementary mitochondrial ATP production -> Strong metabolic synergy **Niacin (Vitamin B3)** Works together in oxidative metabolism through NAD/FAD-dependent pathways -> Strong synergy **Vitamin B6** Riboflavin is required for conversion of vitamin B6 into its active coenzyme form (P5P) -> Strong physiological synergy **Glutathione System** Supports glutathione reductase activity and endogenous antioxidant defenses -> Positive antioxidant synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Vitamin D3 - Magnesium - Zinc at FEMSTATE doses. ### Known Considerations No clinically significant nutrient interactions have been identified at nutritional doses. # 10. Regulatory Status Riboflavin is: - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Widely accepted for use in dietary supplements. - Included in international nutritional recommendations. # 11. Evidence Gaps & Future Research Current evidence strongly supports riboflavin for: - mitochondrial ATP production - flavoprotein metabolism - antioxidant physiology - cellular energy production Areas requiring further investigation include: - Phase-specific riboflavin utilization throughout the menstrual cycle. - Mitochondrial flavoprotein activity during regenerative and anabolic physiology. - Clinical evaluation of riboflavin within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated riboflavin within a phase-aligned nutritional formulationOverall Scientific Confidence # 12. Conclusion Riboflavin (Vitamin B2) is a foundational metabolic nutrient within the FEMSTATE™ platform because of its indispensable role in mitochondrial respiration, ATP production, antioxidant defense, and cellular metabolism. The selected dose of **5 mg/day** provides robust physiological support while remaining well within established safety parameters. Its inclusion in **RESET™** and **LIFT™** reflects the increased metabolic demands associated with tissue regeneration and anabolic growth. Through its roles in flavoprotein metabolism, activation of vitamin B6, and maintenance of glutathione physiology, riboflavin supports the energetic foundation required for the regenerative and biosynthetic priorities of these menstrual phases without directly influencing reproductive hormone physiology. ## References - National Institutes of Health Office of Dietary Supplements. Riboflavin Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - Guyton and Hall Textbook of Medical Physiology. - The American Journal of Clinical Nutrition. Reviews on riboflavin metabolism and human physiology. - Nutrients. Systematic reviews on riboflavin, flavoproteins, and mitochondrial metabolism. - The Journal of Clinical Endocrinology & Metabolism. Reviews on metabolism, oxidative physiology, and women's health. # Ingredient Scientific Monograph # Niacin (Vitamin B3) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Niacin **Chemical Name:** Vitamin B3 **Ingredient Forms:** - **Niacin (Nicotinic Acid)** - RESET™ and LIFT™ - **Niacinamide (Nicotinamide)** - SOOTHE™ **FEMSTATE™ Daily Dose** | Formula | Ingredient Form | Dose | | --- | --- | --- | | RESET™ | Niacin | 5 mg NE | | LIFT™ | Niacin | 5 mg NE | | SHINE™ | - | - | | SOOTHE™ | Niacinamide | 100 mg | FEMSTATE™ intentionally uses **two different forms of vitamin B3** because they serve different physiological purposes. Small nutritional doses of **niacin** provide foundational support for mitochondrial metabolism and cellular energy production during the regenerative and anabolic phases, whereas **niacinamide** was selected for SOOTHE™ because it supports cellular metabolism without causing the vasodilatory "niacin flush" associated with nicotinic acid. # 2. Physiological Role Vitamin B3 is an essential water-soluble vitamin required for synthesis of **nicotinamide adenine dinucleotide (NAD⁺) **and **nicotinamide adenine dinucleotide phosphate (NADP⁺),** two of the most important coenzymes in human metabolism. NAD⁺ and NADP⁺ participate in hundreds of oxidation-reduction reactions regulating mitochondrial ATP production, carbohydrate metabolism, lipid metabolism, DNA repair, antioxidant defense, and cellular signaling.(1-4) Vitamin B3 contributes to: - Mitochondrial ATP production - Oxidative phosphorylation - Glucose metabolism - Lipid metabolism - DNA repair - Cellular resilience - Antioxidant systems - Nervous system physiology These functions are fundamental throughout the menstrual cycle and become particularly relevant during tissue regeneration (RESET™), anabolic metabolism (LIFT™), and neuroendocrine stabilization (SOOTHE™). # 3. Mechanism of Action Vitamin B3 functions primarily through formation of **NAD⁺** and **NADP⁺**. ### Cellular Energy Production NAD⁺ participates in: - Glycolysis - Citric acid cycle - Electron transport chain - ATP production These pathways are essential for efficient mitochondrial function. ### Cellular Repair NAD⁺ serves as a substrate for: - PARP enzymes involved in DNA repair - Sirtuins involved in cellular stress responses - Multiple signaling pathways regulating cellular homeostasis ### Antioxidant Physiology NADPH participates in: - glutathione regeneration - reductive biosynthesis - maintenance of cellular redox balance ### Nervous System Function Vitamin B3 contributes to: - neuronal metabolism - neurotransmitter physiology - maintenance of cellular energy within the central nervous system # 4. Why Included in FEMSTATE™ ## RESET™ During the menstrual phase: - tissue repair - mitochondrial recovery - DNA repair - cellular regeneration require efficient NAD⁺-dependent metabolism. A nutritional dose of niacin supports these physiological priorities. ## LIFT™ The follicular phase emphasizes: - anabolic metabolism - cellular proliferation - mitochondrial activation - ATP production Niacin supports these biological processes through its central role in oxidative metabolism. ## SOOTHE™ The luteal phase emphasizes: - neuroendocrine regulation - cellular maintenance - metabolic stability - DNA repair Niacinamide was selected because it supports NAD⁺ metabolism while avoiding the vasodilatory flushing effects of nicotinic acid, making it more appropriate for daily use at the higher dose included in SOOTHE™. # 5. Dose Justification ## RESET™ and LIFT™ ### Selected Dose: 5 mg Niacin Equivalents (NE) ### Scientific Rationale The selected dose: - complements dietary intake - supports mitochondrial metabolism - contributes to NAD⁺ synthesis - maintains nutritional balance within the B-complex This dose emphasizes physiological support rather than pharmacological effects. ## SOOTHE™ ### Selected Dose: 100 mg Niacinamide ### Scientific Rationale Niacinamide was selected because: - it contributes directly to NAD⁺ metabolism - it supports cellular energy production - it avoids prostaglandin-mediated flushing - it supports long-term daily tolerability The dose remains well below levels commonly associated with clinically significant adverse effects while providing greater physiological exposure than nutritional maintenance doses. # 6. Human Clinical Evidence Vitamin B3 has been extensively studied in relation to: - NAD⁺ metabolism - energy production - lipid metabolism - cellular repair - neurological physiology Strong evidence supports its biochemical functions, while therapeutic benefits at pharmacological doses depend upon the clinical indication. # 7. Safety Considerations Vitamin B3 safety depends upon the chemical form. ### Recommended Dietary Allowance (Women): 14 mg NE/day ### FEMSTATE Doses RESET™: 5 mg NE LIFT™: 5 mg NE SOOTHE™: 100 mg Niacinamide ### Safety Profile The low nutritional doses of **niacin** included in RESET™ and LIFT™ are not expected to produce flushing. Niacinamide does not typically produce flushing because it does not activate the same prostaglandin-mediated pathway as nicotinic acid. Potential adverse effects associated with very high intakes include: - gastrointestinal discomfort - liver toxicity (primarily pharmacological doses) - insulin resistance at pharmacological doses These effects occur at doses substantially higher than those used in FEMSTATE™. # 8. HR+ Safety Review Vitamin B3 was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Vitamin B3 is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Thiamin (Vitamin B1)** Supports complementary carbohydrate metabolism -> Strong metabolic synergy **Riboflavin (Vitamin B2)** Supports oxidative phosphorylation through FAD/NAD pathways -> Strong synergy **Pantothenic Acid (Vitamin B5)** Supports Coenzyme A synthesis and ATP production -> Strong metabolic synergy **Magnesium** Supports ATP-dependent reactions involving NAD⁺ -> Positive physiological synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Vitamin D3 - Zinc - Selenium at FEMSTATE doses. ### Known Considerations Individuals with severe liver disease should avoid high-dose pharmacological niacin without medical supervision. The doses used in FEMSTATE™ remain nutritional to moderate and are not intended for lipid-lowering therapy. # 10. Regulatory Status Vitamin B3 is: - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an essential nutrient. - Widely accepted for use in dietary supplements. - Included in international nutritional recommendations. # 11. Evidence Gaps & Future Research Current evidence strongly supports vitamin B3 for: - NAD⁺ metabolism - mitochondrial physiology - cellular energy production - DNA repair Areas requiring additional investigation include: - Phase-specific NAD⁺ metabolism across the menstrual cycle. - Neuroendocrine physiology during the luteal phase. - Clinical evaluation of niacinamide within comprehensive phase-aligned nutritional systems. No randomized controlled trials have specifically evaluated vitamin B3 within a phase-aligned formulation such as FEMSTATE™. # 12. Conclusion Vitamin B3 was strategically incorporated into the FEMSTATE™ platform using **two complementary forms** to match the physiological priorities of different menstrual phases. Low-dose **niacin** in RESET™ and LIFT™ provides foundational support for mitochondrial ATP production and anabolic metabolism, while **niacinamide** in SOOTHE™ supports NAD⁺-dependent cellular maintenance and neuroendocrine physiology without the flushing associated with nicotinic acid. This differentiated approach reflects the FEMSTATE™ philosophy of aligning nutrient form as well as dose with changing biological priorities throughout the menstrual cycle. Rather than targeting endocrine function directly, vitamin B3 supports the cellular energy systems that underpin tissue regeneration, anabolic growth, and physiological recovery. ## References - National Institutes of Health Office of Dietary Supplements. Niacin Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on niacin, NAD⁺ metabolism, and human physiology. - Cell Metabolism. Reviews on NAD⁺ biology, cellular metabolism, and mitochondrial function. - Nutrients. Systematic reviews on niacin, nicotinamide, and human health. - The Journal of Clinical Endocrinology & Metabolism. Reviews on metabolism, endocrine physiology, and women's health. # Ingredient Scientific Monograph # Magnesium (as Magnesium Glycinate) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Magnesium **Chemical Name:** Magnesium Bisglycinate Chelate (Magnesium Glycinate) **Ingredient Form:** Magnesium Glycinate **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 250 mg elemental magnesium | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | - (Magnesium L-threonate is used instead) | Magnesium glycinate was specifically selected for **RESET™** because this phase emphasizes **cellular regeneration, mitochondrial recovery, muscle relaxation, tissue repair, and restoration of physiological homeostasis**. Glycinate was chosen over other magnesium salts because of its high bioavailability, excellent gastrointestinal tolerability, and minimal laxative effect, making it particularly appropriate during menstruation. # 2. Physiological Role Magnesium is the second most abundant intracellular cation and functions as an essential cofactor in more than **600 enzymatic reactions**. It is indispensable for ATP production, protein synthesis, DNA repair, RNA transcription, muscle contraction, nerve conduction, glucose metabolism, and maintenance of cellular homeostasis.(1-4) Magnesium contributes to: - ATP production - Mitochondrial function - Protein synthesis - DNA repair - Muscle physiology - Neuromuscular signaling - Electrolyte balance - Bone physiology - Cellular stress responses These physiological functions are particularly relevant during the regenerative biology of the menstrual phase. # 3. Mechanism of Action Magnesium exerts its physiological effects through multiple interconnected biochemical pathways. ### ATP Production Over 90% of intracellular ATP exists as **Mg-ATP**, meaning magnesium is required for virtually all ATP-dependent cellular reactions. Magnesium supports: Glucose -> ATP -> Cellular energy -> Tissue repair ### Protein Synthesis Magnesium is required for: - ribosomal function - translation - protein assembly - tissue regeneration ### DNA Repair Magnesium functions as a cofactor for enzymes involved in: - DNA replication - DNA repair - RNA synthesis These pathways are particularly active during tissue regeneration. ### Muscle and Nervous System Physiology Magnesium regulates: - calcium transport - neuromuscular signaling - muscle relaxation - membrane stability This contributes to normal muscle physiology and cellular homeostasis. # 4. Why Included in FEMSTATE™ ## RESET™ During the menstrual phase, biological priorities include: - tissue repair - mitochondrial recovery - protein synthesis - restoration of cellular homeostasis - muscle physiology - connective tissue regeneration Magnesium glycinate supports these physiological processes through its central role in ATP production, enzymatic activity, and protein synthesis. Unlike magnesium citrate, glycinate provides excellent absorption with minimal gastrointestinal effects, an important consideration during menstruation. # 5. Dose Justification ## Selected Dose: 250 mg elemental magnesium The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **250 mg elemental magnesium** provides meaningful physiological support for ATP production, protein synthesis, mitochondrial metabolism, and cellular repair while contributing substantially toward the daily requirement. ### Human Clinical Evidence Human intervention studies evaluating magnesium have commonly investigated doses ranging from **200-400 mg/day** of elemental magnesium for various physiological outcomes. The selected dose falls squarely within this clinically studied range. ### Safety The selected dose remains within ranges widely used in clinical nutrition. Although the adult UL for **supplemental magnesium** is **350 mg/day**, this limit is based primarily on gastrointestinal effects (particularly diarrhea) rather than systemic toxicity. Magnesium glycinate is among the most well-tolerated supplemental forms because it produces fewer gastrointestinal symptoms than magnesium oxide or citrate.² ### Formulation Compatibility Magnesium glycinate was selected because it: - provides high bioavailability - minimizes gastrointestinal discomfort - complements vitamin D - complements vitamin B6 - supports ATP production - fits comfortably within the formulation serving size ### HR+ Philosophy Magnesium demonstrates no endocrine activity and fully aligns with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Magnesium is one of the most extensively studied minerals in clinical nutrition. Strong evidence supports its physiological roles in: - ATP production - neuromuscular physiology - energy metabolism - glucose metabolism - enzyme activation Evidence specific to menstrual physiology is strongest for maintenance of normal magnesium status and general physiological support rather than for phase-specific supplementation. **7. Safety Considerations** Magnesium glycinate has an excellent safety profile. ### Recommended Dietary Allowance (Women): 310-320 mg/day ### FEMSTATE Dose: 250 mg elemental magnesium ### Tolerable Upper Intake Level 350 mg/day **from supplemental sources** (does not include dietary magnesium).(2) Potential adverse effects: - mild gastrointestinal discomfort (uncommon with glycinate) - diarrhea (significantly less frequent than with magnesium citrate or oxide) Systemic toxicity is extremely uncommon in healthy individuals with normal kidney function. # 8. HR+ Safety Review Magnesium glycinate was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Magnesium glycinate is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin D3** Magnesium is required for activation and metabolism of vitamin D -> Strong physiological synergy **Vitamin B6 (P5P)** Supports complementary enzymatic reactions involved in neurotransmitter synthesis and cellular metabolism -> Strong synergy **Thiamin, Riboflavin, Niacin, Pantothenic Acid** Together support mitochondrial ATP production -> Strong metabolic synergy **Vitamin K2** Supports coordinated skeletal physiology alongside vitamin D -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Selenium - Chromium at FEMSTATE doses. ### Known Considerations Magnesium may reduce absorption of certain medications, including: - tetracycline antibiotics - fluoroquinolone antibiotics - bisphosphonates - levothyroxine When applicable, supplementation should be separated by several hours. # 10. Regulatory Status Magnesium glycinate is: - Recognized as a dietary ingredient. - Widely used in dietary supplements. - Supported by the National Institutes of Health Office of Dietary Supplements. - Considered one of the most bioavailable supplemental forms of magnesium. # 11. Evidence Gaps & Future Research Current evidence strongly supports magnesium for: - ATP production - mitochondrial physiology - neuromuscular function - enzyme activation Areas requiring further investigation include: - Phase-specific magnesium utilization across the menstrual cycle. - Magnesium requirements during tissue regeneration. - Clinical evaluation of magnesium glycinate within a complete phase-aligned nutritional system such as FEMSTATE™. No randomized controlled trials have specifically evaluated magnesium glycinate within a phase-aligned formulation. # 12. Conclusion Magnesium glycinate is a cornerstone ingredient within the **RESET™** formulation because of its central role in mitochondrial ATP production, protein synthesis, DNA repair, neuromuscular physiology, and cellular regeneration. The selected dose of **250 mg elemental magnesium** reflects a balance between physiological relevance, robust human evidence, excellent tolerability, and long-term safety. The glycinate form was intentionally chosen because of its superior gastrointestinal tolerance and bioavailability compared with many other magnesium salts. Within the FEMSTATE™ platform, magnesium glycinate supports the regenerative physiology of the menstrual phase by helping maintain the cellular energy systems and enzymatic processes required for tissue repair and restoration of homeostasis, without directly influencing reproductive hormone production. ## References - National Institutes of Health Office of Dietary Supplements. Magnesium Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - Guyton and Hall Textbook of Medical Physiology. - Nutrients. Systematic reviews on magnesium bioavailability, glycinate, and human physiology. - The American Journal of Clinical Nutrition. Reviews on magnesium and mitochondrial metabolism. - The Journal of Clinical Endocrinology & Metabolism. Reviews on magnesium, endocrine physiology, and women's health. # FEMSTATE™ Phase Applications ## RESET™ ### Dose: 250 mg elemental magnesium ### Scientific Rationale The menstrual phase is characterized by tissue regeneration, extracellular matrix remodeling, ATP production, and restoration of physiological homeostasis. The higher dose was selected to support: - mitochondrial ATP production - tissue regeneration - protein synthesis - enzymatic activity - cellular repair ## LIFT™ ### Dose: 200 mg elemental magnesium ### Scientific Rationale During the follicular phase, physiological priorities shift toward: - anabolic metabolism - cellular proliferation - protein synthesis - mitochondrial activation Because LIFT™ also contains **1 g of myo-inositol**, collagen, hyaluronic acid, and other metabolically active ingredients, a **200 mg** elemental magnesium dose provides sufficient physiological support while allowing greater formulation space for ingredients directly supporting follicular anabolic biology. The slightly lower dose should **not** be interpreted as reduced importance of magnesium. Instead, it reflects optimization of the complete formulation according to the biological priorities of the follicular phase. | RESET™ | LIFT™ | | --- | --- | | 250 mg | 200 mg | | Regeneration | Growth | | Tissue repair | Cellular proliferation | | Recovery | Anabolic metabolism | | Higher emphasis on restoration | Greater formulation space for anabolic ingredients | The difference between **250 mg** and **200 mg** is therefore a **formulation engineering decision**, not a difference in magnesium physiology. # Ingredient Scientific Monograph # Iron (as Ferrous Bisglycinate Chelate - Ferrochel®) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Iron **Chemical Name:** Ferrous Bisglycinate Chelate **Branded Ingredient:** **Ferrochel®** **Ingredient Form:** Ferrous Bisglycinate Chelate **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 18 mg elemental iron | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | - | Iron is included **exclusively in RESET™** because menstruation represents the only phase of the menstrual cycle associated with **physiological blood loss**. The formulation uses **Ferrochel®**, a patented ferrous bisglycinate chelate, selected for its superior bioavailability and gastrointestinal tolerability compared with many conventional iron salts. Unlike ferrous sulfate, Ferrochel® is less reactive within the gastrointestinal tract and has demonstrated efficient absorption in human studies while producing fewer gastrointestinal adverse effects.(1-5) # 2. Physiological Role Iron is an essential trace mineral required for oxygen transport, mitochondrial energy production, cellular respiration, DNA synthesis, immune function, and numerous enzymatic reactions. Approximately **65-70% of total body iron** is contained within hemoglobin, while the remainder is distributed among myoglobin, ferritin, cytochromes, and other iron-containing proteins.(1-4) Iron contributes to: - Hemoglobin synthesis - Oxygen transport - Mitochondrial ATP production - Cellular respiration - DNA synthesis - Cell proliferation - Immune physiology - Connective tissue repair Because menstruation is the principal physiological mechanism of iron loss in reproductive-aged women, iron is uniquely relevant during the RESET™ phase. # 3. Mechanism of Action Iron participates in multiple physiological pathways. ### Oxygen Transport Iron is the central atom within hemoglobin. Hemoglobin -> Oxygen transport -> Cellular respiration -> ATP production -> Tissue repair This pathway is fundamental for regeneration of the endometrium following menstruation. ### Mitochondrial Energy Production Iron functions as a component of: - cytochromes - iron-sulfur proteins - electron transport chain complexes These proteins are essential for oxidative phosphorylation and ATP synthesis. ### DNA Synthesis Iron-dependent enzymes participate in: - DNA replication - cellular proliferation - tissue regeneration These processes become particularly active during endometrial repair. ### Immune Physiology Iron supports: - lymphocyte proliferation - macrophage physiology - normal immune function Adequate iron availability contributes to physiological tissue regeneration while maintaining immune homeostasis. # 4. Why Included in FEMSTATE™ ## RESET™ Menstruation is associated with **physiological iron loss** through endometrial bleeding. The menstrual phase simultaneously requires: - tissue regeneration - angiogenesis - hemoglobin synthesis - mitochondrial ATP production - restoration of iron homeostasis Iron therefore supports the biological priorities unique to the RESET™ phase. Importantly, the formulation is **not intended to treat iron deficiency anemia**. Rather, it provides nutritional support aligned with the physiology of menstruation, particularly for women with normal menstrual blood loss. # 5. Dose Justification ## Selected Dose: 18 mg elemental iron The selected dose was based on five scientific criteria. ### Physiological Relevance The dose corresponds to the **Recommended Dietary Allowance (RDA)** for premenopausal women in the United States. It supports: - maintenance of iron status - hemoglobin synthesis - physiological iron replacement following menstruation ### Human Clinical Evidence Numerous human studies have demonstrated that **18 mg/day** effectively supports iron intake in women of reproductive age when dietary intake alone is insufficient to meet physiological requirements. Ferrous bisglycinate has consistently demonstrated: - excellent absorption - high bioavailability - improved gastrointestinal tolerability relative to conventional ferrous salts.(3-5) ### Safety The selected dose remains well below the **Tolerable Upper Intake Level (UL)** of **45 mg/day** established for healthy adults.(2) Using the RDA rather than a pharmacologic dose minimizes gastrointestinal side effects while providing meaningful physiological support. ### Formulation Compatibility Ferrochel® was selected because it: - demonstrates excellent bioavailability - produces fewer gastrointestinal adverse effects than ferrous sulfate - works synergistically with vitamin C - is compatible with once-daily supplementation ### HR+ Philosophy Iron demonstrates no estrogenic or endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Iron is among the most extensively studied minerals in clinical nutrition. Strong evidence supports its role in: - maintenance of iron status - prevention of iron deficiency - hemoglobin synthesis - oxygen transport - mitochondrial metabolism Ferrous bisglycinate has been evaluated in numerous randomized controlled trials demonstrating comparable or superior absorption with improved gastrointestinal tolerance compared with ferrous sulfate.(3-5) # 7. Safety Considerations Iron has an excellent safety profile when used at nutritional doses in appropriate populations. ### Recommended Dietary Allowance (Premenopausal Women): 18 mg/day ### FEMSTATE Dose: 18 mg/day ### Tolerable Upper Intake Level: 45 mg/day Potential adverse effects associated with excessive intake include: - constipation - nausea - abdominal discomfort - iron overload in susceptible individuals These effects are less common with **ferrous bisglycinate** than with many conventional iron preparations. Iron supplementation should not be used by individuals with: - hereditary hemochromatosis - iron overload disorders - elevated ferritin without medical supervision # 8. HR+ Safety Review Ferrochel® was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Iron is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin C** Vitamin C enhances absorption of non-heme iron by reducing ferric iron to the more absorbable ferrous form -> Strong physiological synergy **Vitamin B12** Supports coordinated erythropoiesis -> Positive synergy **Folate** Supports DNA synthesis and red blood cell formation -> Positive synergy ### Potential Negative Interactions Absorption may be reduced by simultaneous intake of: - calcium - high-dose zinc - phytates - tannins (tea and coffee) These interactions can be minimized by appropriate timing of supplementation. ### Known Considerations Individuals with diagnosed iron overload disorders or elevated ferritin concentrations should not supplement iron unless directed by a healthcare professional. # 10. Regulatory Status Ferrochel® is: - An internationally recognized branded ingredient. - Widely used in dietary supplements. - Supported by multiple human bioavailability studies. - Accepted for use in nutritional products worldwide. Iron is recognized as an essential nutrient by: - National Institutes of Health Office of Dietary Supplements. - Dietary Reference Intakes. # 11. Evidence Gaps & Future Research Current evidence strongly supports iron for: - maintenance of iron status - hemoglobin synthesis - oxygen transport - erythropoiesis Areas requiring additional investigation include: - Phase-specific iron utilization throughout the menstrual cycle. - Biomarker-guided phase-aligned iron supplementation. - Clinical evaluation of RESET™ as an integrated formulation supporting menstrual physiology. No randomized controlled trials have specifically evaluated **Ferrochel®** within a phase-aligned nutritional system. # 12. Conclusion Iron, provided as **Ferrochel® (ferrous bisglycinate chelate)**, is one of the most physiologically targeted ingredients within the FEMSTATE™ platform. Its inclusion is limited to **RESET™**, reflecting the unique biology of menstruation as the only phase associated with physiological blood loss. The selected dose of **18 mg elemental iron** corresponds to the Recommended Dietary Allowance for premenopausal women and was chosen based on biological relevance, extensive human clinical evidence, excellent gastrointestinal tolerability, and long-term safety. Ferrochel® was specifically selected because it combines high bioavailability with improved tolerability compared with conventional iron salts. Within the FEMSTATE™ formulation strategy, iron supports the physiological priorities of tissue regeneration, erythropoiesis, mitochondrial metabolism, and restoration of iron homeostasis without altering endocrine function or serving as a treatment for iron deficiency anemia. ## References - National Institutes of Health Office of Dietary Supplements. Iron Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - The American Journal of Clinical Nutrition. Reviews on iron metabolism and women's health. - Nutrients. Systematic reviews on ferrous bisglycinate bioavailability and tolerability. - The Journal of Clinical Endocrinology & Metabolism. Reviews on iron physiology, erythropoiesis, and female nutrition. - Williams Textbook of Endocrinology. # Ingredient Scientific Monograph # Zinc (as Zinc Picolinate) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Zinc **Chemical Name:** Zinc **Ingredient Form:** Zinc Picolinate **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 10 mg elemental zinc | | LIFT™ | 10 mg elemental zinc | | SHINE™ | - | | SOOTHE™ | - | Zinc is included in **RESET™** and **LIFT™** because of its essential role in **cellular repair, DNA synthesis, immune regulation, protein synthesis, antioxidant defense, and reproductive physiology**. Zinc picolinate was selected because it is a highly bioavailable form that has demonstrated efficient intestinal absorption compared with several inorganic zinc salts.(1-4) # 2. Physiological Role Zinc is an essential trace mineral involved in the activity of more than **300 enzymes** and over **2,000 transcription factors**. It participates in virtually every aspect of cellular metabolism, including DNA synthesis, RNA transcription, protein synthesis, immune regulation, wound healing, antioxidant defense, reproductive physiology, and cell signaling.(1-4) Zinc contributes to: - DNA synthesis - Cellular proliferation - Protein synthesis - Connective tissue remodeling - Immune homeostasis - Antioxidant defense - Wound healing - Skin physiology - Reproductive tissue maintenance These biological functions are particularly relevant during the regenerative physiology of **RESET™** and the anabolic physiology of **LIFT™.** # Mechanism of Action Zinc exerts its physiological effects through numerous biochemical pathways. ### DNA and RNA Synthesis Zinc functions as a structural and catalytic cofactor for enzymes involved in: - DNA replication - RNA transcription - Cell division - Tissue regeneration These pathways are fundamental to endometrial repair and follicular growth. ### Protein Synthesis Zinc supports: - ribosomal function - translation - enzyme synthesis - connective tissue remodeling This mechanism is particularly relevant during tissue regeneration and anabolic physiology. ### Immune Regulation Zinc contributes to: - lymphocyte development - neutrophil physiology - macrophage function - cytokine regulation Rather than stimulating immunity, zinc supports maintenance of **normal immune homeostasis**. ### Antioxidant Physiology Zinc serves as a structural component of **superoxide dismutase (Cu/Zn-SOD),** one of the body’s principal endogenous antioxidant enzymes. This pathway contributes to maintenance of physiological redox balance during tissue remodeling and cellular metabolism. # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase emphasizes: - tissue regeneration - wound repair - immune homeostasis - extracellular matrix remodeling Zinc supports these biological priorities through its roles in DNA synthesis, protein synthesis, immune physiology, and antioxidant defense. ## LIFT™ The follicular phase emphasizes: - cellular proliferation - anabolic metabolism - connective tissue growth - follicular development Zinc supports these physiological priorities by facilitating DNA replication, protein synthesis, and cellular growth. # 5. Dose Justification ## Selected Dose: 10 mg elemental zinc The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **10 mg/day** provides approximately **90% of the Daily Value**, supporting normal cellular physiology while complementing dietary zinc intake. This dose supports: - tissue regeneration - immune homeostasis - protein synthesis - cellular proliferation without approaching excessive intake. ### Human Clinical Evidence Numerous randomized controlled trials have evaluated zinc supplementation across a range of physiological outcomes. Human studies commonly use doses between **10-30 mg/day**, with 10 mg representing an effective nutritional maintenance dose for healthy adults. ### Safety The selected dose remains well below the established **Tolerable Upper Intake Level (UL)** of **40 mg/day** for adults.² This minimizes the risk of long-term disturbances in copper metabolism while maintaining physiological efficacy. ### Formulation Compatibility Zinc picolinate was selected because it: - demonstrates excellent bioavailability - supports long-term daily supplementation - complements vitamin C and selenium - fits well within the formulation without excessive mineral competition ### HR+ Philosophy Zinc demonstrates no direct endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Zinc is among the most extensively studied trace minerals in human nutrition. Strong evidence supports its role in: - immune physiology - wound healing - DNA synthesis - protein synthesis - maintenance of normal zinc status Evidence supporting female reproductive physiology primarily relates to normal ovarian function and reproductive health rather than phase-specific supplementation. # 7. Safety Considerations Zinc has an excellent safety profile at nutritional doses. ### Recommended Dietary Allowance (Women): 8 mg/day ### FEMSTATE Dose: 10 mg/day ### Tolerable Upper Intake Level: 40 mg/day Potential adverse effects associated with excessive intake include: - nausea - gastrointestinal discomfort - impaired copper absorption - reduced HDL cholesterol (with prolonged excessive intake) These effects occur primarily with long-term intakes substantially exceeding the FEMSTATE dose. # 8. HR+ Safety Review Zinc was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor agonist activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Zinc is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin C** Supports complementary immune physiology and connective tissue repair -> Positive synergy **Vitamin A** Works together to maintain epithelial integrity and immune function -> Strong physiological synergy **Selenium** Supports complementary endogenous antioxidant systems -> Positive synergy ### Potential Negative Interactions High supplemental intakes of: - iron - calcium - copper may reduce zinc absorption when consumed simultaneously at pharmacological doses. These interactions are minimal at the nutritional doses used within FEMSTATE™. ### Known Considerations Long-term zinc supplementation above the UL should be accompanied by appropriate copper intake. The FEMSTATE dose does not approach levels associated with clinically meaningful copper depletion. # 10. Regulatory Status Zinc picolinate is: - Widely accepted for use in dietary supplements. - Recognized by the National Institutes of Health Office of Dietary Supplements as an appropriate supplemental zinc form. - Included in the U.S. Dietary Reference Intakes. - Supported by international nutritional recommendations. # 11. Evidence Gaps & Future Research Current evidence strongly supports zinc for: - immune physiology - DNA synthesis - wound healing - cellular metabolism Areas requiring further investigation include: - Phase-specific zinc utilization during the menstrual cycle. - Zinc requirements during regenerative versus anabolic physiology. - Clinical evaluation of zinc picolinate within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated zinc picolinate within a phase-aligned formulation. # 12. Conclusion Zinc, provided as **zinc picolinate**, is a foundational trace mineral within the FEMSTATE™ platform because of its established roles in DNA synthesis, protein synthesis, immune regulation, wound healing, connective tissue biology, and antioxidant defense. The selected dose of **10 mg/day** provides meaningful physiological support while remaining well below the established upper intake level for long-term supplementation. Zinc picolinate was intentionally selected because of its favorable bioavailability and compatibility with the formulation. Within FEMSTATE™, zinc supports the regenerative physiology of **RESET™** and the anabolic biology of **LIFT™**, aligning with the biological priorities of tissue renewal and cellular growth without directly influencing reproductive hormone production. ## References - National Institutes of Health Office of Dietary Supplements. Zinc Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on zinc physiology and human metabolism. - Nutrients. Systematic reviews on zinc supplementation, immune physiology, and wound healing. - The Journal of Clinical Endocrinology & Metabolism. Reviews on zinc, reproductive physiology, and endocrine health. - Free Radical Biology and Medicine. Reviews on zinc and endogenous antioxidant systems. # Ingredient Scientific Monograph # Selenium (as L-Selenomethionine) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Selenium **Chemical Name:** Selenium **Ingredient Form:** L-Selenomethionine **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 55 mcg | | LIFT™ | 55 mcg | | SHINE™ | 55 mcg | | SOOTHE™ | 55 mcg | Selenium is included in all four FEMSTATE™ formulations because of its essential role in **antioxidant defense, thyroid hormone metabolism, immune regulation, mitochondrial function, and cellular protection**. L-selenomethionine was selected because it demonstrates excellent oral bioavailability and efficiently supports physiological selenium status. Unlike phase-specific ingredients, selenium supports fundamental biological processes that remain active throughout the menstrual cycle. # 2. Physiological Role Selenium is an essential trace mineral incorporated into at least **25 human selenoproteins**, many of which regulate antioxidant defense, thyroid hormone activation, redox homeostasis, immune function, and cellular metabolism. Selenium is unique among trace minerals because it is incorporated directly into proteins as the amino acid **selenocysteine**, allowing specialized biological functions.(1-4) Selenium contributes to: - Antioxidant defense - Glutathione peroxidase activity - Thyroid hormone metabolism - Immune homeostasis - Mitochondrial function - DNA protection - Cellular redox regulation - Reproductive physiology These physiological functions remain important throughout every phase of the menstrual cycle. # 3. Mechanism of Action Selenium functions primarily through incorporation into **selenoproteins**. ### Antioxidant Physiology Selenium is required for synthesis of: - Glutathione peroxidase (GPx) - Thioredoxin reductase - Selenoprotein P These enzymes protect cells from excessive oxidative damage while maintaining physiological redox signaling. Unlike exogenous antioxidants, selenium supports the body's **endogenous antioxidant systems**. ### Thyroid Hormone Metabolism Selenium-dependent iodothyronine deiodinases convert: T4 -> T3 maintaining normal thyroid physiology. Because thyroid hormones regulate metabolism, selenium indirectly supports cellular energy production. ### Immune Regulation Selenium contributes to: - lymphocyte proliferation - natural killer cell function - cytokine regulation - maintenance of immune homeostasis Its role is regulatory rather than stimulatory. ### Mitochondrial Function Selenium-dependent antioxidant enzymes help preserve: - mitochondrial membrane integrity - oxidative phosphorylation - ATP production particularly during periods of increased metabolic activity. # 4. Why Included in FEMSTATE™ Unlike phase-specific nutrients, selenium supports physiological systems that remain active throughout the menstrual cycle. ### RESET™ Supports: - endogenous antioxidant defense - tissue regeneration - immune homeostasis ### LIFT™ Supports: - mitochondrial metabolism - cellular proliferation - antioxidant regulation ### SHINE™ Supports: - physiological oxidative balance - mitochondrial resilience - protection during ovulatory remodeling ### SOOTHE™ Supports: - immune regulation - metabolic homeostasis - thyroid physiology - maintenance of cellular integrity For these reasons, selenium is maintained at a constant dose across all four formulations. # 5. Dose Justification ## Selected Dose: 55 mcg The selected dose was based on five scientific criteria. ### Physiological Relevance A dose of **55 mcg/day** corresponds to the **Recommended Dietary Allowance (RDA)** for adult women and supports normal selenoprotein synthesis and antioxidant physiology. ### Human Clinical Evidence Human intervention studies demonstrate that selenium intake at recommended levels supports: - glutathione peroxidase activity - thyroid hormone metabolism - maintenance of selenium status Higher doses have not consistently demonstrated additional physiological benefit in selenium-replete individuals. ### Safety The selected dose remains well below the adult **Tolerable Upper Intake Level (UL)** of **400 mcg/day**, providing an excellent safety margin. ### Formulation Compatibility The selected dose: - complements vitamin E - complements vitamin C - complements CoQ10 - supports endogenous antioxidant systems - avoids excessive selenium exposure when combined with dietary intake ### HR+ Philosophy Selenium demonstrates no known estrogenic or progesterone receptor activity and aligns fully with the FEMSTATE™ HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Selenium has been extensively studied in relation to: - antioxidant physiology - thyroid function - immune regulation - maintenance of selenium status The strongest evidence supports maintenance of normal selenium nutrition and selenoprotein function rather than pharmacological supplementation. # 7. Safety Considerations Selenium has an excellent safety profile at nutritional doses. ### Recommended Dietary Allowance (Women): 55 mcg/day ### FEMSTATE Dose: 55 mcg/day ### Tolerable Upper Intake Level: 400 mcg/day Chronic excessive selenium intake may produce: - brittle hair - brittle nails - gastrointestinal upset - garlic odor on breath - neurological symptoms (selenosis) These effects occur at intakes substantially higher than the dose used in FEMSTATE™. # 8. HR+ Safety Review Selenium was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Current evidence does not support selenium supplementation as a treatment for hormone-sensitive cancers. Within nutritional doses, selenium is considered compatible with the HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin E** Selenium and vitamin E function synergistically within endogenous antioxidant systems -> Strong antioxidant synergy **Vitamin C** Supports complementary redox physiology -> Positive synergy **CoQ10** Supports mitochondrial antioxidant physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Magnesium - Zinc - Vitamin D3 - Vitamin K2 at FEMSTATE doses. ### Known Considerations Individuals taking high-dose selenium supplements from multiple sources should monitor total intake to remain below the established UL. # 10. Regulatory Status L-selenomethionine is: - Recognized as a dietary ingredient. - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements as an appropriate selenium source. - Widely accepted for use in dietary supplements worldwide. # 11. Evidence Gaps & Future Research Current evidence strongly supports selenium for: - glutathione peroxidase activity - thyroid hormone metabolism - antioxidant physiology - immune regulation Areas requiring further investigation include: - Phase-specific selenium metabolism across the menstrual cycle. - Selenium requirements during ovulatory oxidative remodeling. - Clinical evaluation of selenium within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated L-selenomethionine within a phase-aligned formulation. # 12. Conclusion Selenium, provided as **L-selenomethionine**, is a foundational micronutrient within the FEMSTATE™ platform because of its indispensable roles in endogenous antioxidant defense, thyroid hormone metabolism, immune regulation, mitochondrial physiology, and cellular protection. The selected dose of **55 mcg/day** corresponds to the Recommended Dietary Allowance for adult women and provides physiological support while maintaining a wide safety margin below the established upper intake level. Its inclusion across **RESET™, LIFT™, SHINE™, and SOOTHE™** reflects the continuous importance of selenoprotein function throughout the menstrual cycle rather than phase-specific endocrine changes. By supporting the body's own antioxidant enzyme systems rather than acting as a direct antioxidant itself, selenium contributes to the maintenance of normal cellular resilience across all physiological phases of the FEMSTATE™ platform. ## References - National Institutes of Health Office of Dietary Supplements. Selenium Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on selenium metabolism and human nutrition. - Nutrients. Systematic reviews on selenium, glutathione peroxidase, and antioxidant physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on selenium, thyroid physiology, and reproductive endocrinology. - Endocrine Reviews. Reviews on selenium biology and endocrine regulation. # Ingredient Scientific Monograph # Chromium (as Chromium Picolinate) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Chromium **Chemical Name:** Trivalent Chromium **Ingredient Form:** Chromium Picolinate **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 35 mcg | | LIFT™ | 35 mcg | | SHINE™ | 35 mcg | | SOOTHE™ | 35 mcg | Chromium is included in all four FEMSTATE™ formulations because of its role in **glucose metabolism, insulin signaling, cellular energy production, and metabolic homeostasis**. Chromium picolinate was selected because it is one of the most extensively studied and bioavailable supplemental forms of chromium, with substantial human clinical literature supporting its physiological role in maintaining normal carbohydrate metabolism.(1-4) Unlike ingredients that target a specific endocrine phase, chromium provides consistent metabolic support throughout the menstrual cycle. # 2. Physiological Role Chromium is an essential trace mineral involved in the regulation of **glucose metabolism and insulin action.** Although only very small amounts are required physiologically, chromium participates in maintaining normal carbohydrate, protein, and lipid metabolism by enhancing the efficiency of insulin signaling.(1-4) Chromium contributes to: - Normal insulin signaling - Glucose utilization - Cellular energy metabolism - Carbohydrate metabolism - Lipid metabolism - Protein metabolism - Maintenance of metabolic homeostasis These physiological functions support cellular metabolism across all menstrual phases. # 3. Mechanism of Action Chromium functions primarily through modulation of insulin signaling. ### Insulin Physiology Current evidence suggests chromium enhances the activity of insulin after insulin binds to its receptor. Insulin -> Insulin receptor activation -> Enhanced intracellular signaling -> Glucose uptake -> ATP production -> Cellular metabolism Importantly, chromium does **not** stimulate insulin secretion. Instead, it supports normal insulin function. ### Cellular Energy Production By facilitating efficient glucose utilization, chromium indirectly supports: - ATP synthesis - mitochondrial metabolism - cellular respiration These pathways are fundamental throughout the menstrual cycle. ### Macronutrient Metabolism Chromium participates in: - carbohydrate metabolism - lipid metabolism - amino acid metabolism supporting overall metabolic homeostasis. # 4. Why Included in FEMSTATE™ Chromium supports metabolic physiology throughout every endocrine phase. ### RESET™ Supports: - restoration of metabolic homeostasis - cellular energy production - glucose metabolism during tissue repair ### LIFT™ Supports: - anabolic metabolism - efficient glucose utilization - mitochondrial ATP production ### SHINE™ Supports: - increased cellular energy demand - metabolic flexibility - maintenance of physiological glucose metabolism ### SOOTHE™ Supports: - metabolic stability - efficient energy utilization - maintenance of normal insulin physiology Because these biological functions remain important throughout the menstrual cycle, chromium is maintained at a constant dose across all four formulations. # 5. Dose Justification ## Selected Dose: 35 mcg The selected dose was based upon five scientific criteria. ### Physiological Relevance A daily intake of **35 mcg** corresponds to the Daily Value used for dietary supplements and provides physiological support for normal insulin function and carbohydrate metabolism. ### Human Clinical Evidence Clinical studies investigating chromium picolinate have evaluated doses ranging from **35-1,000 mcg/day**, depending on the population and clinical objective. For healthy women without metabolic disease, a nutritional dose of **35 mcg/day** supports normal chromium status while avoiding unnecessary pharmacologic exposure. ### Safety The selected dose provides nutritional support while remaining substantially below doses evaluated in therapeutic research. ### Formulation Compatibility The selected dose: - complements magnesium - complements B-complex vitamins - supports mitochondrial metabolism - supports long-term daily supplementation ### HR+ Philosophy Chromium demonstrates no direct endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Chromium picolinate has been extensively studied in relation to: - glucose metabolism - insulin physiology - maintenance of chromium status - carbohydrate metabolism The strongest evidence supports chromium's role in maintaining normal glucose metabolism in individuals with inadequate chromium intake. Evidence for additional metabolic benefits in healthy chromium-replete populations is less consistent. # 7. Safety Considerations Chromium picolinate has an excellent safety profile at nutritional doses. ### Adequate Intake (Women): 25 mcg/day ### FEMSTATE Dose: 35 mcg/day - Tolerable Upper Intake Level No UL has been established because adverse effects have not been consistently demonstrated from nutritional chromium intake.² Rare reports of adverse events have generally involved prolonged consumption of doses hundreds of times greater than those used in FEMSTATE™. # 8. HR+ Safety Review Chromium picolinate was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Chromium picolinate is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Magnesium** Supports complementary insulin signaling and glucose metabolism -> Positive metabolic synergy **Vitamin B3** Supports carbohydrate metabolism and mitochondrial physiology -> Positive synergy **Vitamin B1** Supports glucose utilization and ATP production -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Vitamin D3 - Zinc - Selenium at FEMSTATE doses. ### Known Considerations Individuals using glucose-lowering medications should discuss chromium supplementation with their healthcare provider, as chromium may modestly influence glucose metabolism. The nutritional dose used in FEMSTATE™ is not intended to treat diabetes or alter medication requirements. # 10. Regulatory Status Chromium picolinate is: - Recognized as a dietary ingredient. - Included in the U.S. Dietary Reference Intakes through Adequate Intake recommendations. - Recognized by the National Institutes of Health Office of Dietary Supplements. - Widely accepted for use in dietary supplements internationally. # 11. Evidence Gaps & Future Research Current evidence strongly supports chromium for: - maintenance of normal glucose metabolism - insulin physiology - carbohydrate metabolism Areas requiring further investigation include: - Phase-specific chromium utilization during the menstrual cycle. - Metabolic flexibility across different endocrine environments. - Clinical evaluation of chromium picolinate within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated chromium picolinate within a phase-aligned nutritional formulation. # 12. Conclusion Chromium, provided as **chromium picolinate**, serves as a foundational metabolic micronutrient within the FEMSTATE™ platform because of its established role in supporting normal insulin signaling, glucose utilization, and cellular energy metabolism. The selected dose of **35 mcg/day** aligns with nutritional recommendations and provides physiological support while maintaining an excellent safety profile. Its inclusion across **RESET™, LIFT™, SHINE™, and SOOTHE™** reflects the continuous importance of metabolic homeostasis throughout the menstrual cycle rather than phase-specific endocrine changes. Chromium does not alter reproductive hormone physiology; instead, it supports the efficient cellular metabolism that underpins tissue regeneration, anabolic growth, ovulatory transition, and physiological maintenance across all phases of the FEMSTATE™ system. ## References - National Institutes of Health Office of Dietary Supplements. Chromium Fact Sheet for Health Professionals. - Institute of Medicine Dietary Reference Intakes. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on chromium physiology and glucose metabolism. - Nutrients. Systematic reviews on chromium picolinate and metabolic health. - The Journal of Clinical Endocrinology & Metabolism. Reviews on insulin physiology, metabolism, and micronutrients. - Endocrine Society. Clinical guidance on metabolic physiology and endocrine health. # Ingredient Scientific Monograph # Potassium (as Potassium Citrate) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Potassium **Chemical Name:** Potassium **Ingredient Form:** Potassium Citrate **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 200 mg elemental potassium | Potassium is included exclusively in **SOOTHE™** because the luteal phase is characterized by **physiological changes in fluid regulation, electrolyte balance, neuromuscular physiology, and cellular homeostasis** under progesterone dominance. Potassium citrate was selected because it is highly bioavailable, well tolerated, and contributes to acid-base balance while supporting normal electrolyte physiology. # 2. Physiological Role Potassium is the principal intracellular cation and is essential for maintaining **cell membrane potential, neuromuscular function, intracellular fluid balance, acid-base homeostasis, cardiovascular physiology, and cellular metabolism**. Approximately 98% of total body potassium resides inside cells, where it plays a critical role in electrical signaling and ATP-dependent transport.(1-4) Potassium contributes to: - Cellular membrane potential - Muscle contraction - Nerve impulse transmission - Fluid balance - Acid-base regulation - Cardiovascular physiology - Cellular energy metabolism - Electrolyte homeostasis These physiological processes are continuously active but become particularly relevant during the luteal phase, when progesterone influences fluid distribution and metabolic regulation. # 3. Mechanism of Action Potassium functions primarily through maintenance of electrochemical gradients across cell membranes. ### Cellular Electrical Activity The sodium-potassium ATPase pump maintains: High intracellular potassium -> Normal membrane potential -> Nerve conduction -> Muscle contraction -> Cellular homeostasis This mechanism is fundamental to every excitable tissue in the body. ### Fluid Regulation Potassium contributes to: - intracellular fluid balance - osmotic regulation - maintenance of normal cell volume These processes complement the physiological adaptations occurring during the luteal phase. ### Neuromuscular Physiology Adequate potassium is required for: - skeletal muscle function - smooth muscle physiology - cardiac electrical activity - nervous system signaling ### Acid-Base Homeostasis Potassium citrate contributes citrate, which is metabolized to bicarbonate, supporting normal physiological acid-base balance. # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase emphasizes: - physiological fluid regulation - metabolic homeostasis - neuromuscular physiology - maintenance of cellular stability - electrolyte balance Progesterone influences renal handling of sodium and water and contributes to normal physiological changes in fluid distribution. Potassium supports these adaptive processes by maintaining intracellular electrolyte balance and normal neuromuscular function. Importantly, potassium is **not included to treat bloating or fluid retention**, but rather to support the normal physiological regulation of electrolyte homeostasis during the luteal phase. # 5. Dose Justification ## Selected Dose: 200 mg elemental potassium The selected dose was based on five scientific criteria. ### Physiological Relevance The dose provides meaningful supplemental potassium while recognizing that potassium requirements are primarily met through food. The formulation is intended to complement - not replace - dietary potassium intake. ### Human Clinical Evidence Clinical research demonstrates that adequate potassium intake supports: - neuromuscular physiology - cardiovascular health - normal blood pressure regulation - electrolyte balance Most intervention studies use dietary approaches rather than supplementation because potassium is abundant in whole foods. ### Safety The selected dose remains modest relative to typical dietary potassium intake and is well tolerated in healthy individuals with normal kidney function. ### Formulation Compatibility The selected dose: - complements magnesium - supports neuromuscular physiology - contributes to electrolyte balance - fits safely within the overall formulation ### HR+ Philosophy Potassium demonstrates no endocrine activity and fully aligns with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Potassium has been extensively studied in relation to: - cardiovascular physiology - electrolyte balance - neuromuscular function - blood pressure regulation The strongest evidence supports maintenance of adequate total potassium intake through diet. Supplemental potassium at nutritional doses contributes to overall potassium intake but is not generally intended as a therapeutic intervention in healthy individuals. # 7. Safety Considerations Potassium is safe at nutritional supplemental doses in healthy individuals. ### Adequate Intake (Women): 2,600 mg/day (primarily from food) ### FEMSTATE Dose: 200 mg/day - Tolerable Upper Intake Level No formal UL has been established for potassium from food. Supplemental potassium requires caution in individuals with impaired renal function or those taking medications that increase serum potassium. Potential adverse effects with excessive supplemental potassium include: - gastrointestinal irritation - hyperkalemia (primarily in susceptible individuals) - cardiac rhythm disturbances in severe cases The dose used in FEMSTATE is conservative and intended for healthy adults. # 8. HR+ Safety Review Potassium citrate was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Potassium citrate is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Magnesium** Potassium and magnesium work together to maintain: - neuromuscular physiology - electrolyte balance - cellular membrane function -> Strong physiological synergy **Sodium** Potassium complements sodium in maintaining fluid and electrolyte homeostasis -> Physiological balance ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Vitamin D3 - Selenium - Zinc at FEMSTATE doses. ### Known Considerations. Individuals with: - chronic kidney disease - adrenal insufficiency - hyperkalemia - those taking potassium-sparing diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), or mineralocorticoid receptor antagonists should consult a healthcare professional before potassium supplementation. # 10. Regulatory Status Potassium citrate is: - Recognized as a dietary ingredient. - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements. - Widely accepted for use in dietary supplements. # 11. Evidence Gaps & Future Research Current evidence strongly supports potassium for: - electrolyte homeostasis - neuromuscular physiology - cardiovascular health Areas requiring additional investigation include: - Electrolyte physiology across different menstrual phases. - Luteal-phase adaptations in intracellular electrolyte regulation. - Clinical evaluation of potassium citrate within phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated potassium citrate within a phase-aligned nutritional formulation. # 12. Conclusion Potassium, provided as **potassium citrate**, was specifically incorporated into **SOOTHE™** because of its established role in maintaining electrolyte balance, neuromuscular physiology, intracellular fluid homeostasis, and cellular stability during the progesterone-dominant luteal phase. The selected dose of **200 mg elemental potassium** provides meaningful supplemental support while recognizing that potassium requirements are primarily met through dietary intake. Rather than functioning as a treatment for fluid retention or premenstrual symptoms, potassium supports the normal physiological adaptations of the luteal phase by contributing to electrolyte homeostasis, neuromuscular function, and metabolic stability. Its inclusion reflects the FEMSTATE™ philosophy of aligning nutritional support with the biological priorities of each endocrine environment. ## References - National Institutes of Health Office of Dietary Supplements. Potassium Fact Sheet for Health Professionals. - Dietary Reference Intakes. - Williams Textbook of Endocrinology. - Guyton and Hall Textbook of Medical Physiology. - The American Journal of Clinical Nutrition. Reviews on potassium physiology and cardiovascular health. - Nutrients. Systematic reviews on potassium intake, electrolyte physiology, and metabolic health. - The Journal of Clinical Endocrinology & Metabolism. Reviews on electrolyte physiology and endocrine regulation. # Ingredient Scientific Monograph # Sodium ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Sodium **Chemical Name:** Sodium **Ingredient Form:** Sodium (mineral salt) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | 15 mg | | SOOTHE™ | 10 mg | Sodium is included in **SHINE™** and **SOOTHE™** as a **physiological electrolyte** rather than as a major dietary sodium source. The amounts included are intentionally small and are designed to complement potassium and magnesium in maintaining **cellular hydration, neuromuscular function, and electrolyte balance** during phases characterized by increased metabolic activity (SHINE™) and physiological stabilization (SOOTHE™). # 2. Physiological Role Sodium is the principal **extracellular cation** and is essential for maintaining extracellular fluid volume, nerve impulse transmission, muscle contraction, acid-base homeostasis, and nutrient transport across cell membranes. Together with potassium, sodium establishes the electrochemical gradients required for normal cellular physiology.(1-4) Sodium contributes to: - Extracellular fluid balance - Cellular hydration - Nerve conduction - Skeletal muscle contraction - Cardiac electrical activity - Nutrient transport - Acid-base regulation - Maintenance of blood volume Unlike potassium, which is predominantly intracellular, sodium functions primarily in the extracellular compartment and works continuously to maintain physiological homeostasis. # 3. Mechanism of Action Sodium functions through maintenance of extracellular electrochemical gradients. ### Sodium-Potassium ATPase The sodium-potassium pump continuously transports: 3 Sodium ions out of the cell -> 2 Potassium ions into the cell -> Maintenance of membrane potential -> Normal nerve transmission -> Muscle contraction -> Cellular homeostasis This ATP-dependent mechanism is fundamental to every excitable tissue in the human body. ### Fluid Homeostasis Sodium regulates: - extracellular osmolarity - plasma volume - tissue perfusion - hydration status These processes are tightly controlled by: - aldosterone - vasopressin (ADH) - the renin-angiotensin-aldosterone system (RAAS) ### Nutrient Transport Sodium gradients drive absorption of: - glucose - amino acids - certain vitamins through sodium-dependent transport proteins within the gastrointestinal tract. # 4. Why Included in FEMSTATE™ ## SHINE™ Ovulation is associated with: - increased cellular metabolism - heightened mitochondrial activity - active tissue remodeling - increased physiological demand for electrolyte homeostasis The small amount of sodium supports normal extracellular electrolyte balance while complementing potassium and magnesium. ## SOOTHE™ The luteal phase emphasizes: - metabolic stability - neuromuscular regulation - maintenance of fluid homeostasis - cellular equilibrium Progesterone influences renal sodium handling through interactions with mineralocorticoid signaling, although the overall physiological response varies among individuals. The small sodium contribution within SOOTHE™ complements the electrolyte profile without materially increasing total dietary sodium intake. # 5. Dose Justification ## Selected Dose **SHINE™ - 15 mg** **SOOTHE™ - 10 mg** The selected doses were based upon five scientific criteria. ### Physiological Relevance The doses provide **electrolyte balance** within the formulation rather than serving as a significant dietary sodium source. Average daily sodium intake from food typically exceeds **2,500–3,500 mg/day**, making the sodium contribution from FEMSTATE nutritionally negligible but formulationally useful. ### Human Clinical Evidence Current evidence supports maintaining normal sodium homeostasis for: - neuromuscular physiology - extracellular fluid regulation - nutrient transport There is **no evidence** that women require phase-specific sodium supplementation during the menstrual cycle. Accordingly, the sodium included in FEMSTATE is intended to support **electrolyte balance within the formulation**, not to alter sodium intake. ### Safety The selected doses are extremely small relative to normal dietary sodium consumption and have no meaningful impact on total sodium intake in healthy adults. ### Formulation Compatibility Low-dose sodium complements: - potassium - magnesium to maintain physiological electrolyte balance without contributing materially to dietary sodium exposure. ### HR+ Philosophy Sodium demonstrates no endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Human evidence strongly supports sodium's role in: - extracellular fluid balance - nerve conduction - muscle physiology - cardiovascular regulation However, there is **no evidence supporting phase-specific sodium supplementation** in healthy menstruating women. For this reason, sodium was included solely to complement the formulation's electrolyte profile. # 7. Safety Considerations ### Adequate Intake (Women): Approximately 1,500 mg/day (varies by guideline and age) ### FEMSTATE Dose: SHINE™: 15 mg / SOOTHE™: 10 mg These represent **less than 1% **of typical daily sodium intake. No safety concerns are anticipated from the amounts included in FEMSTATE. # 8. HR+ Safety Review Sodium was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. ### Findings Current evidence demonstrates: ✔ No estrogen receptor activity ✔ No progesterone receptor activity ✔ No aromatase modulation ✔ No endocrine activity ✔ Favorable oncology safety profile # 9. Ingredient Interactions ### Positive Interactions **Potassium** Maintains physiological electrochemical gradients -> Strong physiological synergy **Magnesium** Supports neuromuscular physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin C - Vitamin D3 - Selenium - Zinc at FEMSTATE doses. ### Known Considerations Individuals following physician-prescribed sodium-restricted diets should continue following medical advice. The sodium contribution from FEMSTATE is extremely small and is unlikely to meaningfully affect total sodium intake. # 10. Regulatory Status Sodium is: - An essential dietary mineral. - Included in the U.S. Dietary Reference Intakes. - Recognized by the National Institutes of Health Office of Dietary Supplements. - Universally accepted for use in foods and dietary supplements. # 11. Evidence Gaps & Future Research Current evidence strongly supports sodium for: - fluid balance - neuromuscular physiology - electrolyte homeostasis However: - There is **little evidence** supporting menstrual phase-specific sodium requirements. - No randomized controlled trials have evaluated low-dose sodium supplementation within a phase-aligned nutritional formulation. Future research may explore electrolyte dynamics across menstrual phases, particularly during exercise and heat stress. # 12. Conclusion Sodium is included in **SHINE™ (15 mg)** and **SOOTHE™ (10 mg)** as a **supportive electrolyte**, not as a major source of dietary sodium. The amounts are intentionally minimal and are designed to complement potassium and magnesium in maintaining normal extracellular fluid balance, neuromuscular physiology, and cellular homeostasis. Because typical dietary sodium intake already greatly exceeds the quantities provided by FEMSTATE™, the rationale for inclusion is formulation balance rather than correction of sodium deficiency. Within the FEMSTATE™ platform, sodium supports the integrated electrolyte physiology of the ovulatory and luteal phases without influencing endocrine function or materially altering total sodium intake. ## References - National Institutes of Health Office of Dietary Supplements. Sodium and Electrolytes Guidance. - Dietary Reference Intakes. - Guyton and Hall Textbook of Medical Physiology. - Williams Textbook of Endocrinology. - The American Journal of Clinical Nutrition. Reviews on sodium physiology and electrolyte balance. - Hypertension. Reviews on sodium homeostasis and cardiovascular physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on electrolyte physiology and endocrine regulation. # Ingredient Scientific Monograph # L-Theanine ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** L-Theanine **Chemical Name:** γ-Glutamylethylamide **Ingredient Form:** L-Theanine **Natural Source:** Primarily found in the leaves of Green tea **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 200 mg | L-Theanine is included exclusively in **SOOTHE™** because the luteal phase is characterized by **progesterone dominance, neuroendocrine regulation, GABAergic modulation, and physiological recovery**. Unlike sedative compounds, L-theanine promotes a state of **relaxed alertness**, supporting normal brain physiology without impairing cognitive function. Its mechanism aligns closely with the biological priorities of the luteal phase, which emphasize neurophysiological stability rather than stimulation. # 2. Physiological Role L-Theanine is a naturally occurring non-protein amino acid that readily crosses the blood-brain barrier and influences several neurotransmitter systems involved in cognitive function, stress adaptation, and neuronal homeostasis. Human and mechanistic studies indicate that L-theanine modulates glutamatergic signaling while indirectly influencing GABA, dopamine, serotonin, and alpha-wave brain activity.(1-4) L-Theanine contributes to: - Neurophysiological regulation - Maintenance of relaxed alertness - Alpha brain wave activity - GABAergic physiology - Glutamate homeostasis - Cognitive performance under stress - Sleep quality support - Neuroendocrine adaptation These physiological functions are particularly relevant during the progesterone-dominant luteal phase. # 3. Mechanism of Action L-Theanine exerts multiple complementary neurophysiological actions. ### Glutamatergic Regulation L-Theanine is structurally similar to glutamate and interacts with glutamate receptors, contributing to regulation of excitatory neurotransmission without acting as a classical sedative. ### GABA Physiology Experimental evidence suggests L-theanine supports normal GABAergic signaling indirectly, contributing to balanced neuronal excitability and maintenance of physiological relaxation. ### Alpha Brain Wave Activity Electroencephalography (EEG) studies consistently demonstrate that L-theanine increases **alpha-wave activity**, a pattern associated with calm attention, mental relaxation, and preserved alertness. ### Stress Physiology Human studies suggest L-theanine may attenuate physiological responses to acute stress through modulation of autonomic nervous system activity and neuroendocrine signaling, while preserving cognitive performance. Importantly, L-theanine **does not induce sedation or impair cognition** at nutritional doses. # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase is characterized by: - Progesterone dominance - Neuroendocrine adaptation - Increased allopregnanolone production - GABAergic modulation - Physiological recovery - Maintenance of neuronal homeostasis L-Theanine complements this endocrine environment by supporting: - physiological relaxation - normal neurotransmitter regulation - maintenance of cognitive function - neuroendocrine stability The formulation objective is **not** to sedate the user but to support the normal neurophysiological environment associated with the luteal phase. # 5. Dose Justification ## Selected Dose: 200 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **200 mg** is one of the most frequently studied doses in randomized controlled trials evaluating: - relaxation - cognitive performance - stress physiology - sleep quality ### Human Clinical Evidence Multiple randomized controlled trials have demonstrated measurable physiological effects following single or repeated administration of **200 mg** L-theanine. This dose consistently supports: - alpha-wave activity - subjective relaxation - cognitive performance under stress without impairing alertness. ### Safety Clinical studies demonstrate excellent tolerability at doses considerably higher than those included in FEMSTATE™. ### Formulation Compatibility The selected dose: - complements magnesium L-threonate - complements GABA - complements chamomile - complements saffron - supports the integrated neurophysiological objectives of SOOTHE™ ### HR+ Philosophy L-Theanine demonstrates no direct endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence L-Theanine has been extensively investigated in randomized controlled trials evaluating: - stress physiology - relaxation - sleep quality - attention - cognitive performance The strongest evidence supports its ability to promote **relaxed alertness** rather than sedation. # 7. Safety Considerations L-Theanine possesses an excellent safety profile. ### FEMSTATE Dose: 200 mg/day Human studies have evaluated doses ranging from **50-400 mg/day**, with several trials using even higher doses without serious adverse effects. Reported adverse events are uncommon and generally mild, including: - headache - mild gastrointestinal discomfort - transient dizziness (rare) L-Theanine does **not** typically impair psychomotor performance or cause daytime sedation. # 8. HR+ Safety Review L-Theanine was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile L-Theanine is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Magnesium L-Threonate** Supports complementary neurophysiological regulation and synaptic function -> Strong neurophysiological synergy **GABA** Supports complementary regulation of neuronal excitability -> Positive synergy **Chamomile** Supports physiological relaxation through complementary mechanisms -> Positive synergy **Saffron** Supports neurophysiological homeostasis through distinct neurotransmitter pathways -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Vitamin B6 - Potassium - Selenium at FEMSTATE doses. ### Known Considerations L-Theanine may produce additive relaxation when combined with sedative medications or significant alcohol intake. Individuals using prescription anxiolytics or hypnotics should consult their healthcare provider before supplementation. # 10. Regulatory Status L-Theanine is: - Widely accepted for use in dietary supplements. - Generally recognized as safe (GRAS) for specified food uses in the United States. - Supported by numerous human clinical trials evaluating cognitive and stress-related outcomes. # 11. Evidence Gaps & Future Research Current evidence strongly supports L-theanine for: - relaxation - stress physiology - alpha-wave activity - cognitive performance Areas requiring additional investigation include: - Neuroendocrine physiology during the luteal phase. - Phase-specific application within menstrual physiology. - Clinical evaluation of L-theanine as part of a comprehensive phase-aligned nutritional system such as FEMSTATE™. No randomized controlled trials have specifically evaluated L-theanine within a phase-aligned formulation. # 12. Conclusion L-Theanine is a cornerstone neurophysiological ingredient within the **SOOTHE™** formulation because of its established ability to promote **relaxed alertness**, support normal stress physiology, enhance alpha-wave activity, and contribute to neuroendocrine homeostasis without impairing cognitive performance. The selected dose of **200 mg** reflects the most consistently studied amount in randomized controlled trials and aligns with the biological priorities of the luteal phase, which emphasize neuronal regulation, physiological recovery, and metabolic stability. Within the FEMSTATE™ platform, L-theanine supports the normal neurophysiological environment created by progesterone dominance rather than modifying reproductive hormone physiology, making it a key component of the phase-aligned strategy for SOOTHE™. ## References - Nutrients. Systematic reviews on L-theanine, stress physiology, and cognitive performance. - Nutritional Neuroscience. Reviews on L-theanine and neurophysiology. - Journal of Functional Foods. Human clinical studies evaluating L-theanine and relaxation. - Nutritional Reviews. Reviews on amino acids and cognitive health. - Williams Textbook of Endocrinology. Neuroendocrine physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on neuroendocrine regulation and women's physiology. # Ingredient Scientific Monograph # L-Tryptophan ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** L-Tryptophan **Chemical Name:** L-Tryptophan **Ingredient Form:** Pharmaceutical-grade L-Tryptophan **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 150 mg | L-Tryptophan is included exclusively in **SOOTHE™** because the luteal phase is characterized by **progesterone dominance, neuroendocrine adaptation, neurotransmitter regulation, sleep physiology, and metabolic stabilization**. As the essential amino acid precursor to **serotonin** and **melatonin**, L-tryptophan supports normal neurophysiology without directly altering reproductive hormone production. # 2. Physiological Role L-Tryptophan is an **essential amino acid**, meaning it cannot be synthesized by the human body and must be obtained from dietary sources. It serves as the precursor for several biologically important molecules, including: - Serotonin - Melatonin - Niacin (Vitamin B3) - Kynurenine pathway metabolites Approximately **90-95%** of dietary tryptophan is metabolized through the kynurenine pathway, while a smaller proportion is converted into serotonin and subsequently melatonin. These pathways contribute to normal nervous system physiology, immune regulation, sleep-wake cycles, and cellular metabolism.(1-4) L-Tryptophan contributes to: - Serotonin synthesis - Melatonin synthesis - Sleep physiology - Neurotransmitter regulation - Protein synthesis - Immune physiology - Cellular metabolism These biological functions align closely with the physiological priorities of the luteal phase. # 3. Mechanism of Action L-Tryptophan functions primarily as a metabolic precursor. ### Serotonin Synthesis L-Tryptophan -> 5-Hydroxytryptophan (5-HTP) -> Serotonin -> Normal neurotransmission -> Neurophysiological homeostasis The conversion of tryptophan to serotonin requires **vitamin B6 (P5P)** as a cofactor, creating an intentional synergy within the SOOTHE™ formulation. ### Melatonin Synthesis Serotonin -> N-acetylserotonin -> Melatonin -> Sleep-wake regulation This pathway supports normal circadian physiology rather than acting as a direct sedative. ### Protein Synthesis As an essential amino acid, tryptophan also contributes to: - structural protein synthesis - tissue maintenance - cellular repair ### Kynurenine Pathway The majority of dietary tryptophan is metabolized through the kynurenine pathway, contributing to: - NAD⁺ synthesis - immune regulation - cellular energy metabolism # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase is characterized by: - progesterone dominance - neuroendocrine adaptation - GABAergic regulation - maintenance of physiological homeostasis - preparation for the next endocrine transition L-Tryptophan supports these biological priorities by providing the physiological precursor required for normal serotonin and melatonin synthesis. Importantly, the formulation **does not aim to increase serotonin pharmacologically**, but rather to support the normal biochemical pathways involved in neurotransmitter production. # 5. Dose Justification ## Selected Dose: 150 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance The dose supports normal precursor availability for serotonin synthesis while complementing dietary protein intake. Unlike therapeutic doses historically used in sleep research (typically 500-2,000 mg), **150 mg** was selected as a physiological nutritional dose within a multi-ingredient formulation. ### Human Clinical Evidence Human intervention studies evaluating L-tryptophan have used a broad range of doses depending on study objectives. The selected dose was chosen because it: - contributes to precursor availability - complements vitamin B6 - integrates well with L-theanine and GABA - maintains excellent tolerability ### Safety The selected dose remains substantially below doses commonly used in clinical sleep studies and has an excellent safety profile. ### Formulation Compatibility 150 mg allows: - synergistic interaction with vitamin B6 - complementary activity with L-theanine - complementary physiology with GABA - maintenance of serving size ### HR+ Philosophy L-Tryptophan demonstrates no known endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence L-Tryptophan has been investigated in relation to: - sleep physiology - serotonin metabolism - mood regulation - stress physiology - cognitive function The strongest evidence supports its role as the physiological precursor of serotonin and melatonin. Evidence supporting supplementation effects is strongest at higher doses than those used in FEMSTATE™, whereas the FEMSTATE dose is intended to provide nutritional support within an integrated formulation rather than therapeutic intervention. # 7. Safety Considerations L-Tryptophan has an excellent safety profile at nutritional doses. ### FEMSTATE Dose: 150 mg/day Clinical studies have commonly evaluated doses between: 500-2,000 mg/day The FEMSTATE dose is substantially lower. Potential adverse effects associated with much higher doses include: - gastrointestinal discomfort - drowsiness - headache Rare historical safety concerns related to eosinophilia-myalgia syndrome were linked to contaminated manufacturing batches in the late 1980s rather than to L-tryptophan itself. # 8. HR+ Safety Review L-Tryptophan was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile L-Tryptophan is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Vitamin B6 (P5P)** Required for conversion of tryptophan into serotonin -> Strong physiological synergy **L-Theanine** Supports complementary neurophysiological regulation -> Positive synergy **GABA** Supports complementary regulation of neuronal excitability -> Positive synergy **Magnesium L-Threonate** Supports normal nervous system physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Selenium - Potassium at FEMSTATE doses. ### Known Considerations Individuals taking: - Selective serotonin reuptake inhibitor - Monoamine oxidase inhibitor - other serotonergic medications should consult their healthcare provider before using supplemental L-tryptophan because of the theoretical risk of excessive serotonergic activity. # 10. Regulatory Status L-Tryptophan is: - Widely accepted for use in dietary supplements. - Recognized as an amino acid ingredient in nutritional products. - Supported by numerous human clinical studies evaluating neurophysiology and sleep. # 11. Evidence Gaps & Future Research Current evidence strongly supports L-tryptophan as: - the physiological precursor of serotonin - the physiological precursor of melatonin Areas requiring further investigation include: - Phase-specific tryptophan metabolism during the menstrual cycle. - Neuroendocrine adaptation during the luteal phase. - Clinical evaluation of L-tryptophan within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated L-tryptophan within a phase-aligned nutritional formulation. # 12. Conclusion L-Tryptophan is a foundational neurophysiological ingredient within **SOOTHE™** because it serves as the natural precursor for serotonin and melatonin synthesis while also contributing to protein metabolism and NAD⁺ biosynthesis. The selected dose of **150 mg** was intentionally chosen as a physiological nutritional dose that complements vitamin B6, L-theanine, GABA, and magnesium L-threonate within the integrated SOOTHE™ formulation. Rather than functioning as a pharmacological sleep aid or mood intervention, L-tryptophan supports the normal biochemical pathways underlying neuroendocrine regulation during the progesterone-dominant luteal phase, making it an integral component of the FEMSTATE™ phase-aligned nutritional strategy. ## References - Nutrients. Reviews on tryptophan metabolism, serotonin physiology, and human nutrition. - Nutritional Neuroscience. Reviews on tryptophan, neurotransmitters, and cognition. - The American Journal of Clinical Nutrition. Reviews on amino acid metabolism and tryptophan physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on neuroendocrine regulation and women's physiology. - Williams Textbook of Endocrinology. - Sleep Medicine Reviews. Reviews on tryptophan, serotonin, melatonin, and sleep physiology. # Ingredient Scientific Monograph # Gamma-Aminobutyric Acid (GABA) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** GABA **Chemical Name:** Gamma-Aminobutyric Acid **Ingredient Form:** Pharmaceutical-grade Gamma-Aminobutyric Acid (GABA) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 150 mg | Gamma-aminobutyric acid (GABA) is included exclusively in **SOOTHE™ **because the luteal phase is characterized by **progesterone dominance, neuroendocrine adaptation, GABAergic modulation, physiological recovery, and maintenance of neuronal homeostasis**. GABA was selected to complement the natural neurophysiological environment established during the luteal phase rather than to function as a sedative or pharmacologic anxiolytic. # 2. Physiological Role GABA is the **primary inhibitory neurotransmitter** in the mammalian central nervous system. It regulates neuronal excitability, maintains the balance between excitatory and inhibitory signaling, and contributes to normal sleep physiology, stress adaptation, motor control, autonomic regulation, and cognitive function.(1-4) Approximately one-third of all synapses in the brain utilize GABAergic signaling. GABA contributes to: - Regulation of neuronal excitability - Maintenance of physiological relaxation - Sleep physiology - Stress adaptation - Motor coordination - Autonomic nervous system regulation - Neuroendocrine homeostasis These physiological functions closely align with the biological priorities of the luteal phase. # 3. Mechanism of Action GABA exerts its effects through activation of: - GABA-A receptors - GABA-B receptors ### Neuronal Regulation GABA binds to inhibitory receptors -> Reduced neuronal firing -> Balanced neuronal activity -> Maintenance of physiological homeostasis Unlike sedative medications, nutritional GABA supplementation is intended to support normal neurophysiology rather than suppress central nervous system activity. ### Neuroendocrine Physiology During the luteal phase: Progesterone -> Allopregnanolone -> Positive modulation of GABA-A receptors -> Physiological neuroendocrine adaptation The inclusion of GABA in SOOTHE™ complements this naturally occurring endocrine environment. ### Autonomic Regulation Experimental evidence suggests GABA participates in: - parasympathetic regulation - stress physiology - autonomic balance although the clinical significance of orally administered GABA remains an active area of investigation. # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase emphasizes: - progesterone dominance - neuroendocrine adaptation - GABAergic physiology - physiological recovery - maintenance of neuronal homeostasis SOOTHE™ includes GABA to complement this biological environment. Importantly, the formulation is **not intended to pharmacologically increase GABA activity** or function as a treatment for anxiety or insomnia. Instead, GABA was selected because it aligns conceptually with the normal neurophysiological priorities of the progesterone-dominant phase. # 5. Dose Justification ## Selected Dose: 150 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **150 mg** represents a moderate nutritional dose commonly used in dietary supplement formulations and clinical research investigating relaxation and stress physiology. ### Human Clinical Evidence Human studies evaluating oral GABA have generally investigated doses ranging from: 100–300 mg/day The selected dose falls comfortably within this clinically investigated range. ### Safety Human studies demonstrate excellent tolerability at doses substantially higher than those used in FEMSTATE™. ### Formulation Compatibility The selected dose: - complements L-theanine - complements magnesium L-threonate - complements L-tryptophan - complements chamomile allowing an integrated neurophysiological formulation without excessive serving size. ### HR+ Philosophy GABA demonstrates no endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence The human evidence supporting oral GABA is moderate. The strongest findings involve: - subjective relaxation - stress physiology - sleep quality - autonomic nervous system responses However, an important scientific consideration is that **the extent to which orally administered GABA crosses the blood-brain barrier remains uncertain**. Some studies suggest limited central penetration, while others propose that observed effects may occur through peripheral nervous system pathways or gut–brain communication. Consequently, although clinical trials have reported favorable outcomes, the precise mechanism by which oral GABA exerts physiological effects remains under investigation. # 7. Safety Considerations GABA demonstrates an excellent safety profile at nutritional doses. ### FEMSTATE Dose: 150 mg/day Human studies have evaluated doses ranging from: 100–750 mg/day with excellent tolerability. Reported adverse effects are uncommon and generally mild: - transient drowsiness - mild gastrointestinal discomfort - headache (rare) # 8. HR+ Safety Review GABA was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile GABA is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **L-Theanine** Supports complementary neurophysiological regulation. ↓ Strong synergy **Magnesium L-Threonate** Supports neuronal signaling and synaptic physiology -> Strong synergy **L-Tryptophan** Supports complementary neurotransmitter physiology -> Positive synergy **Chamomile** Supports physiological relaxation through complementary pathways -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Potassium - Selenium at FEMSTATE doses. ### Known Considerations Individuals using: - benzodiazepines - barbiturates - prescription sedative medications should consult their healthcare provider before using GABA-containing supplements because additive central nervous system effects are theoretically possible, although evidence at nutritional doses remains limited. # 10. Regulatory Status GABA is: - Widely accepted for use in dietary supplements. - Supported by multiple human clinical studies. - Commercially available in numerous international markets. # 11. Evidence Gaps & Future Research Current evidence supports GABA for: - relaxation - stress physiology - sleep quality However, important research questions remain. Future investigation should address: - Blood-brain barrier transport of oral GABA. - Peripheral versus central mechanisms of action. - Neuroendocrine physiology during the luteal phase. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have evaluated oral GABA as part of a phase-aligned nutritional formulation. # 12. Conclusion Gamma-aminobutyric acid (GABA) was incorporated exclusively into **SOOTHE™** because its physiological role closely mirrors the neuroendocrine priorities of the progesterone-dominant luteal phase. The selected dose of **150 mg** reflects commonly studied nutritional doses and integrates effectively with L-theanine, magnesium L-threonate, L-tryptophan, and chamomile to create a formulation focused on neuronal homeostasis rather than sedation. Current evidence supports oral GABA as a safe ingredient with moderate human evidence for relaxation and stress physiology, while recognizing ongoing scientific uncertainty regarding its mechanism of action after oral administration. Within the FEMSTATE™ platform, GABA is included not to alter endocrine function but to complement the natural neurophysiological environment established during the luteal phase. ## References - Nutrients. Systematic reviews on oral GABA supplementation and human physiology. - Frontiers in Neuroscience. Reviews on GABA physiology, neurotransmission, and neuroendocrine regulation. - Nutritional Neuroscience. Human studies evaluating oral GABA and stress physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on neuroendocrine physiology and women's health. - Williams Textbook of Endocrinology. - Neuroscience & Biobehavioral Reviews. Reviews on GABAergic signaling and central nervous system physiology.Bottom of Form # Ingredient Scientific Monograph # Myo-Inositol ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Myo-Inositol **Chemical Name:** Myo-Inositol **Ingredient Form:** Myo-Inositol **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | 1,000 mg | | SHINE™ | - | | SOOTHE™ | - | Myo-inositol is included exclusively in **LIFT™** because the follicular phase is characterized by** follicular growth, increasing insulin sensitivity, mitochondrial activation, cellular proliferation, and ovarian metabolic activity.** Myo-inositol was selected to support the physiological environment of the follicular phase rather than to treat endocrine disorders. Although myo-inositol has been extensively studied in women with Polycystic Ovary Syndrome, its inclusion in FEMSTATE™ is based on its established role in normal cellular signaling and ovarian physiology. # 2. Physiological Role Myo-inositol is a naturally occurring carbohydrate-like molecule that functions as a structural component of cell membranes and as a precursor for **inositol phosphates** and **phosphatidylinositol**, key intracellular signaling molecules. It plays a central role in insulin signaling, calcium signaling, follicular physiology, glucose metabolism, and cellular communication.(1-4) Myo-inositol contributes to: - Intracellular signal transduction - Insulin signaling - Glucose metabolism - Calcium signaling - Ovarian follicular physiology - Mitochondrial metabolism - Cellular proliferation - Membrane integrity Because these biological processes become particularly active during the follicular phase, myo-inositol aligns closely with the biological priorities of **LIFT™.** # 3. Mechanism of Action Myo-inositol functions primarily as a precursor of intracellular second messengers. ### Cellular Signaling Myo-inositol -> Phosphatidylinositol -> Inositol triphosphate (IP₃) -> Calcium signaling -> Cellular communication This signaling pathway regulates numerous physiological processes throughout the body. ### Insulin Physiology Myo-inositol participates in intracellular insulin signaling. Normal insulin binding -> Intracellular inositol signaling -> Glucose uptake -> Cellular metabolism Importantly, myo-inositol **does not stimulate insulin secretion** but contributes to normal intracellular signaling. ### Ovarian Physiology Within the ovary, myo-inositol contributes to: - granulosa cell physiology - follicular maturation - intracellular calcium signaling - mitochondrial function These mechanisms have been extensively investigated in reproductive endocrinology. ### Mitochondrial Function Through its effects on cellular signaling, myo-inositol supports: - ATP production - metabolic regulation - cellular proliferation during anabolic physiology. # 4. Why Included in FEMSTATE™ ## LIFT™ The follicular phase is characterized by: - follicular growth - increasing estradiol - cellular proliferation - mitochondrial activation - anabolic metabolism Myo-inositol supports these biological priorities by contributing to: - intracellular signaling - glucose metabolism - ovarian cellular physiology - metabolic homeostasis Importantly, FEMSTATE™ **does not include myo-inositol to treat PCOS or induce ovulation**. Instead, it is incorporated because intracellular signaling and ovarian metabolism are fundamental components of normal follicular physiology. # 5. Dose Justification ## Selected Dose: 1,000 mg The selected dose was based on five scientific criteria. ### Physiological Relevance A dose of **1,000 mg/day** provides meaningful physiological exposure while fitting within a multi-ingredient formulation designed for healthy women. This dose supports: - intracellular signaling - ovarian physiology - glucose metabolism - mitochondrial function without approaching pharmacological dosing strategies commonly used in clinical management of PCOS. ### Human Clinical Evidence Clinical trials in reproductive endocrinology frequently use **2-4 g/day** of myo-inositol in women with PCOS. However, these doses are intended to address a pathological metabolic condition. For FEMSTATE™, a lower dose of **1 g/day** was intentionally selected because the objective is to support **normal follicular physiology**, not to treat insulin resistance or endocrine disease. ### Safety Myo-inositol has demonstrated excellent tolerability in human studies, including trials using substantially higher doses than those incorporated into FEMSTATE™. ### Formulation Compatibility The selected dose: - complements magnesium - complements collagen - complements hyaluronic acid - supports the anabolic physiology of LIFT™ - allows sufficient formulation space for additional phase-specific nutrients ### HR+ Philosophy Myo-inositol demonstrates no estrogenic activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Myo-inositol has been extensively investigated in women with PCOS, insulin resistance, and reproductive disorders. The strongest human evidence supports: - insulin signaling - ovarian physiology - follicular development - metabolic regulation However, **most clinical evidence comes from women with metabolic or reproductive disorders rather than healthy cycling women**. Therefore, extrapolation to phase-aligned nutrition should be made cautiously. # 7. Safety Considerations Myo-inositol demonstrates an excellent safety profile. ### FEMSTATE Dose 1,000 mg/day Clinical studies have safely evaluated doses up to **12 g/day**, although reproductive studies most commonly use **2–4 g/day**. Reported adverse effects are generally mild and may include: - transient gastrointestinal discomfort - mild nausea - abdominal bloating (uncommon) The FEMSTATE™ dose remains well below amounts commonly evaluated in therapeutic studies. Overall Safety Rating ★★★★★ Excellent # 8. HR+ Safety Review Myo-inositol was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Although myo-inositol influences intracellular signaling involved in ovarian physiology, it does not directly stimulate estrogen production or function as a hormone. # 9. Ingredient Interactions ### Positive Interactions **Magnesium** Supports intracellular signaling and ATP production -> Strong physiological synergy **Chromium** Supports complementary glucose metabolism and insulin signaling -> Positive metabolic synergy **Vitamin B Complex** Supports mitochondrial metabolism and cellular energy production -> Positive synergy **Collagen & Hyaluronic Acid** Complement the anabolic physiology of the follicular phase -> Positive formulation synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Zinc - Selenium at FEMSTATE™ doses. ### Known Considerations Individuals taking glucose-lowering medications should consult their healthcare provider before combining high-dose myo-inositol with prescription therapy. The **1 g** dose in FEMSTATE™ is nutritional and not intended for treatment of insulin resistance. # 10. Regulatory Status Myo-inositol is: - Widely accepted for use in dietary supplements. - Extensively investigated in reproductive endocrinology. - Commonly used in nutritional products supporting women's health. - Recognized internationally as a nutritional ingredient. # 11. Evidence Gaps & Future Research Current evidence strongly supports myo-inositol for: - intracellular signaling - ovarian physiology - insulin signaling - follicular biology Areas requiring further investigation include: - Phase-specific application in healthy menstruating women. - Optimal nutritional dosing outside PCOS populations. - Clinical evaluation within phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated **1 g/day **myo-inositol within a phase-aligned nutritional formulation for healthy women. # 12. Conclusion Myo-inositol is a key metabolic ingredient within **LIFT™** because of its established roles in intracellular signaling, ovarian physiology, glucose metabolism, and cellular communication. The selected dose of **1,000 mg** reflects a deliberate distinction between **physiological nutritional support** and **therapeutic dosing **commonly used in women with PCOS. Rather than targeting endocrine dysfunction, the FEMSTATE™ formulation uses myo-inositol to support the normal anabolic and metabolic environment of the follicular phase, aligning with the platform's physiology-first philosophy. Its excellent safety profile, strong mechanistic rationale, and extensive reproductive endocrinology literature make it one of the strongest evidence-based ingredients within the LIFT™ formulation. ## References - International Journal of Endocrinology. Reviews on myo-inositol and reproductive endocrinology. - Nutrients. Systematic reviews on myo-inositol, insulin signaling, and ovarian physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on myo-inositol and female reproductive physiology. - Gynecological Endocrinology. Clinical studies of myo-inositol in ovarian function. - Williams Textbook of Endocrinology. - Yen and Jaffe's Reproductive Endocrinology. # Ingredient Scientific Monograph # Ginger (Zingiber officinale) Root Extract ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Ginger **Scientific Name:** Ginger **Botanical Source:** Zingiber officinale Roscoe **Ingredient Form:** Standardized Ginger Root Extract **Primary Bioactive Compounds:** - 6-Gingerol - 8-Gingerol - 10-Gingerol - 6-Shogaol - Zingerone **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 250 mg | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | - | Ginger is included exclusively in **RESET™** because the menstrual phase is characterized by **physiological inflammatory remodeling, uterine tissue regeneration, oxidative metabolism, and gastrointestinal adaptation**. Ginger was selected because of its well-established roles in supporting normal inflammatory physiology, antioxidant defense, gastrointestinal function, and comfort during menstruation. Importantly, the rationale for inclusion extends beyond symptom management and is based on its participation in the biological processes active during menstrual tissue repair. # 2. Physiological Role Ginger is one of the most extensively studied medicinal botanicals in human nutrition. Its biological activity is primarily attributed to gingerols and shogaols, which influence inflammatory signaling pathways, oxidative balance, gastrointestinal motility, and cellular stress responses.(1-4) Experimental and human studies demonstrate that ginger contributes to: - Physiological inflammatory regulation - Endogenous antioxidant defense - Gastrointestinal physiology - Cellular redox balance - Smooth muscle physiology - Mitochondrial protection Within the FEMSTATE™ platform, these physiological functions align closely with the regenerative biology of the menstrual phase. # 3. Mechanism of Action Ginger exerts multiple complementary biological effects. ### Physiological Inflammatory Regulation Gingerols and shogaols influence several inflammatory signaling pathways, including modulation of: - Cyclooxygenase (COX) - Lipoxygenase (LOX) - Nuclear factor-kappa B (NF-κB) Rather than suppressing normal inflammation, ginger helps maintain balanced inflammatory signaling during physiological tissue remodeling. ### Antioxidant Physiology Ginger contributes to: - maintenance of endogenous antioxidant enzyme activity - regulation of reactive oxygen species - preservation of cellular redox homeostasis These mechanisms complement the oxidative physiology associated with endometrial regeneration. ### Gastrointestinal Physiology Human studies consistently demonstrate that ginger supports: - normal gastric emptying - gastrointestinal motility - digestive comfort These actions may be particularly relevant during menstruation when gastrointestinal physiology can be influenced by prostaglandin signaling. ### Smooth Muscle Physiology Experimental evidence suggests ginger may influence smooth muscle activity through multiple biochemical pathways. While these mechanisms have been investigated extensively, the clinical significance in healthy menstruating women remains an area of active research. # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase is characterized by: - controlled inflammatory remodeling - endometrial regeneration - oxidative metabolism - tissue repair - physiological gastrointestinal adaptation Ginger supports these biological priorities through: - regulation of inflammatory signaling - endogenous antioxidant physiology - gastrointestinal homeostasis - cellular resilience The ingredient was **not selected solely for menstrual comfort**, but because its physiological actions complement the regenerative environment created during menstruation. # 5. Dose Justification ## Selected Dose: 250 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **250 mg/day** provides meaningful exposure to ginger bioactive compounds while integrating effectively within a multi-ingredient formulation. ### Human Clinical Evidence Randomized controlled trials evaluating ginger for women's health and gastrointestinal physiology commonly use doses between **250 mg and 2,000 mg/day**, depending on the study objective. The selected dose represents the lower end of clinically investigated ranges while maintaining excellent tolerability. ### Safety The selected dose provides physiological support while remaining substantially below doses associated with gastrointestinal intolerance. ### Formulation Compatibility The selected dose: - complements vitamin C - complements magnesium - complements tart cherry - supports the regenerative objectives of RESET™ without contributing excessive botanical load. ### HR+ Philosophy Ginger demonstrates no clinically meaningful estrogenic activity and aligns with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Ginger is supported by numerous randomized controlled trials and systematic reviews. The strongest evidence supports: - gastrointestinal physiology - maintenance of normal inflammatory responses - menstrual comfort - antioxidant physiology Several meta-analyses have reported that ginger supplementation can reduce **primary dysmenorrhea pain intensity **compared with placebo, although FEMSTATE™ does not position ginger as a treatment for menstrual pain. Instead, these findings provide supportive evidence for ginger's role in menstrual physiology.¹,³ # 7. Safety Considerations Ginger has an excellent safety profile. ### FEMSTATE Dose: 250 mg/day Clinical studies have safely evaluated doses ranging from: 250-2,000 mg/day Reported adverse effects are generally mild: - heartburn - mild gastrointestinal discomfort - belching These effects are uncommon at the dose used in FEMSTATE™. # 8. HR+ Safety Review Ginger was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - phytoestrogen activity - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No clinically meaningful estrogen receptor agonist activity ✔ No progesterone receptor agonist activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Current evidence does not support classification of ginger as a hormonally active botanical. # 9. Ingredient Interactions ### Positive Interactions **Vitamin C** Supports complementary antioxidant physiology -> Positive synergy **Tart Cherry Extract** Supports complementary regulation of physiological inflammatory pathways -> Positive synergy **Magnesium** Supports complementary smooth muscle and neuromuscular physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Iron - Zinc - Selenium at FEMSTATE doses. ### Known Considerations Ginger may have mild antiplatelet activity. Individuals taking anticoagulant or antiplatelet medications, or those with bleeding disorders, should consult a healthcare professional before using concentrated ginger supplements, particularly before surgery. # 10. Regulatory Status Ginger is: - Widely accepted for use in dietary supplements. - Recognized as a traditional food and botanical ingredient. - Supported by numerous human clinical trials. - Generally recognized as safe (GRAS) for use in foods in the United States. # 11. Evidence Gaps & Future Research Current evidence strongly supports ginger for: - gastrointestinal physiology - menstrual comfort - physiological inflammatory regulation - antioxidant biology Areas requiring further investigation include: - Mechanistic studies examining ginger during normal menstrual tissue regeneration. - Phase-specific application within physiology-based nutritional systems. - Clinical evaluation of ginger as part of the complete RESET™ formulation. No randomized controlled trials have specifically evaluated ginger within a phase-aligned nutritional system such as FEMSTATE™. # 12. Conclusion Ginger (Zingiber officinale) is a key botanical ingredient within **RESET™** because its physiological activities closely align with the biological priorities of the menstrual phase. The selected dose of **250 mg** is supported by extensive human clinical research demonstrating favorable effects on gastrointestinal physiology, normal inflammatory regulation, antioxidant biology, and menstrual comfort. Within the FEMSTATE™ platform, ginger is incorporated **not as a symptomatic intervention**, but as a botanical that complements the coordinated tissue remodeling, oxidative balance, and regenerative physiology characteristic of menstruation. Its excellent safety profile, strong human evidence, and compatibility with the HR+-conscious formulation philosophy make it one of the highest-confidence botanical ingredients in the RESET™ formulation. ## References - Pain Medicine. Systematic reviews and meta-analyses of ginger for primary dysmenorrhea. - Nutrients. Reviews on ginger phytochemistry, antioxidant activity, and human health. - Phytotherapy Research. Clinical trials of ginger in women's health and gastrointestinal physiology. - Journal of Ethnopharmacology. Reviews on ginger pharmacology and inflammatory signaling. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on menstrual physiology, inflammation, and reproductive biology. # Ingredient Scientific Monograph # Tart Cherry (Montmorency Cherry) Fruit Extract ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Tart Cherry **Scientific Name:** Montmorency tart cherry **Botanical Source:** Prunus cerasus L. **Ingredient Form:** Standardized Tart Cherry Fruit Extract **Primary Bioactive Compounds:** - Anthocyanins - Cyanidin glycosides - Flavonoids - Phenolic acids - Melatonin (naturally occurring, trace amounts) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 300 mg | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | - | Tart cherry extract is included exclusively in **RESET™** because the menstrual phase is characterized by **physiological inflammatory remodeling, oxidative metabolism, connective tissue regeneration, and cellular recovery**. Tart cherry was selected as an HR+-compatible alternative to botanical ingredients with potential endocrine concerns (such as curcumin), providing support for normal recovery physiology through antioxidant and polyphenol pathways rather than hormonal mechanisms. # 2. Physiological Role Tart cherry is naturally rich in **polyphenols**, particularly anthocyanins, which contribute to endogenous antioxidant physiology and regulation of normal inflammatory signaling. Human studies have investigated tart cherry primarily in the context of exercise recovery, muscle physiology, oxidative stress, sleep, and inflammatory biomarkers.(1-4) Its principal physiological functions include: - Endogenous antioxidant support - Maintenance of physiological inflammatory balance - Recovery following tissue stress - Cellular redox homeostasis - Connective tissue physiology - Vascular function - Muscle recovery Within the FEMSTATE™ platform, these biological activities align closely with the regenerative physiology of the menstrual phase. # 3. Mechanism of Action Tart cherry exerts its physiological effects primarily through its polyphenol content. ### Antioxidant Physiology Anthocyanins support endogenous antioxidant systems by: - scavenging reactive oxygen species (ROS) - supporting glutathione-dependent pathways - maintaining physiological redox homeostasis Importantly, tart cherry **supports normal oxidative balance** rather than eliminating physiologic ROS required for tissue repair. ### Physiological Inflammatory Regulation Experimental studies suggest tart cherry polyphenols influence: - cyclooxygenase (COX) pathways - nuclear factor-kappa B (NF-κB) - cytokine signaling These actions support normal inflammatory regulation during tissue remodeling. ### Connective Tissue Recovery By supporting physiological inflammatory resolution and antioxidant balance, tart cherry contributes to the normal recovery of connective tissues following physiological stress. ### Vascular Physiology Polyphenols may support endothelial nitric oxide bioavailability and vascular function, although these effects are modest and remain under investigation. # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase emphasizes: - endometrial regeneration - connective tissue remodeling - physiological inflammatory repair - oxidative metabolism - restoration of tissue homeostasis Tart cherry supports these biological priorities through: - endogenous antioxidant physiology - regulation of physiological inflammatory signaling - maintenance of cellular resilience - support of tissue recovery The ingredient was intentionally selected to complement the regenerative biology of menstruation while maintaining compatibility with the HR+-conscious formulation philosophy. # 5. Dose Justification ## Selected Dose: 300 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **300 mg** provides meaningful exposure to tart cherry polyphenols while fitting within a comprehensive multi-ingredient formulation. ### Human Clinical Evidence Human intervention studies have commonly evaluated standardized tart cherry extracts in doses ranging from **240-600 mg/day**, depending on extract standardization and study objectives. The selected dose falls comfortably within the lower-to-middle portion of clinically investigated ranges. ### Safety The selected dose provides physiological support while maintaining excellent gastrointestinal tolerability and long-term safety. ### Formulation Compatibility The selected dose: - complements vitamin C - complements ginger - complements magnesium - complements selenium creating an integrated regenerative formulation without excessive botanical loading. ### HR+ Philosophy Tart cherry was selected because it demonstrates no clinically meaningful estrogenic activity and provides a conservative botanical option consistent with the FEMSTATE™ HR+ safety strategy. # 6. Human Clinical Evidence Human clinical studies have investigated tart cherry in relation to: - exercise recovery - muscle soreness - oxidative stress biomarkers - inflammatory biomarkers - sleep quality The strongest evidence supports its ability to support **normal recovery physiology** and reduce exercise-induced oxidative and inflammatory responses. Direct evidence in menstrual physiology remains limited. # 7. Safety Considerations Tart cherry extract has an excellent safety profile. ### FEMSTATE Dose: 300 mg/day Human clinical studies have evaluated similar and substantially higher doses without serious adverse effects. Reported adverse events are uncommon and generally mild: - transient gastrointestinal discomfort - mild bloating (rare) # 8. HR+ Safety Review Tart cherry extract was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - phytoestrogen content - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No clinically meaningful estrogen receptor agonist activity ✔ No progesterone receptor agonist activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Unlike certain botanical extracts commonly marketed for inflammation, tart cherry has **no evidence of clinically relevant hormonal activity**. # 9. Ingredient Interactions ### Positive Interactions **Vitamin C** Supports complementary antioxidant physiology -> Strong antioxidant synergy **Ginger** Supports complementary physiological inflammatory regulation -> Positive synergy **Selenium** Supports endogenous antioxidant enzyme systems -> Positive synergy **Vitamin E** Provides complementary lipid and water-soluble antioxidant support -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Iron - Magnesium - Zinc at FEMSTATE™ doses. ### Known Considerations Individuals with allergies to cherries or other stone fruits should avoid supplementation. Because tart cherry contains naturally occurring polyphenols, theoretical interactions with anticoagulant medications have been discussed but have not been demonstrated at nutritional doses. # 10. Regulatory Status Tart cherry extract is: - Widely accepted for use in dietary supplements. - Commonly used in sports nutrition and recovery products. - Supported by multiple randomized controlled trials evaluating recovery physiology. - Generally recognized as safe (GRAS) as a food ingredient. # 11. Evidence Gaps & Future Research Current evidence strongly supports tart cherry for: - antioxidant physiology - recovery biology - exercise-induced inflammatory responses Areas requiring further investigation include: - Menstrual tissue regeneration. - Physiological inflammatory remodeling during menstruation. - Clinical evaluation within phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated tart cherry within a menstrual phase-aligned nutritional formulation. # 12. Conclusion Tart cherry (Prunus cerasus) was selected as a key botanical ingredient within **RESET™** because its physiological activities closely align with the biological priorities of the menstrual phase. Rich in anthocyanins and other polyphenols, tart cherry supports endogenous antioxidant systems, physiological inflammatory regulation, connective tissue recovery, and cellular resilience without demonstrating clinically meaningful endocrine activity. The selected dose of **300 mg**reflects clinically investigated ranges while maintaining excellent tolerability and compatibility with the overall formulation. Importantly, tart cherry was intentionally chosen as an HR+-conscious botanical alternative to ingredients with greater endocrine uncertainty, reinforcing the FEMSTATE™ philosophy of supporting normal regenerative physiology through evidence-based nutritional strategies rather than hormonal modulation. ## References - Nutrients. Systematic reviews on tart cherry, recovery physiology, and antioxidant biology. - Scandinavian Journal of Medicine & Science in Sports. Randomized controlled trials evaluating tart cherry and exercise recovery. - Journal of the International Society of Sports Nutrition. Reviews on tart cherry supplementation and recovery. - Antioxidants. Reviews on anthocyanins, oxidative physiology, and polyphenols. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on oxidative physiology and women's health. # Ingredient Scientific Monograph # Broccoli Sprout Extract (Source of Sulforaphane) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Broccoli Sprout Extract **Scientific Name:** Broccoli **Botanical Source:** Young broccoli sprouts (Brassica oleracea var. italica) **Primary Bioactive Compound:** Sulforaphane (generated from glucoraphanin by the enzyme myrosinase) **Ingredient Form:** Broccoli Sprout Extract **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 10 mg | | LIFT™ | 10 mg | | SHINE™ | - | | SOOTHE™ | - | Broccoli sprout extract is included in **RESET™** and **LIFT™** because of its role in supporting **cellular defense systems, endogenous antioxidant pathways, detoxification enzymes, mitochondrial resilience, and normal inflammatory regulation**. Rather than functioning as a direct antioxidant, sulforaphane activates the body's own cytoprotective mechanisms through regulation of the **Nrf2 (Nuclear factor erythroid 2-related factor 2) **pathway. Importantly, broccoli sprout extract was intentionally selected as an **HR+-conscious alternative** to botanicals with potential endocrine activity. # 2. Physiological Role Sulforaphane is one of the most extensively studied dietary isothiocyanates. Unlike conventional antioxidants that directly neutralize reactive oxygen species, sulforaphane functions primarily by activating endogenous cellular defense systems. Physiological functions include: - Activation of Nrf2 signaling - Induction of Phase II detoxification enzymes - Maintenance of cellular redox homeostasis - Mitochondrial protection - Regulation of oxidative stress responses - Cellular resilience - Support of normal inflammatory regulation These biological processes are particularly relevant during: - tissue regeneration (RESET™) - anabolic cellular growth (LIFT™) # 3. Mechanism of Action Sulforaphane functions primarily through activation of the **Nrf2-Keap1 signaling pathway**. ### Nrf2 Activation Sulforaphane -> Modification of Keap1 -> Release of Nrf2 -> Nuclear translocation -> Activation of Antioxidant Response Elements (ARE) -> Increased expression of cytoprotective genes -> Enhanced endogenous cellular defense This pathway regulates expression of numerous protective enzymes including: - Glutathione S-transferases - NAD(P)H quinone oxidoreductase-1 (NQO1) - Heme oxygenase-1 (HO-1) - Glutamate-cysteine ligase ### Cellular Redox Homeostasis Sulforaphane supports: - glutathione synthesis - oxidative stress adaptation - mitochondrial resilience Unlike direct antioxidants, it enhances the body’s own antioxidant capacity. ### Detoxification Physiology Sulforaphane induces Phase II detoxification enzymes involved in normal metabolism of endogenous and exogenous compounds. Importantly, this should **not **be interpreted as “detoxifying the body,” but rather as supporting normal hepatic and cellular detoxification pathways. ### Cellular Stress Adaptation Sulforaphane promotes cellular resilience during: - oxidative metabolism - tissue regeneration - physiological inflammatory remodeling # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase is characterized by: - tissue regeneration - physiological inflammatory remodeling - oxidative metabolism - extracellular matrix repair Sulforaphane supports these biological priorities by activating endogenous antioxidant defenses and maintaining cellular resilience during regeneration. ## LIFT™ The follicular phase emphasizes: - cellular proliferation - mitochondrial activation - anabolic metabolism - connective tissue synthesis Sulforaphane supports these processes by maintaining redox homeostasis during increased cellular activity. Importantly, the ingredient was selected to support **normal cellular physiology**, not to influence reproductive hormone production. # 5. Dose Justification ## Selected Dose: 10 mg Broccoli Sprout Extract The selected dose was based on five scientific criteria. ### Physiological Relevance The selected amount contributes sulforaphane precursors while fitting within a multi-ingredient formulation designed for long-term daily use. Because broccoli sprout extracts differ considerably in glucoraphanin concentration and myrosinase activity, **the physiologically relevant dose is ultimately determined by standardized sulforaphane yield rather than extract weight alone.** ### Human Clinical Evidence Clinical studies have evaluated a wide range of broccoli sprout preparations. Rather than attempting to reproduce pharmacological doses used in disease-focused trials, FEMSTATE uses a nutritional dose intended to complement endogenous antioxidant physiology. ### Safety Broccoli sprout extracts demonstrate excellent tolerability in human studies. ### Formulation Compatibility The selected dose: - complements vitamin C - complements selenium - complements tart cherry - complements antioxidant physiology while maintaining formulation balance. ### HR+ Philosophy Broccoli sprout extract was selected because it demonstrates a favorable endocrine safety profile while supporting cellular defense pathways. # 6. Human Clinical Evidence Sulforaphane has been investigated in hundreds of human studies. The strongest evidence supports: - activation of Nrf2 - induction of Phase II enzymes - glutathione metabolism - antioxidant physiology - cellular protection Evidence for clinical disease outcomes remains variable and depends on study population, formulation, and dose. # 7. Safety Considerations Broccoli sprout extract possesses an excellent safety profile. ### FEMSTATE Dose: 10 mg/day Human intervention studies have evaluated substantially larger amounts of standardized broccoli sprout preparations without major safety concerns. Reported adverse effects are uncommon: - mild gastrointestinal discomfort - bloating - transient digestive symptoms # 8. HR+ Safety Review This is one of the most important ingredients within the FEMSTATE™ HR+ framework. Broccoli sprout extract was independently evaluated for: - estrogen receptor agonism - progesterone receptor activity - aromatase modulation - phytoestrogen properties - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor agonist activity ✔ No phytoestrogen properties ✔ No evidence of direct endocrine stimulation Importantly, sulforaphane has been extensively investigated in laboratory and translational oncology research because of its effects on Nrf2 signaling and cellular defense pathways. However, these findings should not be interpreted as evidence that broccoli sprout extract prevents, treats, or reduces the risk of cancer. Within FEMSTATE™, the ingredient is included solely to support normal cellular physiology and endogenous antioxidant mechanisms. # 9. Ingredient Interactions ### Positive Interactions **Vitamin C** Supports complementary antioxidant physiology -> Strong synergy **Selenium** Supports glutathione-dependent antioxidant systems -> Strong synergy **Tart Cherry** Supports complementary regulation of oxidative physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Iron - Magnesium - Zinc - Vitamin D at FEMSTATE doses. ### Known Considerations Individuals taking anticoagulant medications or with thyroid disorders consuming very high amounts of cruciferous vegetables should follow standard dietary guidance. The amount included in FEMSTATE™ is nutritional and not expected to meaningfully affect thyroid function in iodine-replete individuals. # 10. Regulatory Status Broccoli sprout extract is: - Widely accepted for use in dietary supplements. - Extensively investigated in nutritional science. - Recognized as a food-derived botanical ingredient. # 11. Evidence Gaps & Future Research Current evidence strongly supports sulforaphane for: - Nrf2 activation - endogenous antioxidant defense - cellular resilience Areas requiring further investigation include: - Phase-specific application during menstrual physiology. - Cellular adaptation during tissue regeneration. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated broccoli sprout extract within a phase-aligned formulation. # 12. Conclusion Broccoli sprout extract, as a source of sulforaphane, is one of the most scientifically distinctive ingredients within the FEMSTATE™ platform. Its inclusion in **RESET™** and **LIFT™** is based on its ability to activate endogenous cellular defense pathways rather than acting as a direct antioxidant. Through regulation of the Nrf2 pathway, sulforaphane supports physiological antioxidant responses, mitochondrial resilience, and cellular adaptation during tissue regeneration and anabolic growth. The selected dose reflects a physiology-based approach focused on long-term nutritional support rather than pharmacological intervention. Its excellent safety profile and favorable HR+ assessment make broccoli sprout extract a highly compatible ingredient within the FEMSTATE™ philosophy of supporting normal cellular biology without directly influencing endocrine function. ## References - Nutrients. Systematic reviews on sulforaphane, Nrf2 activation, and human health. - Cancer Prevention Research. Human studies on broccoli sprout extracts and sulforaphane biomarkers. - Free Radical Biology and Medicine. Reviews on Nrf2 signaling and endogenous antioxidant systems. - Molecular Nutrition & Food Research. Reviews on sulforaphane metabolism and cellular defense. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on oxidative physiology and endocrine regulation. # Ingredient Scientific Monograph # Chamomile Flower Extract (Matricaria chamomilla L.) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Chamomile **Scientific Name:** Chamomile (German Chamomile) **Botanical Source:** Matricaria chamomilla L. **Ingredient Form:** Standardized Chamomile Flower Extract **Primary Bioactive Compounds:** - Apigenin - Bisabolol - Chamazulene - Flavonoids - Terpenoids **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 150 mg | Chamomile is included exclusively in **SOOTHE™** because the luteal phase is characterized by **progesterone dominance, neuroendocrine adaptation, physiological recovery, immune regulation, and maintenance of homeostasis**. Chamomile was selected for its well-characterized effects on **relaxation physiology, GABAergic signaling, and inflammatory regulation**, which complement the biological priorities of the luteal phase without directly influencing reproductive hormone production. # 2. Physiological Role Chamomile is one of the most extensively studied medicinal botanicals in traditional and modern phytotherapy. Its biological activity is attributed primarily to flavonoids - particularly **apigenin **- along with sesquiterpenes such as bisabolol and chamazulene. Experimental and clinical research indicates that chamomile contributes to: - Neurophysiological regulation - GABAergic signaling - Physiological relaxation - Sleep physiology - Immune homeostasis - Antioxidant physiology - Normal inflammatory regulation These biological functions align closely with the physiological priorities of the luteal phase. # 3. Mechanism of Action Chamomile exerts multiple complementary physiological actions. ### GABAergic Physiology Apigenin has been shown experimentally to bind to the **benzodiazepine site of the GABA-A receptor**, where it may positively modulate inhibitory neurotransmission. Unlike benzodiazepines, chamomile does not produce clinically significant central nervous system depression at nutritional doses. Instead, it supports normal neurophysiological relaxation. ### Physiological Relaxation Human studies suggest chamomile contributes to: - physiological relaxation - maintenance of sleep quality - neuroendocrine adaptation These effects are believed to result from combined flavonoid activity rather than a single bioactive compound. ### Physiological Inflammatory Regulation Chamomile constituents influence several inflammatory signaling pathways, including: - Cyclooxygenase (COX) - Lipoxygenase (LOX) - NF-κB signaling These actions support **normal inflammatory homeostasis** rather than suppression of physiological inflammation. ### Antioxidant Physiology Chamomile flavonoids contribute to endogenous antioxidant physiology through regulation of oxidative signaling and maintenance of cellular redox balance. # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase emphasizes: - neuroendocrine regulation - physiological recovery - GABAergic physiology - metabolic stability - immune homeostasis Chamomile supports these biological priorities through: - maintenance of physiological relaxation - complementary GABAergic regulation - antioxidant physiology - normal inflammatory signaling The ingredient was selected to complement progesterone-mediated neurophysiology rather than to function as a sedative or sleep medication. # 5. Dose Justification ## Selected Dose: 150 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **150 mg** provides meaningful exposure to chamomile flavonoids while integrating effectively within a comprehensive multi-ingredient formulation. ### Human Clinical Evidence Clinical studies evaluating standardized chamomile extracts have commonly investigated doses ranging from **150-1,500 mg/day**, depending on extract composition and study objectives. The selected dose represents a conservative nutritional dose that complements the broader SOOTHE™ formulation. ### Safety The selected dose provides physiological support while maintaining excellent long-term tolerability. ### Formulation Compatibility The selected dose: - complements L-theanine - complements GABA - complements magnesium L-threonate - complements saffron - complements L-tryptophan creating an integrated neurophysiological formulation. ### HR+ Philosophy Chamomile demonstrates minimal endocrine activity and aligns with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Chamomile has been investigated in numerous randomized controlled trials evaluating: - relaxation - generalized anxiety symptoms - sleep quality - inflammatory physiology - gastrointestinal function The strongest evidence supports: - physiological relaxation - sleep quality - stress adaptation Evidence for reproductive physiology remains limited. # 7. Safety Considerations Chamomile possesses an excellent safety profile. ### FEMSTATE Dose: 150 mg/day Human clinical trials have safely evaluated substantially larger doses than those used in FEMSTATE™. Reported adverse effects are uncommon and generally mild: - gastrointestinal discomfort - mild drowsiness - allergic reactions in individuals sensitive to plants in the **Asteraceae (ragweed)** family # 8. HR+ Safety Review Chamomile was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - phytoestrogen activity - endocrine disruption - oncology safety ### Findings Current evidence indicates: ✔ No clinically meaningful estrogen receptor agonist activity at nutritional doses ✔ No progesterone receptor agonist activity ✔ No aromatase stimulation ✔ No evidence supporting clinically relevant hormonal effects Although isolated laboratory studies have reported weak flavonoid interactions with estrogen receptors, these findings have **not translated into clinically meaningful endocrine effects** at typical dietary or supplemental intakes. Accordingly, chamomile is considered compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **L-Theanine** Supports complementary physiological relaxation -> Strong synergy **GABA** Supports complementary GABAergic physiology -> Strong synergy **L-Tryptophan** Supports complementary neurophysiology and sleep regulation -> Positive synergy **Magnesium L-Threonate** Supports neuronal physiology and neuromuscular homeostasis -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Selenium - Potassium at FEMSTATE™ doses. ### Known Considerations Individuals with allergies to ragweed or other Asteraceae plants may experience hypersensitivity reactions. Chamomile may have mild additive effects when combined with sedative medications. # 10. Regulatory Status Chamomile is: - Widely accepted for use in dietary supplements. - Commonly used in herbal medicine worldwide. - Generally recognized as safe (GRAS) as a food ingredient in the United States. - Supported by numerous human clinical studies. # 11. Evidence Gaps & Future Research Current evidence strongly supports chamomile for: - relaxation physiology - sleep quality - stress physiology Areas requiring further investigation include: - Neuroendocrine adaptation during the luteal phase. - Phase-specific application within menstrual physiology. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated chamomile within a phase-aligned formulation. # 12. Conclusion Chamomile (Matricaria chamomilla) is a key botanical ingredient within **SOOTHE™** because its physiological activities closely align with the neuroendocrine and recovery-oriented biology of the luteal phase. The selected dose of **150 mg **supports normal GABAergic physiology, physiological relaxation, antioxidant defense, and inflammatory homeostasis while maintaining an excellent safety profile. Importantly, chamomile was selected as a supportive neurophysiological botanical rather than as a sedative or hormone-modulating ingredient. Within the FEMSTATE™ platform, it complements progesterone-driven physiology by supporting the natural transition toward physiological stability and recovery during the luteal phase. ## References - Phytomedicine. Reviews on chamomile pharmacology and clinical applications. - Journal of Clinical Psychopharmacology. Randomized controlled trials of chamomile and anxiety. - Nutrients. Reviews on chamomile, flavonoids, and human health. - Journal of Ethnopharmacology. Reviews on chamomile phytochemistry and mechanisms of action. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on neuroendocrine physiology and women's health. # Ingredient Scientific Monograph # Saffron Extract (Crocus sativus L.) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Saffron **Scientific Name:** Saffron **Botanical Source:** Crocus sativus L. **Ingredient Form:** Standardized Saffron Stigma Extract **Primary Bioactive Compounds:** - Crocin - Crocetin - Safranal - Picrocrocin **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 30 mg | Saffron is included exclusively in **SOOTHE™** because the luteal phase is characterized by **progesterone dominance, neuroendocrine adaptation, neurotransmitter regulation, oxidative balance, and physiological recovery**. Standardized saffron extract was selected because it is one of the best-studied botanicals for supporting normal mood physiology and emotional well-being in healthy adults, with multiple randomized controlled trials using **30 mg/day**. Importantly, saffron is included to support **normal neurophysiology**, not to treat depression, anxiety, or premenstrual disorders. # 2. Physiological Role Saffron contains a unique combination of carotenoid-derived compounds that influence multiple biological pathways involved in neurophysiology, antioxidant defense, and cellular signaling. Human and experimental studies suggest that saffron contributes to: - Neurotransmitter regulation - Oxidative balance - Neuroprotection - Cellular resilience - Emotional well-being - Cognitive physiology - Endogenous antioxidant systems These biological activities align with the neuroendocrine priorities of the luteal phase. # 3. Mechanism of Action The biological activity of saffron is attributed primarily to **crocin**, **crocetin**, and **safranal**. ### Neurotransmitter Regulation Experimental evidence suggests saffron influences: - serotonin signaling - dopamine signaling - norepinephrine signaling Unlike pharmaceutical antidepressants, saffron does **not** function through potent inhibition of neurotransmitter reuptake. Instead, it appears to support normal neurotransmitter physiology through multiple complementary mechanisms. ### Antioxidant Physiology Crocin and crocetin contribute to: - endogenous antioxidant defense - reduction of oxidative stress biomarkers - maintenance of neuronal redox balance These actions support cellular resilience during the progesterone-dominant phase. ### Neuroprotection Experimental studies suggest saffron supports: - neuronal survival - mitochondrial integrity - synaptic physiology Although promising, these mechanisms remain primarily supported by preclinical and translational research. ### Neuroendocrine Adaptation Emerging evidence suggests saffron may influence stress physiology through modulation of the hypothalamic–pituitary–adrenal (HPA) axis, although these mechanisms require additional investigation. # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase emphasizes: - neuroendocrine regulation - physiological recovery - GABAergic adaptation - neurotransmitter homeostasis - oxidative balance Saffron supports these biological priorities through: - maintenance of normal neurotransmitter physiology - endogenous antioxidant support - cellular resilience - neurophysiological homeostasis Importantly, saffron was selected to complement the biological environment established by progesterone rather than to modify endocrine function. # 5. Dose Justification ## Selected Dose: 30 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **30 mg/day** represents the most extensively studied dose in human randomized controlled trials evaluating saffron. ### Human Clinical Evidence The overwhelming majority of clinical trials investigating saffron for emotional well-being, mood, and cognitive outcomes have used **30 mg/day,** making this the best-supported evidence-based dose. ### Safety Human studies consistently demonstrate excellent tolerability at **30 mg/day**. This dose remains far below amounts associated with toxicity. ### Formulation Compatibility The selected dose: - complements L-theanine - complements GABA - complements chamomile - complements magnesium L-threonate creating an integrated neurophysiological formulation. ### HR+ Philosophy Saffron demonstrates no clinically meaningful estrogenic activity and aligns with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Saffron possesses one of the strongest human evidence bases among botanical ingredients used for neurophysiological support. Numerous randomized controlled trials and meta-analyses have investigated saffron in relation to: - emotional well-being - mood - stress physiology - sleep quality - cognitive function Importantly, several randomized controlled trials have also evaluated saffron in women experiencing **premenstrual symptoms**, demonstrating improvements in emotional and physical symptom scores compared with placebo. While these findings are encouraging, FEMSTATE™ does **not **position saffron as a treatment for PMS. Rather, these data support its inclusion as a botanical that aligns with the neurophysiological priorities of the luteal phase. # 7. Safety Considerations Saffron demonstrates an excellent safety profile at nutritional doses. ### FEMSTATE Dose: 30 mg/day Human clinical trials have safely evaluated **30 mg/day** for periods extending up to several months. Reported adverse effects are uncommon and generally mild: - headache - nausea - dry mouth - dizziness Toxicity has been reported only at doses many times higher than those used in dietary supplements. # 8. HR+ Safety Review Saffron was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - phytoestrogen properties - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No clinically meaningful estrogen receptor agonist activity ✔ No progesterone receptor agonist activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Although saffron has been investigated in reproductive health, current evidence does not support classification as a hormonally active botanical. # 9. Ingredient Interactions ### Positive Interactions **L-Theanine** Supports complementary neurophysiological regulation -> Strong synergy **GABA** Supports complementary neuronal homeostasis -> Positive synergy **Chamomile** Supports complementary physiological relaxation -> Positive synergy **Magnesium L-Threonate** Supports neuronal physiology and synaptic function -> Strong physiological synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Potassium - Selenium at FEMSTATE doses. ### Known Considerations Individuals taking: - antidepressant medications - serotonergic drugs - anticoagulants should consult a healthcare professional before using concentrated saffron supplements. # 10. Regulatory Status Saffron extract is: - Widely accepted for use in dietary supplements. - Supported by numerous randomized controlled trials. - Commonly used in nutritional products targeting emotional well-being and cognitive health. # 11. Evidence Gaps & Future Research Current evidence strongly supports saffron for: - mood physiology - emotional well-being - stress physiology Areas requiring further investigation include: - Neuroendocrine adaptation during the luteal phase. - Mechanistic interaction with progesterone physiology. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have evaluated saffron within a complete phase-aligned nutritional formulation. # 12. Conclusion Saffron (Crocus sativus L.) is one of the most scientifically supported botanical ingredients within the **SOOTHE™ **formulation. The selected dose of **30 mg/day** reflects the dose most consistently validated in randomized controlled trials evaluating emotional well-being, neurophysiology, and stress adaptation. Within the FEMSTATE™ platform, saffron is incorporated not as a treatment for depression or premenstrual syndrome, but as a botanical whose physiological activities align with the neuroendocrine priorities of the progesterone-dominant luteal phase. Its excellent safety profile, strong human clinical evidence, and favorable HR+ assessment make saffron one of the highest-confidence botanical ingredients in the entire formulation. ## References - Journal of Affective Disorders. Randomized controlled trials and meta-analyses of saffron for mood and emotional well-being. - Phytotherapy Research. Clinical studies evaluating saffron in women's health and neurophysiology. - Nutrients. Systematic reviews on saffron, crocin, and human health. - Journal of Ethnopharmacology. Reviews on saffron phytochemistry and mechanisms of action. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on neuroendocrine physiology and women's health. # Ingredient Scientific Monograph # Resveratrol (from Japanese Knotweed Root Extract) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Resveratrol **Chemical Name:** trans-Resveratrol **Botanical Source:** Japanese knotweed (formerly Polygonum cuspidatum) **Ingredient Form:** Standardized trans-Resveratrol **Primary Bioactive Compound:** - trans-Resveratrol **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | 100 mg | | SOOTHE™ | - | Resveratrol is included exclusively in **SHINE™** because the ovulatory phase is characterized by **increased mitochondrial activity, physiological oxidative metabolism, endothelial adaptation, extracellular matrix remodeling, and cellular resilience**. Resveratrol was selected because of its well-characterized effects on cellular stress-response pathways, mitochondrial physiology, endothelial function, and endogenous antioxidant systems. Importantly, resveratrol is included to support **normal cellular physiology**, **not** to influence estrogen signaling or reproductive hormone production. # 2. Physiological Role Resveratrol is a naturally occurring polyphenol found in grapes, berries, peanuts, and Japanese knotweed. It has been extensively investigated for its effects on **cellular resilience, mitochondrial biology, oxidative physiology, endothelial function, and healthy aging**.(1-5) Resveratrol contributes to: - Cellular stress adaptation - Mitochondrial physiology - Endothelial function - Nitric oxide signaling - Endogenous antioxidant defense - Cellular energy metabolism - Healthy inflammatory regulation - Vascular homeostasis Within FEMSTATE™, these physiological activities align with the biological priorities of the ovulatory phase. # 3. Mechanism of Action Resveratrol influences multiple cellular signaling pathways. ### SIRT1 Activation Experimental evidence suggests resveratrol may activate **Sirtuin-1 (SIRT1).** SIRT1 -> Mitochondrial biogenesis -> Cellular stress adaptation -> Metabolic regulation -> Cellular resilience Although the physiological significance of SIRT1 activation in humans continues to be investigated, this pathway represents one of the principal mechanisms associated with resveratrol biology. ### AMPK Signaling Resveratrol has been shown experimentally to influence: AMP-activated protein kinase (AMPK) -> Cellular energy sensing -> Mitochondrial function -> ATP homeostasis ### Endothelial Physiology Resveratrol supports: - nitric oxide bioavailability - endothelial function - vascular physiology These actions complement the increased vascular activity associated with ovulation. ### Antioxidant Physiology Resveratrol contributes to endogenous antioxidant defense through regulation of: - Nrf2 signaling - antioxidant enzyme expression - mitochondrial oxidative balance Unlike direct antioxidants, resveratrol primarily influences **cellular signaling pathways** involved in oxidative adaptation. # 4. Why Included in FEMSTATE™ ## SHINE™ The ovulatory phase emphasizes: - mitochondrial activation - endothelial adaptation - extracellular matrix remodeling - physiological oxidative metabolism - cellular resilience Resveratrol supports these biological priorities through: - mitochondrial physiology - vascular biology - endogenous antioxidant regulation - cellular stress adaptation The formulation objective is to support the physiological demands of ovulation rather than modify endocrine function. # 5. Dose Justification ## Selected Dose: 100 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **100 mg/day** provides meaningful exposure to trans-resveratrol while remaining appropriate for long-term nutritional supplementation. ### Human Clinical Evidence Human intervention studies have evaluated doses ranging from: 50–1,000 mg/day The **100 mg **dose represents one of the most commonly studied nutritional doses and demonstrates favorable tolerability while supporting cellular physiology. ### Safety The selected dose remains well below doses associated with gastrointestinal intolerance in clinical studies. ### Formulation Compatibility The selected dose: - complements CoQ10 - complements astaxanthin - complements quercetin - complements vitamin C - complements vitamin E creating an integrated formulation supporting mitochondrial physiology and cellular resilience. ### HR+ Philosophy Resveratrol required one of the most comprehensive HR+ evaluations within the FEMSTATE™ formulation because of its extensive literature in reproductive biology and oncology. # 6. Human Clinical Evidence Resveratrol has been extensively investigated in relation to: - cardiovascular physiology - endothelial function - oxidative stress - mitochondrial metabolism - healthy aging The strongest human evidence supports improvements in vascular function and oxidative physiology. Evidence regarding female reproductive physiology remains mixed and should be interpreted cautiously. # 7. Safety Considerations Resveratrol demonstrates an excellent safety profile at nutritional doses. ### FEMSTATE Dose: 100 mg/day Human clinical studies have safely evaluated doses substantially higher than 100 mg/day. Reported adverse effects are generally mild: - gastrointestinal discomfort - nausea - diarrhea (primarily at much higher doses) # 8. HR+ Safety Review Resveratrol underwent an extensive HR+ safety review because it has been investigated in laboratory models of hormone-sensitive cancers. The literature was reviewed for: - estrogen receptor agonism - estrogen receptor antagonism - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence indicates: ✔ No evidence that nutritional doses of **100 mg/day** produce clinically meaningful estrogenic stimulation. ✔ Laboratory studies demonstrate complex interactions with estrogen receptors that are **dose-dependent, tissue-specific, and often contradictory**. ✔ Human clinical evidence does **not **support classification of resveratrol as an estrogenic botanical at nutritional doses. Accordingly, the FEMSTATE™ Scientific Advisory Framework considers **100 mg/day** compatible with the HR+-conscious formulation strategy, while recognizing that higher pharmacological doses investigated in experimental oncology should not be extrapolated to nutritional supplementation. # 9. Ingredient Interactions ### Positive Interactions **Quercetin** Supports complementary polyphenol physiology -> Strong synergy **Astaxanthin** Supports complementary antioxidant physiology -> Positive synergy **CoQ10** Supports mitochondrial function through complementary mechanisms -> Strong synergy **Vitamin C** Supports endogenous antioxidant systems -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Magnesium - Zinc - Selenium at FEMSTATE doses. ### Known Considerations Resveratrol may exhibit mild antiplatelet activity. Individuals using: - anticoagulants - antiplatelet medications should consult their healthcare provider before supplementation. # 10. Regulatory Status Resveratrol is: - Widely accepted for use in dietary supplements. - Commonly derived from Japanese knotweed. - Extensively investigated in human clinical trials. - Recognized internationally as a nutritional polyphenol. # 11. Evidence Gaps & Future Research Current evidence strongly supports resveratrol for: - endothelial physiology - antioxidant biology - mitochondrial function Areas requiring additional investigation include: - Phase-specific physiology during ovulation. - Cellular adaptation during reproductive tissue remodeling. - Long-term studies evaluating nutritional-dose resveratrol in healthy reproductive-aged women. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated **100 mg/day** resveratrol within a phase-aligned formulation. # 12. Conclusion Resveratrol is one of the most scientifically sophisticated polyphenols within the **SHINE™** formulation. The selected dose of **100 mg/day** supports the physiological priorities of the ovulatory phase by contributing to mitochondrial biology, endothelial function, cellular resilience, and endogenous antioxidant regulation. Its inclusion is based on systems physiology rather than symptom management. Because resveratrol has been extensively investigated in hormone-related research, it underwent an expanded HR+ safety evaluation. Current evidence supports the compatibility of nutritional-dose resveratrol with the FEMSTATE™ HR+-conscious formulation philosophy while recognizing the need for continued surveillance as the scientific literature evolves. Within FEMSTATE™, resveratrol serves as a cellular resilience ingredient supporting the dynamic biology of ovulation rather than modifying endocrine function. ## References - Nature Reviews Drug Discovery. Reviews on resveratrol biology and therapeutic potential. - Nutrients. Systematic reviews on resveratrol, mitochondrial physiology, and human health. - The American Journal of Clinical Nutrition. Reviews on resveratrol and cardiovascular physiology. - Free Radical Biology and Medicine. Reviews on resveratrol, oxidative signaling, and cellular stress adaptation. - The Journal of Clinical Endocrinology & Metabolism. Reviews on resveratrol, endocrine physiology, and women's health. - Williams Textbook of Endocrinology. # Ingredient Scientific Monograph # Quercetin (as Quercetin Dihydrate) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Quercetin **Chemical Name:** Quercetin Dihydrate **Ingredient Form:** Quercetin Dihydrate **Natural Sources:** Apples, onions, berries, capers, leafy vegetables, and tea **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | 250 mg | | SOOTHE™ | - | Quercetin is included exclusively in **SHINE™** because the ovulatory phase is characterized by **physiological oxidative signaling, localized inflammatory remodeling, vascular adaptation, extracellular matrix turnover, and cellular resilience**. Quercetin was selected as a polyphenol that supports endogenous antioxidant systems, mast cell stability, endothelial physiology, and normal inflammatory signaling during this highly dynamic endocrine transition. # 2. Physiological Role Quercetin is a naturally occurring flavonol widely present in plant foods. It has been extensively studied for its roles in **redox physiology, endothelial function, cellular signaling, immune regulation, and inflammatory homeostasis**. Quercetin contributes to: - Endogenous antioxidant defense - Physiological inflammatory regulation - Mast cell stabilization - Endothelial function - Nitric oxide bioavailability - Cellular resilience - Mitochondrial physiology - Immune homeostasis Within FEMSTATE™, these functions align most closely with the biological priorities of **SHINE™,** where ovulation requires controlled tissue remodeling and redox balance. # 3. Mechanism of Action Quercetin acts through multiple complementary pathways. ### Antioxidant and Redox Physiology Quercetin supports redox homeostasis by: - scavenging reactive oxygen species - supporting endogenous antioxidant enzyme activity - influencing Nrf2-related cellular defense pathways - reducing lipid peroxidation markers in some human studies This is relevant during ovulation, when physiological ROS signaling participates in follicular rupture and tissue remodeling. ### Physiological Inflammatory Regulation Quercetin has been shown experimentally to influence: - NF-κB signaling - cyclooxygenase pathways - lipoxygenase pathways - cytokine signaling These actions support normal inflammatory regulation without suppressing the physiological inflammatory remodeling required for ovulation. ### Endothelial and Vascular Physiology Quercetin may support: - endothelial function - nitric oxide bioavailability - vascular responsiveness - microcirculatory physiology This aligns with the vascular remodeling and increased ovarian blood flow associated with the ovulatory transition. ### Mast Cell and Immune Regulation Quercetin is often studied for mast cell stabilization and histamine-related pathways. Within FEMSTATE™, this is framed conservatively as support for **normal immune homeostasis**, not as treatment of allergy or inflammatory disease. # 4. Why Included in FEMSTATE™ ## SHINE™ The ovulatory phase emphasizes: - LH-driven follicular rupture - localized inflammatory remodeling - transient oxidative metabolism - angiogenesis - endothelial adaptation - extracellular matrix remodeling - cellular resilience Quercetin supports these biological priorities through its effects on redox balance, inflammatory signaling, endothelial physiology, and immune homeostasis. Importantly, quercetin is not included to alter ovulation, suppress inflammation, or modify reproductive hormones. It is included to support normal cellular physiology during a phase of heightened biological activity. # 5. Dose Justification ## Selected Dose: 250 mg The selected dose was based on five scientific criteria. ### Physiological Relevance A dose of **250 mg/day** provides meaningful polyphenol exposure while remaining appropriate for long-term nutritional supplementation. ### Human Clinical Evidence Human trials commonly evaluate quercetin doses ranging from **250-1,000 mg/day**, depending on the outcome studied. The selected dose represents the lower end of clinically investigated supplemental ranges and was chosen to support cellular physiology without excessive polyphenol loading. ### Safety Quercetin has demonstrated good tolerability at doses substantially higher than 250 mg/day in human studies. ### Formulation Compatibility The selected dose: - complements resveratrol - complements vitamin C - complements vitamin E - complements astaxanthin - complements CoQ10 creating an integrated SHINE™ formulation focused on mitochondrial function, antioxidant physiology, vascular biology, and cellular resilience. ### HR+ Philosophy Quercetin underwent HR+ review because flavonoids can demonstrate receptor activity in some in vitro systems. At nutritional doses, current human evidence does not support clinically meaningful estrogenic activity. # 6. Human Clinical Evidence Quercetin has been evaluated in randomized controlled trials and systematic reviews for: - antioxidant biomarkers - inflammatory markers - endothelial function - blood pressure physiology - immune-related outcomes The strongest human evidence supports roles in oxidative physiology and cardiovascular biomarkers. Direct evidence in ovulatory or menstrual phase-specific physiology remains limited. # 7. Safety Considerations Quercetin has a favorable safety profile at nutritional supplemental doses. ### FEMSTATE Dose: 250 mg/day Human studies have commonly evaluated doses up to **1,000 mg/day** with good tolerability. Potential adverse effects are uncommon and may include: - mild gastrointestinal discomfort - headache - nausea At very high doses or in susceptible individuals, caution is appropriate due to potential effects on drug metabolism. # 8. HR+ Safety Review Quercetin was evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor agonism - estrogen receptor antagonism - progesterone receptor activity - aromatase modulation - phytoestrogen properties - oncology safety ### Findings Current evidence indicates: ✔ Quercetin is a dietary flavonoid with some in vitro receptor-related findings. ✔ Human evidence does not support clinically meaningful estrogenic activity at nutritional supplemental doses. ✔ No evidence supports quercetin as a progesterone receptor agonist. ✔ No evidence supports clinically meaningful aromatase stimulation at the FEMSTATE™ dose. Because quercetin has complex cell-signaling effects in laboratory models, FEMSTATE™ classifies it as **HR+ compatible with ongoing literature surveillance**. # 9. Ingredient Interactions ### Positive Interactions **Resveratrol** Supports complementary polyphenol signaling and cellular resilience -> Strong synergy **Vitamin C** Supports antioxidant network function and may help preserve flavonoid redox activity -> Positive synergy **Vitamin E** Supports complementary lipid-phase antioxidant physiology -> Positive synergy **CoQ10** Supports mitochondrial physiology through complementary mechanisms -> Positive synergy **Astaxanthin** Supports cellular and membrane antioxidant physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Selenium - Zinc - Magnesium - Vitamin D3 at FEMSTATE doses. ### Known Considerations Quercetin may interact with certain medications through effects on drug transporters or cytochrome P450 enzymes. Individuals taking prescription medications with narrow therapeutic windows, anticoagulants, or immunosuppressants should consult a healthcare professional before using concentrated quercetin supplements. # 10. Regulatory Status Quercetin is: - Widely accepted for use in dietary supplements. - Naturally present in commonly consumed foods. - Supported by numerous human clinical studies. - Commonly used in nutritional products focused on antioxidant and immune physiology. # 11. Evidence Gaps & Future Research Current evidence supports quercetin for: - redox physiology - endothelial function - inflammatory biomarker modulation - immune homeostasis Areas requiring further investigation include: - Ovulatory phase-specific redox biology. - Quercetin pharmacokinetics within a multi-polyphenol formulation. - Clinical evaluation within phase-aligned systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated quercetin within an ovulation-aligned nutritional formulation. # 12. Conclusion Quercetin dihydrate is included in **SHINE™** because its biological profile aligns with the ovulatory phase’s needs for cellular resilience, endothelial support, antioxidant regulation, and controlled inflammatory remodeling. The selected dose of **250 mg** sits within clinically studied supplemental ranges while remaining conservative for long-term nutritional use. Within FEMSTATE™, quercetin is positioned as a polyphenol support ingredient for normal ovulatory physiology, not as a hormone modulator, anti-inflammatory drug, or fertility intervention. Its strongest role is as part of the integrated SHINE™ polyphenol-antioxidant network alongside resveratrol, vitamin C, vitamin E, astaxanthin, selenium, and CoQ10. ## References - Boots AW, Haenen GRMM, Bast A. Health effects of quercetin: From antioxidant to nutraceutical. Health effects of quercetin: From antioxidant to nutraceutical. Eur J Pharmacol. 2008;585(2-3):325-337. - Li Y, Yao J, Han C, et al. Quercetin, Inflammation and Immunity. Quercetin, inflammation and immunity. Nutrients.2016;8(3):167. - Brito AF, Ribeiro M, Abrantes AM, et al. Quercetin in Cancer Treatment, Alone or in Combination with Conventional Therapeutics?. Quercetin in cancer treatment, alone or in combination with conventional therapeutics? Curr Med Chem. 2015;22(26):3025-3039. - D'Andrea G. Quercetin: A flavonol with multifaceted therapeutic applications?. Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia. 2015;106:256-271. - Serban MC, Sahebkar A, Zanchetti A, et al. Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-analysis. Effects of quercetin on blood pressure: A systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5:e002713. - Xu D, Hu MJ, Wang YQ, Cui YL. Antioxidant Activities of Quercetin and Its Complexes. Antioxidant activities of quercetin and its complexes. Food Chem. 2019;279:56-63. - Ulusoy HG, Sanlier N. A Minireview of Quercetin: From Its Metabolism to Possible Mechanisms of Its Biological Activities. A minireview of quercetin: From its metabolism to possible mechanisms of its biological activities. Crit Rev Food Sci Nutr. 2020. - Andres S, Pevny S, Ziegenhagen R, et al. Safety Aspects of the Use of Quercetin as a Dietary Supplement. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 2018;62:e1700447. - Williams Textbook of Endocrinology. Chapter on oxidative stress, inflammation, and endocrine physiology. - Guyton and Hall Textbook of Medical Physiology. Chapters on endothelial physiology, oxidative metabolism, and cellular homeostasis. - The Journal of Clinical Endocrinology & Metabolism. Reviews on oxidative physiology, endothelial biology, and female endocrine physiology. - Nutrients. Reviews on flavonoids, polyphenols, and women's health. # Ingredient Scientific Monograph # Coenzyme Q10 (CoQ10) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Coenzyme Q10 **Chemical Name:** Ubiquinone-10 **Common Abbreviation:** CoQ10 **Ingredient Form:** Coenzyme Q10 (Ubiquinone) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | 100 mg | | SOOTHE™ | - | Coenzyme Q10 (CoQ10) is included exclusively in **SHINE™** because the ovulatory phase is characterized by **peak mitochondrial activity, increased ATP demand, steroidogenesis, extracellular matrix remodeling, endothelial adaptation, and physiological oxidative metabolism**. CoQ10 was selected because it plays a central role in mitochondrial energy production while simultaneously functioning as an endogenous lipid-soluble antioxidant. Unlike stimulant ingredients, CoQ10 supports the body's natural bioenergetic systems, making it highly compatible with the physiological priorities of ovulation. # 2. Physiological Role Coenzyme Q10 is a naturally occurring lipid-soluble quinone synthesized in virtually every human cell. It is highly concentrated in tissues with elevated metabolic activity, including: - Heart - Brain - Liver - Skeletal muscle - Ovaries CoQ10 serves two principal physiological functions: - Mitochondrial ATP production - Endogenous antioxidant protection It contributes to: - Electron transport chain activity - Cellular energy production - Membrane stabilization - Oxidative balance - Endothelial physiology - Cellular resilience - Mitochondrial integrity These biological functions closely align with the increased metabolic demands of the ovulatory phase. # 3. Mechanism of Action CoQ10 functions primarily within mitochondria. ### Mitochondrial ATP Production CoQ10 serves as an electron carrier within the electron transport chain. NADH -> Complex I -> CoQ10 -> Complex III -> ATP Production Without CoQ10, efficient oxidative phosphorylation cannot occur. ### Antioxidant Physiology Reduced CoQ10 (ubiquinol) protects: - mitochondrial membranes - phospholipid membranes - lipoproteins from oxidative damage. Unlike direct antioxidants, CoQ10 participates continuously in mitochondrial redox cycling. ### Cellular Bioenergetics CoQ10 contributes to: - mitochondrial efficiency - ATP availability - cellular resilience - metabolic homeostasis These mechanisms become particularly relevant during ovulation, when ovarian energy demand increases substantially. ### Endothelial Function Human studies suggest CoQ10 supports: - endothelial physiology - nitric oxide bioavailability - vascular homeostasis These actions complement the vascular remodeling associated with ovulation. # 4. Why Included in FEMSTATE™ ## SHINE™ The ovulatory phase is characterized by: - LH surge - follicular rupture - steroid hormone synthesis - angiogenesis - extracellular matrix remodeling - mitochondrial activation These biological processes require substantial ATP production. CoQ10 supports: - mitochondrial bioenergetics - cellular resilience - oxidative balance - endothelial physiology Importantly, CoQ10 is **not included to improve fertility or ovarian reserve**, but rather to support the increased cellular energy demands associated with normal ovulatory physiology. # 5. Dose Justification ## Selected Dose: 100 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **100 mg/day** provides meaningful physiological exposure while remaining appropriate for long-term nutritional supplementation. ### Human Clinical Evidence Human intervention studies have commonly investigated CoQ10 doses ranging from: 100–300 mg/day The selected dose of **100 mg** is among the most frequently studied nutritional doses and has demonstrated favorable effects on mitochondrial physiology and endothelial function. ### Safety The selected dose provides physiological support while remaining substantially below doses associated with adverse effects. ### Formulation Compatibility The selected dose: - complements resveratrol - complements quercetin - complements vitamin E - complements vitamin C - complements astaxanthin creating an integrated formulation focused on mitochondrial function and cellular resilience. ### HR+ Philosophy CoQ10 demonstrates no endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence CoQ10 has been extensively investigated in randomized controlled trials evaluating: - mitochondrial physiology - cardiovascular health - endothelial function - exercise physiology - healthy aging Evidence supporting ovarian physiology primarily comes from women with diminished ovarian reserve or infertility, often using doses of **200-600 mg/day**. These therapeutic studies should not be extrapolated to healthy reproductive-aged women or to the dose used in FEMSTATE™. Within FEMSTATE™, CoQ10 is included for **cellular bioenergetics**, not fertility enhancement. # 7. Safety Considerations CoQ10 demonstrates an excellent safety profile. ### FEMSTATE Dose: 100 mg/day Human studies have safely evaluated doses exceeding: 1,200 mg/day Reported adverse effects are uncommon: - mild gastrointestinal discomfort - nausea - headache These events are generally mild and infrequent. # 8. HR+ Safety Review CoQ10 was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile CoQ10 is fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Resveratrol** Supports complementary mitochondrial physiology -> Strong synergy **Quercetin** Supports complementary cellular resilience -> Positive synergy **Vitamin E** Supports lipid membrane antioxidant protection -> Strong synergy **Vitamin C** Supports regeneration of antioxidant systems -> Positive synergy **Astaxanthin** Supports complementary mitochondrial and membrane antioxidant physiology -> Strong synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Magnesium - Selenium - Zinc at FEMSTATE doses. ### Known Considerations CoQ10 may modestly reduce the anticoagulant effect of Warfarin in some individuals. Patients taking vitamin K antagonists should consult their healthcare provider before supplementation. # 10. Regulatory Status Coenzyme Q10 is: - Widely accepted for use in dietary supplements. - Extensively studied in human clinical trials. - Commonly used in cardiovascular and mitochondrial health formulations. - Recognized internationally as a nutritional ingredient. # 11. Evidence Gaps & Future Research Current evidence strongly supports CoQ10 for: - mitochondrial ATP production - endothelial physiology - cellular bioenergetics - antioxidant physiology Areas requiring additional investigation include: - Mitochondrial adaptation during normal ovulation. - Phase-specific ATP requirements throughout the menstrual cycle. - Clinical evaluation of CoQ10 within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated **100 mg/day** CoQ10 within a phase-aligned nutritional formulation. # 12. Conclusion Coenzyme Q10 is one of the cornerstone ingredients of the **SHINE™** formulation because it directly supports the increased mitochondrial energy production required during ovulation. The selected dose of **100 mg/day** is one of the most extensively studied nutritional doses and aligns with the physiological priorities of the ovulatory phase, including ATP production, endothelial adaptation, oxidative balance, and cellular resilience. Unlike therapeutic fertility protocols that employ much higher doses, FEMSTATE™ incorporates CoQ10 to support **normal mitochondrial physiology** during the body's most metabolically active endocrine transition. Its exceptional safety profile, robust human evidence, and complete compatibility with the HR+-conscious formulation philosophy make CoQ10 one of the highest-confidence ingredients within the SHINE™ formulation. ## References - BioFactors. Reviews on coenzyme Q10 physiology, mitochondrial function, and human health. - Mitochondrion. Reviews on CoQ10, oxidative phosphorylation, and bioenergetics. - Nutrients. Systematic reviews on CoQ10 supplementation and clinical outcomes. - The American Journal of Clinical Nutrition. Reviews on CoQ10 metabolism and cardiovascular physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on mitochondrial physiology, ovarian metabolism, and endocrine health. - Williams Textbook of Endocrinology. - Fertility and Sterility. Clinical studies evaluating CoQ10 in ovarian physiology and reproductive medicine. # Ingredient Scientific Monograph # Hyaluronic Acid (as Sodium Hyaluronate) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Hyaluronic Acid **Chemical Name:** Hyaluronan **Ingredient Form:** Sodium Hyaluronate **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | 120 mg | | SHINE™ | - | | SOOTHE™ | - | Hyaluronic acid is included exclusively in **LIFT™** because the follicular phase is characterized by **cellular proliferation, extracellular matrix synthesis, connective tissue remodeling, angiogenesis, and anabolic physiology**. Sodium hyaluronate was selected because of its excellent stability, bioavailability, and extensive clinical evidence supporting connective tissue, skin, and joint physiology. Within the FEMSTATE™ platform, hyaluronic acid is **not included as a cosmetic ingredient**, but as a structural component supporting the connective tissue biology and extracellular matrix remodeling that naturally occur during the estrogen-dominant follicular phase. # 2. Physiological Role Hyaluronic acid is a naturally occurring **glycosaminogly can** present throughout the extracellular matrix of nearly every connective tissue in the body. Highest concentrations are found in: - Skin - Synovial fluid - Cartilage - Connective tissue - Eyes - Umbilical cord - Ovarian follicles - Endometrium Hyaluronic acid contributes to: - Extracellular matrix organization - Tissue hydration - Cellular migration - Connective tissue integrity - Angiogenesis - Wound healing - Joint lubrication - Skin physiology These biological functions closely align with the regenerative and anabolic physiology of the follicular phase. # 3. Mechanism of Action Hyaluronic acid functions primarily as a structural molecule within the extracellular matrix. ### Extracellular Matrix Organization Hyaluronic acid -> Water binding -> Extracellular matrix expansion -> Cell migration -> Tissue remodeling -> Connective tissue physiology Its extraordinary water-binding capacity contributes to tissue elasticity and structural organization. ### Cellular Signaling Hyaluronic acid interacts with receptors including: - CD44 - RHAMM These receptors regulate: - cell migration - proliferation - wound repair - extracellular matrix remodeling ### Tissue Hydration Hyaluronic acid binds large quantities of water, contributing to: - tissue hydration - connective tissue flexibility - extracellular matrix viscosity This role is especially important in tissues undergoing active remodeling. ### Ovarian Physiology Within the ovary, hyaluronic acid contributes to: - follicular extracellular matrix - cumulus-oocyte complex expansion - ovulatory tissue remodeling These physiological roles support its inclusion during the follicular phase. # 4. Why Included in FEMSTATE™ ## LIFT™ The follicular phase is characterized by: - increasing estradiol - connective tissue remodeling - angiogenesis - extracellular matrix synthesis - follicular maturation - anabolic physiology Hyaluronic acid supports these biological priorities through: - extracellular matrix organization - connective tissue physiology - tissue hydration - cellular migration Importantly, FEMSTATE™ includes hyaluronic acid to support **normal connective tissue biology**, not for cosmetic skin enhancement. # 5. Dose Justification ## Selected Dose: 120 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **120 mg/day** supports connective tissue physiology while fitting appropriately within a comprehensive multi-ingredient formulation. ### Human Clinical Evidence Randomized controlled trials evaluating oral sodium hyaluronate have commonly investigated doses ranging from: 120-240 mg/day The selected dose represents one of the most frequently studied nutritional doses for connective tissue physiology. ### Safety The selected dose demonstrates excellent long-term tolerability. ### Formulation Compatibility The selected dose: - complements collagen peptides - complements vitamin C - complements magnesium - complements myo-inositol creating an integrated anabolic formulation supporting extracellular matrix biology. ### HR+ Philosophy Hyaluronic acid demonstrates no endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Human clinical studies have investigated oral hyaluronic acid in relation to: - skin hydration - connective tissue physiology - joint function - extracellular matrix biology The strongest evidence supports improvements in skin hydration and joint comfort. While these outcomes are not the primary objective of FEMSTATE™, they support hyaluronic acid's established physiological role in connective tissue biology. Evidence regarding ovarian physiology is primarily mechanistic. # 7. Safety Considerations Hyaluronic acid demonstrates an excellent safety profile. ### FEMSTATE Dose: 120 mg/day Human studies have safely evaluated doses exceeding: 240 mg/day Reported adverse effects are uncommon: - mild gastrointestinal discomfort - bloating (rare) # 8. HR+ Safety Review Hyaluronic acid was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Although hyaluronic acid participates in ovarian extracellular matrix physiology, it **does not** influence endocrine signaling. # 9. Ingredient Interactions ### Positive Interactions **Collagen Peptides** Supports complementary extracellular matrix biology -> Strong connective tissue synergy **Vitamin C** Supports collagen synthesis while hyaluronic acid supports extracellular matrix hydration -> Strong synergy **Myo-Inositol** Supports follicular physiology through complementary mechanisms -> Positive synergy **Magnesium** Supports ATP-dependent connective tissue metabolism -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Selenium - Zinc at FEMSTATE doses. ### Known Considerations No clinically significant nutrient interactions have been reported at nutritional doses. Individuals with severe allergies to the manufacturing source (if fermentation-derived or animal-derived) should verify product sourcing, although most modern sodium hyaluronate is produced through microbial fermentation. # 10. Regulatory Status Sodium hyaluronate is: - Widely accepted for use in dietary supplements. - Extensively studied in human clinical trials. - Commonly used in nutritional products supporting connective tissue and skin physiology. - Recognized internationally as a safe nutritional ingredient. # 11. Evidence Gaps & Future Research Current evidence strongly supports hyaluronic acid for: - connective tissue physiology - extracellular matrix biology - tissue hydration Areas requiring further investigation include: - Ovarian extracellular matrix remodeling during the follicular phase. - Endometrial connective tissue physiology. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated hyaluronic acid within a phase-aligned nutritional formulation. # 13. Conclusion Hyaluronic acid, provided as **sodium hyaluronate**, is a foundational connective tissue ingredient within **LIFT™** because of its central role in extracellular matrix organization, tissue hydration, angiogenesis, and cellular migration. The selected dose of **120 mg/day** reflects one of the most extensively studied oral doses and aligns with the anabolic physiology of the follicular phase, during which connective tissue remodeling and extracellular matrix synthesis are naturally increased. Rather than functioning as a cosmetic ingredient, hyaluronic acid supports the structural biology of tissue growth and regeneration that accompanies rising estrogen. Its excellent safety profile, strong human clinical evidence, and complete compatibility with the HR+-conscious formulation philosophy make it one of the highest-confidence structural ingredients within the FEMSTATE™ platform. ## References - Nutrients. Systematic reviews on oral hyaluronic acid, connective tissue physiology, and skin health. - Nutrients. Reviews of randomized controlled trials evaluating oral sodium hyaluronate. - International Journal of Biological Macromolecules. Reviews on hyaluronic acid biology and extracellular matrix physiology. - Matrix Biology. Reviews on hyaluronan, connective tissue remodeling, and cell signaling. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on ovarian physiology, extracellular matrix remodeling, and reproductive biology. # Ingredient Scientific Monograph # Astaxanthin ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Astaxanthin **Chemical Name:** Astaxanthin **Ingredient Form:** Natural Astaxanthin **Primary Source:** Haematococcus pluvialis microalgae **Primary Bioactive Compound:** - Astaxanthin (xanthophyll carotenoid) **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | 6 mg | | SOOTHE™ | - | Astaxanthin is included exclusively in **SHINE™** because the ovulatory phase represents the period of **greatest physiological oxidative metabolism**, requiring efficient endogenous antioxidant regulation, mitochondrial resilience, membrane stability, and cellular protection. Astaxanthin was selected because it is one of the most potent naturally occurring carotenoid antioxidants and demonstrates excellent biological activity in mitochondrial and membrane physiology. Unlike conventional antioxidants, astaxanthin integrates into lipid membranes, allowing protection of both membrane surfaces while preserving normal physiological oxidative signaling. # 2. Physiological Role Astaxanthin is a naturally occurring xanthophyll carotenoid synthesized primarily by Haematococcus pluvialis. It accumulates in marine organisms such as salmon, trout, shrimp, lobster, and krill. Within human physiology, astaxanthin contributes to: - Cellular antioxidant defense - Mitochondrial protection - Membrane stability - Endothelial physiology - Immune homeostasis - Skin physiology - Muscle recovery - Cellular resilience These biological functions closely align with the increased oxidative metabolism associated with ovulation. # 3. Mechanism of Action Astaxanthin functions through multiple complementary mechanisms. ### Membrane Antioxidant Protection Astaxanthin spans the phospholipid bilayer. Unlike vitamin C (water-soluble) or vitamin E (lipid-soluble), astaxanthin protects: - inner membrane surface - lipid membrane core - outer membrane surface -> Improved membrane stability -> Cellular resilience ### Mitochondrial Physiology Astaxanthin contributes to: - maintenance of mitochondrial membrane integrity - reduction of oxidative injury - preservation of ATP production These functions become particularly relevant during ovulation, when mitochondrial activity increases substantially. ### Oxidative Balance Astaxanthin supports: - endogenous antioxidant systems - maintenance of physiological redox balance - regulation of oxidative metabolism Importantly, it does **not **eliminate physiological reactive oxygen species required for ovulation. ### Endothelial Function Human studies suggest astaxanthin supports: - endothelial physiology - nitric oxide bioavailability - vascular function These mechanisms complement the vascular remodeling that accompanies ovulation. # 4. Why Included in FEMSTATE™ ## SHINE™ The ovulatory phase is characterized by: - LH surge - extracellular matrix remodeling - angiogenesis - mitochondrial activation - physiological oxidative metabolism - increased ATP demand Astaxanthin supports these biological priorities through: - membrane protection - mitochondrial physiology - endogenous antioxidant regulation - cellular resilience Within FEMSTATE™, astaxanthin is included to support **normal cellular adaptation** during ovulation rather than to suppress oxidative physiology. # 5. Dose Justification ## Selected Dose: 6 mg The selected dose was based upon five scientific criteria. ### Physiological Relevance A daily dose of **6 mg** provides meaningful physiological exposure while remaining practical for long-term supplementation. ### Human Clinical Evidence Human intervention studies evaluating astaxanthin have commonly investigated doses ranging from: 4-12 mg/day The selected dose of **6 mg** falls within the most frequently studied range for antioxidant physiology and mitochondrial support. ### Safety Clinical trials consistently demonstrate excellent tolerability at doses considerably higher than 6 mg/day. ### Formulation Compatibility The selected dose: - complements CoQ10 - complements vitamin E - complements vitamin C - complements quercetin - complements resveratrol creating an integrated mitochondrial and antioxidant network within SHINE™. ### HR+ Philosophy Astaxanthin demonstrates no endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Astaxanthin has been investigated in randomized controlled trials evaluating: - oxidative stress biomarkers - exercise physiology - skin physiology - endothelial function - mitochondrial physiology The strongest evidence supports improvements in biomarkers of oxidative stress and cellular resilience. Evidence directly relating to ovulatory physiology remains limited. # 7. Safety Considerations Astaxanthin demonstrates an excellent safety profile. ### FEMSTATE Dose 6 mg/day Human studies have safely evaluated doses ranging from: 4-40 mg/day Reported adverse effects are uncommon and generally mild: - orange discoloration of stool (rare) - mild gastrointestinal discomfort - headache (rare) No serious safety concerns have been consistently reported at nutritional doses. # 8. HR+ Safety Review Astaxanthin was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Astaxanthin is considered fully compatible with the FEMSTATE™ HR+-conscious formulation philosophy. # 9. Ingredient Interactions ### Positive Interactions **Coenzyme Q10** Supports complementary mitochondrial physiology -> Strong synergy **Vitamin E** Supports membrane antioxidant protection -> Strong synergy **Vitamin C** Regenerates antioxidant systems -> Positive synergy **Resveratrol** Supports complementary cellular resilience pathways -> Positive synergy **Quercetin** Supports complementary polyphenol-mediated antioxidant physiology -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Selenium - Zinc - Magnesium at FEMSTATE doses. ### Known Considerations No clinically significant nutrient interactions have been consistently reported. Individuals taking anticoagulant medications should consult a healthcare provider before initiating concentrated carotenoid supplementation, although current evidence suggests minimal interaction at nutritional doses. # 10. Regulatory Status Astaxanthin is: - Widely accepted for use in dietary supplements. - Commonly derived from Haematococcus pluvialis microalgae. - Supported by numerous randomized controlled trials. - Recognized internationally as a nutritional carotenoid. # 11. Evidence Gaps & Future Research Current evidence strongly supports astaxanthin for: - antioxidant physiology - mitochondrial function - membrane protection - endothelial physiology Areas requiring further investigation include: - Physiological oxidative metabolism during ovulation. - Phase-specific application in healthy reproductive-aged women. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated astaxanthin within a phase-aligned nutritional formulation. # 12. Conclusion Astaxanthin is one of the cornerstone antioxidant ingredients within **SHINE™** because of its exceptional ability to support mitochondrial integrity, membrane stability, endothelial physiology, and endogenous antioxidant defense during the metabolically demanding ovulatory phase. The selected dose of **6 mg/day** aligns with the most consistently studied range in human clinical trials and complements the integrated mitochondrial network formed by CoQ10, vitamin C, vitamin E, quercetin, and resveratrol. Rather than suppressing physiological oxidative signaling, astaxanthin supports the body's natural antioxidant systems while preserving the oxidative processes required for normal ovulation. Its excellent safety profile, robust human evidence, and complete HR+ compatibility make it one of the highest-confidence ingredients within the SHINE™ formulation. ## References - Marine Drugs. Reviews on astaxanthin pharmacology, bioavailability, and human health. - Nutrients. Systematic reviews on astaxanthin supplementation and antioxidant physiology. - Antioxidants. Reviews on astaxanthin, mitochondrial function, and oxidative stress. - The American Journal of Clinical Nutrition. Reviews on carotenoids, endothelial physiology, and human metabolism. - Journal of Clinical Biochemistry and Nutrition. Randomized controlled trials evaluating astaxanthin in healthy adults. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on oxidative physiology, mitochondrial metabolism, and women's health. # Ingredient Scientific Monograph # Ceramides (as CeraLOK® Rice Bran Extract) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Ceramides **Ingredient Form:** Plant-Derived Glucosylceramides **Branded Ingredient:** CeraLOK® **Source:** Rice Bran Extract **Primary Bioactive Components:** - Glucosylceramides - Plant Ceramides **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | 0.6 mg glucosylceramides | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | - | CeraLOK® is included exclusively in **RESET™** because the menstrual phase is characterized by **epithelial renewal, connective tissue repair, extracellular matrix remodeling, and restoration of barrier integrity.** Rather than serving as a cosmetic ingredient, plant ceramides support the physiological regeneration of epithelial tissues and maintenance of skin barrier function during the body's primary regenerative phase. # 2. Physiological Role Ceramides are sphingolipids that constitute approximately **50% of the lipid matrix of the stratum corneum**, the outermost layer of the skin. They are also present in cell membranes throughout the body, where they contribute to membrane organization, cellular signaling, and barrier integrity.(1-4) Ceramides contribute to: - Epidermal barrier function - Skin hydration - Cellular membrane integrity - Extracellular lipid organization - Water retention - Cellular signaling - Tissue resilience Although best known for their role in skin physiology, ceramides are fundamental structural molecules involved in maintenance of epithelial tissues. # 3. Mechanism of Action Plant-derived glucosylceramides support epidermal physiology through multiple mechanisms. ### Epidermal Barrier Function Ceramides form organized lipid lamellae within the stratum corneum. Ceramides -> Lipid bilayer organization -> Reduced transepidermal water loss -> Improved barrier integrity -> Maintenance of tissue hydration ### Cellular Membrane Structure Ceramides contribute to: - membrane stability - lipid organization - cellular resilience ### Skin Hydration Human studies demonstrate oral plant ceramides support: - skin moisture - barrier function - epidermal integrity These physiological effects appear to result from modulation of epidermal lipid metabolism rather than direct incorporation into skin. ### Tissue Recovery By supporting epithelial integrity and barrier physiology, ceramides complement the regenerative biology of the menstrual phase. # 4. Why Included in FEMSTATE™ ## RESET™ The menstrual phase is characterized by: - tissue regeneration - epithelial renewal - extracellular matrix remodeling - connective tissue repair Ceramides support these biological priorities by helping maintain: - epithelial barrier integrity - tissue hydration - cellular resilience - connective tissue physiology Within FEMSTATE™, CeraLOK® is positioned as a **structural support ingredient,** reflecting the body’s regenerative priorities rather than cosmetic goals. # 5. Dose Justification ## Selected Dose: 0.6 mg glucosylceramides The selected dose was based upon five scientific criteria. ### Physiological Relevance CeraLOK® is a highly standardized ingredient with demonstrated biological activity at relatively low doses because the active glucosylceramide fraction is concentrated. The selected dose supports epithelial physiology while maintaining efficient formulation design. ### Human Clinical Evidence Human clinical trials evaluating plant-derived ceramides have commonly investigated doses between **0.6 mg and 3.5 mg/day**, depending on ingredient standardization. The selected dose corresponds to the clinically investigated range for CeraLOK®. ### Safety Plant-derived ceramides demonstrate excellent tolerability and are appropriate for long-term daily use. ### Formulation Compatibility The selected dose: - complements vitamin C - complements collagen-supportive physiology - complements vitamin A - complements zinc creating an integrated regenerative formulation. ### HR+ Philosophy Rice-derived ceramides demonstrate no endocrine activity and align fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Human clinical studies have investigated oral plant ceramides in relation to: - skin hydration - barrier function - transepidermal water loss - epidermal physiology The strongest evidence supports improvements in objective measures of skin barrier function. Although these studies primarily evaluate dermatological outcomes, they support ceramides' physiological role as structural lipids. # 7. Safety Considerations Plant-derived ceramides have an excellent safety profile. ### FEMSTATE Dose: 0.6 mg/day Human studies have safely evaluated substantially higher doses. Reported adverse effects are rare and generally limited to mild gastrointestinal discomfort. No serious adverse effects have been consistently reported. # 8. HR+ Safety Review CeraLOK® was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Rice-derived glucosylceramides function as structural lipids and have **no known hormonal activity**. # 9. Ingredient Interactions ### Positive Interactions **Vitamin C** Supports connective tissue physiology while ceramides support epithelial barrier integrity -> Strong structural synergy **Vitamin A** Supports epithelial differentiation -> Complementary epithelial physiology **Zinc** Supports tissue repair and epithelial regeneration -> Positive synergy **Collagen-supportive nutrients** Complement extracellular matrix biology -> Positive structural synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Magnesium - Selenium - Iron at FEMSTATE doses. ### Known Considerations Individuals with rice allergy should verify ingredient suitability, although purified glucosylceramide extracts generally contain minimal allergenic proteins. # 10. Regulatory Status CeraLOK® rice bran extract is: - Widely accepted for use in dietary supplements. - Supported by multiple randomized controlled trials. - Commonly used in nutritional products supporting skin barrier physiology. - Derived from food-grade rice bran. # 11. Evidence Gaps & Future Research Current evidence strongly supports plant ceramides for: - skin hydration - epithelial barrier function - transepidermal water loss Areas requiring additional investigation include: - Connective tissue regeneration during menstruation. - Epithelial biology beyond dermatological outcomes. - Clinical evaluation within phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated CeraLOK® within a phase-aligned nutritional formulation. # 12. Conclusion CeraLOK® rice-derived glucosylceramides were incorporated into **RESET™** because they support one of the central biological priorities of the menstrual phase: **epithelial regeneration and restoration of tissue integrity**. The selected dose of **0.6 mg** reflects clinically investigated amounts shown to improve skin barrier function and hydration while maintaining excellent long-term safety. Within the FEMSTATE™ platform, ceramides are positioned as **structural lipids **that complement connective tissue repair, extracellular matrix remodeling, and epithelial recovery during menstruation. Their inclusion broadens the concept of tissue regeneration beyond the endometrium to encompass whole-body epithelial physiology, reinforcing FEMSTATE's systems biology approach to phase-aligned nutrition. ## References - Nutrients. Systematic reviews on oral ceramides, skin barrier function, and human physiology. - Journal of Cosmetic Dermatology. Randomized controlled trials evaluating plant-derived ceramides and skin hydration. - International Journal of Molecular Sciences. Reviews on ceramide biology, epidermal barrier function, and lipid metabolism. - Experimental Dermatology. Reviews on ceramides and epidermal physiology. - Williams Textbook of Endocrinology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on tissue remodeling and epithelial physiology. # Ingredient Scientific Monograph # Inulin (Prebiotic Dietary Fiber) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Inulin **Chemical Name:** Fructan (β-2,1-linked Fructooligosaccharide) **Ingredient Form:** Chicory Root–Derived Inulin **Botanical Source:** Chicory Root **Ingredient Class:** Soluble Prebiotic Dietary Fiber **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 3 g | Inulin is included exclusively in **SOOTHE™ **because the luteal phase is characterized by **metabolic stabilization, gastrointestinal adaptation, neuroendocrine regulation, immune homeostasis, and preparation for the transition into the next menstrual cycle**. Inulin was selected because it is one of the most extensively studied prebiotic fibers, supporting the gut microbiota, production of short-chain fatty acids (SCFAs), intestinal barrier integrity, and the gut-brain axis. Within FEMSTATE™, inulin is included to support **normal gastrointestinal and metabolic physiology**, not as a laxative or digestive treatment. # 2. Physiological Role Inulin is a naturally occurring soluble dietary fiber that resists digestion in the upper gastrointestinal tract and is selectively fermented by beneficial gut microorganisms in the colon. This fermentation produces **short-chain fatty acids (SCFAs)** - primarily acetate, propionate, and butyrate - which contribute to gastrointestinal physiology, immune regulation, metabolic homeostasis, and gut barrier function.(1-5) Inulin contributes to: - Gut microbiome diversity - Short-chain fatty acid production - Intestinal barrier integrity - Gastrointestinal physiology - Immune homeostasis - Mineral absorption - Gut–brain communication - Metabolic regulation These biological functions align closely with the physiological priorities of the luteal phase. # 3. Mechanism of Action Inulin functions primarily as a **prebiotic substrate**. ### Prebiotic Fermentation Inulin -> Fermentation by beneficial bacteria -> Short-chain fatty acids -> Gut barrier support -> Immune homeostasis -> Metabolic regulation Unlike probiotics, inulin does **not** introduce microorganisms but provides nourishment for existing beneficial bacteria. ### Short-Chain Fatty Acid Production SCFAs contribute to: - maintenance of intestinal epithelial cells - regulation of immune signaling - maintenance of gut barrier integrity - metabolic physiology ### Gut-Brain Axis Emerging evidence suggests that alterations in gut microbial activity influence communication between the gastrointestinal tract and central nervous system through: - microbial metabolites - immune signaling - vagal pathways - endocrine mediators Although this field is rapidly evolving, these mechanisms provide a biological rationale for including a prebiotic during the neuroendocrine-focused SOOTHE™ phase. ### Mineral Absorption Inulin may modestly enhance absorption of certain minerals, particularly calcium and magnesium, through fermentation-related reductions in colonic pH. # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase emphasizes: - metabolic stability - gastrointestinal physiology - neuroendocrine regulation - immune homeostasis - physiological recovery During this phase, progesterone can influence gastrointestinal motility and digestive physiology. Inulin supports these biological priorities by: - maintaining gut microbiome activity - supporting gut barrier function - contributing to SCFA production - supporting metabolic homeostasis Importantly, FEMSTATE™ does **not** position inulin as a treatment for constipation, irritable bowel syndrome, or gastrointestinal disease. # 5. Dose Justification ## Selected Dose: 3 g The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **3 g/day** represents one of the most widely studied nutritional doses for prebiotic activity and consistently demonstrates measurable effects on the gut microbiota and SCFA production. ### Human Clinical Evidence Randomized controlled trials evaluating inulin have commonly investigated doses ranging from: 3-10 g/day The selected dose represents the **minimum effective dose** for consistent prebiotic activity while minimizing gastrointestinal intolerance. ### Safety Higher doses may increase bloating and gastrointestinal discomfort. The selected dose provides meaningful prebiotic activity while maintaining excellent tolerability. ### Formulation Compatibility The selected dose: - complements the probiotic blend - complements magnesium L-threonate - complements L-theanine - complements GABA creating an integrated gut–brain support system. ### HR+ Philosophy Inulin demonstrates no endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Inulin is among the most extensively studied prebiotic fibers. Strong evidence supports: - increased Bifidobacterium abundance - SCFA production - gut microbiome modulation - bowel regularity - gastrointestinal physiology Emerging evidence supports roles in: - metabolic physiology - gut–brain communication - immune regulation However, evidence specifically evaluating menstrual physiology remains limited. # 7. Safety Considerations Inulin has an excellent safety profile. ### FEMSTATE Dose: 3 g/day Human studies have safely evaluated doses exceeding: 10-20 g/day The most common adverse effects are dose-dependent and include: - bloating - flatulence - mild abdominal discomfort These symptoms occur more frequently at doses substantially higher than **3 g/day**. # 8. HR+ Safety Review Inulin was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Although the gut microbiome contributes to estrogen metabolism through the **estrobolome**, there is **no evidence that nutritional inulin supplementation directly increases circulating estrogen concentrations** in healthy women. # 9. Ingredient Interactions ### Positive Interactions **Probiotic Blend** Provides fermentable substrate supporting probiotic survival and activity -> Strong synbiotic synergy **Magnesium** May modestly enhance magnesium absorption through SCFA-mediated effects on the colon -> Positive synergy **Calcium** Supports physiological calcium absorption -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Selenium - Zinc - L-Theanine at FEMSTATE doses. ### Known Considerations Individuals with: - irritable bowel syndrome (IBS) - FODMAP sensitivity - severe gastrointestinal disorders may experience increased bloating when introducing prebiotic fibers. Gradual adaptation generally improves tolerance. # 10. Regulatory Status Inulin is: - Widely accepted for use in foods and dietary supplements. - Recognized as a dietary fiber. - Generally recognized as safe (GRAS) in the United States. - Supported by numerous international nutrition organizations as a prebiotic fiber. # 11. Evidence Gaps & Future Research Current evidence strongly supports inulin for: - gut microbiome modulation - prebiotic activity - gastrointestinal physiology - SCFA production Areas requiring further investigation include: - Gut microbiome dynamics across the menstrual cycle. - Gut-brain interactions during the luteal phase. - Clinical evaluation of synbiotic formulations within phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated **3 g/day** inulin within a phase-aligned nutritional formulation. # 12. Conclusion Inulin is a cornerstone prebiotic ingredient within **SOOTHE™** because it supports one of the most rapidly advancing areas of women's physiology: the interaction between the **gut microbiome, immune system, metabolism, and neuroendocrine function**. The selected dose of **3 g/day** represents one of the best-supported nutritional doses for promoting beneficial microbial fermentation while maintaining excellent gastrointestinal tolerability. Within the FEMSTATE™ platform, inulin is included not to treat gastrointestinal symptoms, but to support the normal gut physiology, microbial activity, and metabolic stability that characterize the progesterone-dominant luteal phase. Its robust human evidence, exceptional safety profile, and complete HR+ compatibility make it one of the strongest evidence-based prebiotic ingredients in the entire formulation. ## References - International Scientific Association for Probiotics and Prebiotics. Scientific Consensus Statement on Prebiotics. - Nature Reviews Gastroenterology & Hepatology. Reviews on prebiotics, gut microbiota, and human health. - Gut. Reviews on dietary fiber, SCFAs, and intestinal physiology. - Nutrients. Systematic reviews on inulin supplementation, gut microbiota, and metabolic health. - The American Journal of Clinical Nutrition. Reviews on prebiotic fibers, mineral absorption, and gastrointestinal physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on the gut microbiome, endocrine physiology, and women's health. - Williams Textbook of Endocrinology. # Ingredient Scientific Monograph # Inulin (Prebiotic Dietary Fiber) ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Inulin **Chemical Name:** Fructan (β-2,1-linked Fructooligosaccharide) **Ingredient Form:** Chicory Root–Derived Inulin **Botanical Source:** Chicory Root **Ingredient Class:** Soluble Prebiotic Dietary Fiber **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | - | | SOOTHE™ | 3 g | Inulin is included exclusively in **SOOTHE™** because the luteal phase is characterized by **metabolic stabilization, gastrointestinal adaptation, neuroendocrine regulation, immune homeostasis, and preparation for the transition into the next menstrual cycle**. Inulin was selected because it is one of the most extensively studied prebiotic fibers, supporting the gut microbiota, production of short-chain fatty acids (SCFAs), intestinal barrier integrity, and the gut-brain axis. Within FEMSTATE™, inulin is included to support **normal gastrointestinal and metabolic physiology,** not as a laxative or digestive treatment. # 2. Physiological Role Inulin is a naturally occurring soluble dietary fiber that resists digestion in the upper gastrointestinal tract and is selectively fermented by beneficial gut microorganisms in the colon. This fermentation produces **short-chain fatty acids (SCFAs)** - primarily acetate, propionate, and butyrate - which contribute to gastrointestinal physiology, immune regulation, metabolic homeostasis, and gut barrier function.(1-5) Inulin contributes to: - Gut microbiome diversity - Short-chain fatty acid production - Intestinal barrier integrity - Gastrointestinal physiology - Immune homeostasis - Mineral absorption - Gut–brain communication - Metabolic regulation These biological functions align closely with the physiological priorities of the luteal phase. # 3. Mechanism of Action Inulin functions primarily as a **prebiotic substrate.** ### Prebiotic Fermentation Inulin -> Fermentation by beneficial bacteria -> Short-chain fatty acids -> Gut barrier support -> Immune homeostasis -> Metabolic regulation Unlike probiotics, inulin does **not** introduce microorganisms but provides nourishment for existing beneficial bacteria. ### Short-Chain Fatty Acid Production SCFAs contribute to: - maintenance of intestinal epithelial cells - regulation of immune signaling - maintenance of gut barrier integrity - metabolic physiology ### Gut-Brain Axis Emerging evidence suggests that alterations in gut microbial activity influence communication between the gastrointestinal tract and central nervous system through: - microbial metabolites - immune signaling - vagal pathways - endocrine mediators Although this field is rapidly evolving, these mechanisms provide a biological rationale for including a prebiotic during the neuroendocrine-focused SOOTHE™ phase. ### Mineral Absorption Inulin may modestly enhance absorption of certain minerals, particularly calcium and magnesium, through fermentation-related reductions in colonic pH. # 4. Why Included in FEMSTATE™ ## SOOTHE™ The luteal phase emphasizes: - metabolic stability - gastrointestinal physiology - neuroendocrine regulation - immune homeostasis - physiological recovery During this phase, progesterone can influence gastrointestinal motility and digestive physiology. Inulin supports these biological priorities by: - maintaining gut microbiome activity - supporting gut barrier function - contributing to SCFA production - supporting metabolic homeostasis Importantly, FEMSTATE™ does **not** position inulin as a treatment for constipation, irritable bowel syndrome, or gastrointestinal disease. # 5. Dose Justification ## Selected Dose: 3 g The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **3 g/day** represents one of the most widely studied nutritional doses for prebiotic activity and consistently demonstrates measurable effects on the gut microbiota and SCFA production. ### Human Clinical Evidence Randomized controlled trials evaluating inulin have commonly investigated doses ranging from: 3–10 g/day The selected dose represents the **minimum effective dose** for consistent prebiotic activity while minimizing gastrointestinal intolerance. ### Safety Higher doses may increase bloating and gastrointestinal discomfort. The selected dose provides meaningful prebiotic activity while maintaining excellent tolerability. ### Formulation Compatibility The selected dose: - complements the probiotic blend - complements magnesium L-threonate - complements L-theanine - complements GABA creating an integrated gut–brain support system. ### HR+ Philosophy Inulin demonstrates no endocrine activity and aligns fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence Inulin is among the most extensively studied prebiotic fibers. Strong evidence supports: - increased Bifidobacterium abundance - SCFA production - gut microbiome modulation - bowel regularity - gastrointestinal physiology Emerging evidence supports roles in: - metabolic physiology - gut-brain communication - immune regulation However, evidence specifically evaluating menstrual physiology remains limited. # 7. Safety Considerations Inulin has an excellent safety profile. ### FEMSTATE Dose: 3 g/day Human studies have safely evaluated doses exceeding: 10-20 g/day The most common adverse effects are dose-dependent and include: - bloating - flatulence - mild abdominal discomfort These symptoms occur more frequently at doses substantially higher than **3 g/day**. # 8. HR+ Safety Review Inulin was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties ✔ Favorable endocrine safety profile Although the gut microbiome contributes to estrogen metabolism through the **estrobolome**, there is **no evidence that nutritional inulin supplementation directly increases circulating estrogen concentrations** in healthy women. # 9. Ingredient Interactions ### Positive Interactions **Probiotic Blend** Provides fermentable substrate supporting probiotic survival and activity -> Strong synbiotic synergy **Magnesium** May modestly enhance magnesium absorption through SCFA-mediated effects on the colon -> Positive synergy **Calcium** Supports physiological calcium absorption -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Vitamin D3 - Selenium - Zinc - L-Theanine at FEMSTATE doses. ### Known Considerations Individuals with: - irritable bowel syndrome (IBS) - FODMAP sensitivity - severe gastrointestinal disorders may experience increased bloating when introducing prebiotic fibers. Gradual adaptation generally improves tolerance. # 10. Regulatory Status Inulin is: - Widely accepted for use in foods and dietary supplements. - Recognized as a dietary fiber. - Generally recognized as safe (GRAS) in the United States. - Supported by numerous international nutrition organizations as a prebiotic fiber. # 11. Evidence Gaps & Future Research Current evidence strongly supports inulin for: - gut microbiome modulation - prebiotic activity - gastrointestinal physiology - SCFA production Areas requiring further investigation include: - Gut microbiome dynamics across the menstrual cycle. - Gut–brain interactions during the luteal phase. - Clinical evaluation of synbiotic formulations within phase-aligned nutritional systems such as FEMSTATE™. No randomized controlled trials have specifically evaluated **3 g/day** inulin within a phase-aligned nutritional formulation. # 12. Conclusion Inulin is a cornerstone prebiotic ingredient within **SOOTHE™** because it supports one of the most rapidly advancing areas of women's physiology: the interaction between the **gut microbiome, immune system, metabolism, and neuroendocrine function**. The selected dose of **3 g/day** represents one of the best-supported nutritional doses for promoting beneficial microbial fermentation while maintaining excellent gastrointestinal tolerability. Within the FEMSTATE™ platform, inulin is included not to treat gastrointestinal symptoms, but to support the normal gut physiology, microbial activity, and metabolic stability that characterize the progesterone-dominant luteal phase. Its robust human evidence, exceptional safety profile, and complete HR+ compatibility make it one of the strongest evidence-based prebiotic ingredients in the entire formulation. ## References - International Scientific Association for Probiotics and Prebiotics. Scientific Consensus Statement on Prebiotics. - Nature Reviews Gastroenterology & Hepatology. Reviews on prebiotics, gut microbiota, and human health. - Gut. Reviews on dietary fiber, SCFAs, and intestinal physiology. - Nutrients. Systematic reviews on inulin supplementation, gut microbiota, and metabolic health. - The American Journal of Clinical Nutrition. Reviews on prebiotic fibers, mineral absorption, and gastrointestinal physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on the gut microbiome, endocrine physiology, and women's health. - Williams Textbook of Endocrinology. # Ingredient Scientific Monograph # Probiotic Blend ## FEMSTATE™ Scientific Evidence Monograph # 1. Ingredient Overview **Common Name:** Probiotic Blend **Ingredient Type:** Multi-Strain Probiotic **Ingredient Form:** Freeze-Dried Probiotic Culture Blend **FEMSTATE™ Daily Dose** | Formula | Dose | | --- | --- | | RESET™ | - | | LIFT™ | - | | SHINE™ | 3 Billion CFU | | SOOTHE™ | - | **Note:** The final formulation should specify each probiotic strain (e.g., Lacticaseibacillus rhamnosus GG, Lactiplantibacillus plantarum, Bifidobacterium lactis, etc.), as scientific evidence is strain-specific. Until the final strain composition is confirmed, this assessment applies to a standardized multi-strain probiotic blend intended to provide approximately **3 billion colony-forming units (CFU).** The probiotic blend is included exclusively in **SHINE™** because ovulation is characterized by **heightened metabolic activity, immune coordination, epithelial remodeling, and increased interaction between reproductive physiology and the gastrointestinal microbiome**. The formulation supports normal gut microbial balance, intestinal barrier integrity, immune homeostasis, and gut–brain communication during one of the most physiologically active phases of the menstrual cycle. # 2. Physiological Role The human gastrointestinal tract contains trillions of microorganisms collectively known as the **gut microbiome**. These microorganisms contribute to digestion, vitamin synthesis, immune regulation, intestinal barrier maintenance, production of short-chain fatty acids (SCFAs), and communication with endocrine and nervous systems.(1-4) Certain probiotic strains contribute to: - Maintenance of microbial diversity - Intestinal barrier integrity - Immune homeostasis - Gut–brain communication - Production of beneficial metabolites - Gastrointestinal physiology - Metabolic homeostasis The gut microbiome also participates in the metabolism of steroid hormones through microbial enzymes collectively referred to as the **estrobolome**, although the clinical implications of nutritional modulation remain under investigation. # 3. Mechanism of Action Probiotics function through several complementary mechanisms. ### Gut Microbiome Support Beneficial microorganisms -> Colonization resistance -> Microbial diversity -> Maintenance of gastrointestinal homeostasis -> Immune regulation ### Intestinal Barrier Function Certain probiotic strains support: - tight junction integrity - mucosal barrier function - epithelial health This contributes to maintenance of normal gastrointestinal physiology. ### Immune Homeostasis Probiotic organisms interact with gut-associated lymphoid tissue (GALT), contributing to: - cytokine regulation - dendritic cell function - regulatory T-cell activity - maintenance of immune homeostasis Importantly, probiotics support **immune regulation**, not generalized immune stimulation. ### Gut–Brain Axis Emerging evidence suggests selected probiotic strains influence communication between the gut and central nervous system through: - microbial metabolites - vagal pathways - immune mediators - neuroendocrine signaling Although this area remains under active investigation, it provides biological rationale for integrating probiotics into the SHINE™ formulation. # 4. Why Included in FEMSTATE™ ## SHINE™ The ovulatory phase is characterized by: - increased metabolic activity - tissue remodeling - immune coordination - endothelial adaptation - physiological oxidative metabolism The probiotic blend supports these biological priorities through: - maintenance of gut barrier integrity - immune homeostasis - microbiome diversity - gut–brain communication - metabolic regulation Rather than targeting digestive symptoms, probiotics were selected to support systemic physiology during this metabolically active endocrine transition. # 5. Dose Justification ## Selected Dose: 3 Billion CFU The selected dose was based upon five scientific criteria. ### Physiological Relevance A dose of **3 billion CFU/day** provides clinically meaningful microbial exposure while maintaining excellent formulation stability and long-term tolerability. ### Human Clinical Evidence Most randomized controlled trials evaluating probiotics have investigated doses ranging from: 1–10 billion CFU/day The selected dose of **3 billion CFU** falls comfortably within this evidence-supported range. ### Safety This dose demonstrates excellent safety in healthy adults. ### Formulation Compatibility The selected dose: - complements inulin (future synbiotic opportunities) - complements antioxidant physiology - supports immune homeostasis - maintains formulation stability ### HR+ Philosophy Probiotics demonstrate no endocrine activity and align fully with the HR+-conscious formulation philosophy. # 6. Human Clinical Evidence **Important Scientific Consideration: **Unlike vitamins and minerals, **probiotic evidence is strain-specific**.** **Scientific conclusions cannot be generalized across all probiotics. For this reason, the final FEMSTATE™ dossier should ultimately cite evidence for each individual strain included in the formulation. Current evidence supports selected probiotic strains for: - gut microbiome modulation - gastrointestinal physiology - immune homeostasis - gut barrier integrity Evidence for reproductive physiology remains emerging. # 7. Safety Considerations Probiotics demonstrate an excellent safety profile in healthy adults. ### FEMSTATE Dose: 3 Billion CFU/day Clinical studies have safely evaluated substantially higher doses. Reported adverse effects are generally mild: - transient bloating - mild gas - temporary changes in bowel habits Serious adverse events are extremely rare and primarily occur in severely immunocompromised individuals or those with central venous catheters. # 8. HR+ Safety Review The probiotic blend was independently evaluated using the FEMSTATE™ HR+ Scientific Review Framework. The literature was reviewed for: - estrogen receptor activity - progesterone receptor activity - aromatase modulation - endocrine disruption - oncology safety ### Findings Current evidence demonstrates: ✔ No direct estrogen receptor agonist activity ✔ No progesterone receptor activity ✔ No aromatase stimulation ✔ No phytoestrogen properties Although the intestinal microbiome participates in estrogen metabolism through the estrobolome, there is **no evidence that nutritional probiotic supplementation at this dose directly increases circulating estrogen concentrations** in healthy women. # 9. Ingredient Interactions ### Positive Interactions **Inulin** Provides fermentable substrate supporting probiotic growth -> Strong synbiotic synergy **Polyphenols (Quercetin, Resveratrol)** Gut microbes metabolize dietary polyphenols into biologically active metabolites -> Positive synergy **Vitamin D3** Supports complementary immune homeostasis -> Positive synergy ### Neutral Interactions No clinically meaningful antagonistic interactions with: - Magnesium - Selenium - Zinc at FEMSTATE doses. ### Known Considerations Individuals with severe immunodeficiency or critical illness should consult a healthcare professional before probiotic supplementation. The final formulation should identify each probiotic strain because safety and efficacy are strain-specific. # 10. Regulatory Status Probiotic blends are: - Widely accepted for use in dietary supplements. - Supported by numerous randomized controlled trials. - Addressed in scientific consensus statements from the International Scientific Association for Probiotics and Prebiotics. - Commonly used in nutritional products supporting gastrointestinal and immune physiology. # 11. Evidence Gaps & Future Research Current evidence strongly supports selected probiotic strains for: - gut microbiome modulation - gastrointestinal physiology - immune homeostasis Areas requiring further investigation include: - Microbiome changes across menstrual phases. - Gut–ovary interactions during ovulation. - Phase-specific probiotic requirements. - Clinical evaluation within comprehensive phase-aligned nutritional systems such as FEMSTATE™. Future versions of this monograph should incorporate **strain-specific evidence** once the final probiotic composition is confirmed. # 12. Conclusion The probiotic blend incorporated into **SHINE™** supports one of the most important emerging concepts in women's physiology: the interaction between the **gut microbiome, immune system, metabolism, and reproductive biology**. The selected dose of **3 billion CFU** provides clinically relevant microbial exposure while maintaining excellent tolerability and formulation stability. Rather than targeting gastrointestinal symptoms, the probiotic blend is included to support gut barrier integrity, immune homeostasis, and systemic physiology during the ovulatory phase. Because probiotic efficacy is inherently **strain-specific**, the final FEMSTATE™ scientific dossier should identify each strain and provide individual evidence summaries. Nevertheless, the current evidence strongly supports the biological rationale for incorporating a carefully selected probiotic blend into the SHINE™ formulation as part of the broader systems biology approach underlying the FEMSTATE™ platform. ## References - International Scientific Association for Probiotics and Prebiotics. Consensus Statement on Probiotics and Prebiotics. - Nature Reviews Gastroenterology & Hepatology. Reviews on probiotics, the gut microbiome, and human physiology. - Gut. Reviews on gut microbiota, barrier function, and immune regulation. - Nutrients. Systematic reviews on probiotic supplementation and human health. - The Lancet Gastroenterology & Hepatology. Reviews on probiotics and gastrointestinal physiology. - The Journal of Clinical Endocrinology & Metabolism. Reviews on the estrobolome, gut microbiome, and endocrine physiology. - Williams Textbook of Endocrinology.